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Abstract
Human disease due to food-borne pathogens remains a medical problem worldwide. 
Campylobacter jejuni is the most common cause of bacterial food-borne diarrhoeal 
disease, but the mechanisms by which it causes disease remain unclear. This 
bacterium is also the most common antecedent to the peripheral neuropathies 
Guillain-Barré syndrome (GBS) and Miller-Fisher syndrome (MFS).
The main aim of this project was to compare cytotoxicity of isolates of C. jejuni 
towards mammalian cells in culture, to purify any cytotoxic activity and to compare 
strains by plasmid and proteomic analysis.
Using the API Campy identification kit, 37 of the 39 strains were identified as C. 
jejuni jejuni serotype 1 or 2 with identification (ID) scores > 98.3%; and two strains 
were identified as C. jejuni jejuni 1 with ID scores of 88.3%. GGT (Gamma 
Glutamyl Transferase) test was the most important test to differentiate between C. 
jejuni jejuni 1 and 2 which showed negative and positive results, respectively.
The cytotoxic activity against Vero and Caco-2 cells of some of the typed strains of 
C. jejuni was tested. Cytotoxic activity was clearly demonstrated using Vero and 
Caco-2 cells and these activities peaked after incubation of the cell culture with 
sample for 16h. Comparison of wild-type strains 81-176 and 11168 with mutants of 
these strains lacking cytolethal distending toxin (CDT) or putative haemolysin or 
phospholipase toxins indicated that the toxicity observed was not due to any of these 
proteins, as cytotoxicity was unaffected by their absence. Some isolates (e.g. COL 12) 
showed low cytotoxicity while others, especially C. jejuni 81-176, consistently
XIX
produced high cytotoxin activity which was heat-labile and lethal to tissue culture 
cells. Cytotoxicity comparisons of inner and outer membrane preparations with a 
cytoplasmic fraction of C. jejuni strain 81-176 and COL 12 indicated that greatest 
activity was found in the inner membrane fraction. Proteins in the membrane 
preparation could not be easily fractionated and cell-free extracts of strains with low 
(COL12) and high (81-176) cytotoxic effects were chosen for further purification and 
characterisation studies. Although some differences were detected after DEAE- 
Sepharose fractionation and two-dimensional electrophoretic (2-DE) separation of 
proteins, no individual proteins could be clearly related to cytotoxicity. However, 
proteomic analysis did reveal some interesting properties of the C. jejuni strains. Of 
the proteins characterised by mass spectrometry after 2-DE, oxidoreductases were 
the most frequently identified in the virulent strain 81-176, but not in the type strain 
11168.
There was no apparent correlation between toxin production and clinical symptoms 
in patients from whom the strains were isolated. The study indicated that not all C. 
jejuni strains tested produced cytotoxin (s), but that cytotoxin producers seemed to be 
predominantly human strains.
The presence of virB ll and tetO genes carried by plasmids was examined by PCR in 
the 39 C. jejuni isolates together with strains 81-176 and NCTC 11168. Detection 
rates for the virB ll and tetO genes in the clinical isolates were 28.2% and 12.82%, 
respectively.
XX
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Chapter one 
Introduction
Introduction
CHAPTER 1: INTRODUCTION
Since the 1970s, Campylobacter jejuni and related species have been known to be 
causative agents of human enterocolitis (Butzler et a t, 1973; Dekeyser et a t, 1972; 
Skin'ow, 1977). The most common cause of bacterial diarrhoea in many 
industrialized countries is C. jejuni infection, which is consequently responsible for a 
major public health and economic burden (ACMSF, 1993; Tauxe, 1992), although, 
the level of public awareness remains limited. Since 1981, in England and Wales, the 
number of laboratory reports of intestinal infection due to Campylobacter spp. has 
been greater than those due to other enteric pathogens, including the more news­
worthy Salmonella. The incidence is also rising and this probably reflects both a 
change in eating patterns, e.g., an increase in the popularity and consumption of 
chicken, and an increased awareness of Campylobacter enteritis by the public health 
services.
The peak isolation rate of Campylobacter spp. in England and Wales is in babies <4 
months of age with a second major peak in young adults. Below the age of 45 years, 
there is an as yet unexplained but consistently higher incidence of Campylobacter 
infection in males than in females; after 45 years the rates become similar (Ketley, 
1997). The consumption of undercooked poultry and cross-contamination of other 
foods with uncooked meat products are leading risk factors for campylobacteriosis in 
humans. Reinforcing hygienic practices in the food chain, from producer to 
consumer, is critical in preventing the disease (Fields & Swerdlow, 1999). In spite of 
Campylobacter’s importance, effective control of this organism in the food chain and 
the design of disease prevention strategies are hindered by a poor understanding of 
the physiology, virulence and genetics of this organism (Parkhill et a t, 2000).
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1.1 Classification of C, Jejuni
There has been considerable confusion in the naming of the genus, species and sub­
species within this bacterial group of spiral organisms because of the relatively few 
phenotypic analyses to distinguish them. Some organisms previously known as 
Campylobacter have been placed in the genera Helicobacter or Arcobacter, since the 
9th edition of Bergey’s manual (AIFST, 1997).
Bacterial classification prior to 1963 was predominantly based on growth 
requirements, cell morphology and immunological and biochemical tests (On, 2005). 
Sebald and Veron (1963) addressed the confused taxonomy of Vibrio, and applied 
Hugh and Leifson’s oxidation fermentation test for fermentative metabolism and the 
G + C ratio in genomic DNA to show that V. fetus and V. bubulus were notably 
different from other Vibrio species. Therefore a new genus -Campylobacter- was 
proposed to include these taxa. The other microaerobic and/or anaerobic 'Vibrio’ 
taxa (in addition to 'V. faecalis’ (Firehammer, 1965)) were reclassified as 
Campylobacter spp. in a more comprehensive taxonomic study which used various 
serological and biochemical tests, and the G + C ratio in DNA (On, 2005). The most 
dramatic changes in taxonomy of Campylobacter took place over the next two 
decades following the seminal study of Veron and Chatelain (1973).
According to Bergey’s Manual of Systematic Bacteriology (Brenner et a l, 2005), 
the families of Campylobacteraceae and Helicobacteraceae are classified in the 
order Campylobacterales. Three genera, Campylobacter, Arcobacter and 
Sulfurospirillum, are grouped into the family Campylobacteraceae, and the genera 
Helicobacter, Thiovulum and Wolinella belong to the family Helicobacteraceae.
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Some characteristic features of the genera Campylobacter, Helicobacter and 
Arcobacter aie shown in Table 1.1.
The genus Campylobacter contains 16 species (three may be divided into defined 
subspecies), six subspecies and several validly named biovars (On, 2005). 
Distinguishing characteristics are given in Table 1.2 and phylogenetic relationships 
inferred by comparisons of 16S rRNA gene sequences are shown in Fig 1.1. 
Although Campylobacter includes 16 species, only C. jejuni and C. coli are of major 
importance in human medicine. Other species, such as C. upsaliensis and C. lari (C. 
laridis), have been isolated from patients with diarrhoea, but they are much less 
common and of unproven pathogenicity.
C..jejuni includes two subspecies {C. jejuni subsp. jejuni and C. jejuni subsp. doylei) 
which differ substantially in their distribution and to some extent ecology (On, 
2005). C. jejuni subsp. jejuni is often simply referred to as C. jejuni and represents 
the taxon first described by Jones et al. (1931) as 'Vibrio jejunV from bovine 
intestine. Since the 1970s, C. jejuni has been widely known as the most commonly 
isolated bacterial cause of human gasteroentritis the world over (Skirrow, 1994). A 
wide range of other complications including neuropathic disorders and septicaemia 
may also occur (Skirrow & Blaser, 2000). C. jejuni subsp. jejuni usually occurs as a 
commensal in a wide range of animals including chickens, cattle, sheeps, dogs, and 
ostriches (Skirrow, 1994); its prevalence in food animals make it one of the most 
important food-borne pathogens today (On, 2005).
C. jejuni subsp. doylei (Steele & Owen, 1988) has been found in cases of gastritis, 
enteritis and septicaemia (Lastovica & Skirrow, 2000). No animal host has been 
found for this species (On, 2005). Also, this organism fails to grow at 42°C or reduce
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Figure 1.1: Phylogeny of Campylobacter species and related bacteria as inferred 
by comparison of 16S rRNA gene sequences.
All of the species shown are, or have previously been described as, a Campylobacter. 
The scale bar indicates 0-25% sequence dissimilarity (On, 2005).
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nitrate, characteristics that were instrumental in its initial recognition as a distinct 
subspecies (Steele et al., 1985).
The majority of human infections are due to thermophilic Campylobacters, 
principally C. jejuni subsp. jejuni, C. coli and C. lari (Tauxe, 1992). C. jejuni 
accounts for approximately 90% of Campylobacter infections, and C. coli for most of 
the remainder (Gillespie et al., 2002). C. jejuni and C. coli are closely related 
bacterial species which cause gasteroenteritis worldwide (Dingle et a l,  2005). Other 
species of campylobacteria may also be human pathogens (Edmonds et a l, 1987; 
Fennell et a l, 1986; Hsueh et a l, 1997; Lerner et a l, 1994; Lindblom et a l, 1995; 
Mishu et a l, 1992; On et a l, 1995; Tee et a l, 1988; Vandamme et a l, 1992).
1.2 Characterisation of C  jejuni
c. jejuni is a Gram-negative, s-shaped rod (0.2-0.8 pm wide and 0.5-5 pm long), non 
spore-forming, catalase, oxidase and hippurate hydrolysis positive, non saccharolytic 
(Griffiths & Park, 1990; Ottosson & Stenstrom, 2003; Vandamme, 2000), motile 
with a characteristic corkscrew-like motion via an unsheated flagellum at one or 
both poles (Fig. 1.2) and occurs as a commensal in waim-blooded animals, especially 
poultry (Fields & Swerdlow, 1999; Song et a l, 2004). C. jejuni may have one or 
more spirals and two rods forming a short chain often appear in a characteristic S or 
gull-winged shape. C. jejuni is exceptionally sensitive to oxygen and superoxides, 
yet for growth some oxygen is essential. A strictly microaerophilic environment must 
be provided for in vitro cultivation, because they are microaerophilic (require 
decreased O2) and capnophilic (require increased CO2). 42-43 °C is the best
Figure 1.2; Normal morphological appearance of C. jejuni.
Image was taken from: http://www.sanger.ac.uk/Projects/C_jejuni/
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temperature for growth (Koneman et a l, 1994). It is sensitive to nalidixic acid and 
resistant to cephalothin. C. jejuni is non-fermentative and non-oxidative in its 
metabolism and derives energy from the consumption of amino acids and four and 
six carbon Krebs cycle intermediates.
C. jejuni strain 11168 has a circular chromosome of 1,641,481 base pairs (bp) 
(30.6% G+C) which is predicted to encode 1,654 proteins and 54 stable RNA species 
(Parkhill et al., 2000). The genome contains two large regions of lower G+C content 
that encompass CDSs (CoDing Sequences) C jll35-C jll48  (25.4%) and Cjl421- 
CJ1442 (26.5%); these correspond to genes within the lipooligosaccharide (LOS) and 
extracellular polysaccharide (EP) biosynthesis clusters, respectively. Functional 
information, including matches to genes of known function or informative 
hydrophobicity profiles, could be deduced for 77.8% of the 1,654 CDSs, whereas 
13.5% CDSs matched genes of unknown function in the database and 8.7% had no 
database match (Parkhill et a l, 2000).
1.3 Clinical aspects
C. jejuni is the most important human pathogen among the Campylobacters. This 
bacterium has worldwide distribution, being recovered from 4% to 35% of faecal 
specimens of patients with acute diarrhoea. In many practice settings, the rate of 
recovery of C. jejuni exceeds the combined recovery of the enteric pathogens 
Salmonella and Shigella species. It is also ubiquitous in domestic animals, house pets 
and the vast majority of chickens and waterfowl are colonized (Koneman et a l, 
1994). Ingestion of raw milk, partially cooked poultry, or contaminated water are the 
usual sources for human infections (Koneman et a l, 1994). The incidence of 
Campylobacter infection, as derived from laboratory isolations, is almost certainly a
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significant underestimate of the true rate of campylobacteriosis in the general 
population. This situation reflects under-reporting due to the fact that not all 
diagnostic laboratories routinely screen and not all physicians request stool cultures 
for Campylobacter spp. (Ketley, 1997).
The clinical spectrum of enteric disease due to C. jejuni ranges from a severe 
inflammatory diarrhoea to generally mild, non-inflammatory, watery diarrhoea 
(Butzler & Skirrow, 1979; Walker et a l, 1986). C. jejuni infection that results in 
inflammatory disease usually begins, in about 50% of patients, with a characteristic 
acute abdominal pain that is often associates with general malaise and fever, before 
the symptoms progress to include a profuse diarrhoea that becomes watery. The 
diarrhoeal stool often contains mucus, fresh blood and an inflammatory exudate with 
leucocytes (Ketley, 1997). Bacteraemia was observed among a small proportion of 
patients with the inflammatory condition (Blaser et a l, 1986; Mandai, 1984) 
especially in the early stages of infection. It is probably more common than 
suspected, but is rarely reported because of infrequent sampling and inappropriate 
culture conditions. The incubation period prior to the appearance of symptoms 
usually ranges from 1 to 7 days, although determination of the exact timing and 
source of infection is often difficult. The acute diarrhoea commonly lasts for 2-3 
days but discomfort and abdominal pain persist sometime after the diarrhoea stops. 
Mucosal changes are usually revealed, ranging from hyperaemia with petechial 
haemorrhages and oedema to mucosal liability observed by sigmoidoscopy. 
Inflammation of some areas of the ileum and jejunum with mesenteric adenitis is 
usually seen in the infection. C. jejuni may be isolated from patients for several 
weeks after the clinical symptoms. Although Campylobacter infection can cause a 
severe illness lasting more than a week, it is usually self-limiting and complications
10
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are uncommon (SkiiTow & Blaser, 1992). Diarrhoeal and enteritis syndromes remain 
the most common manifestation of Campylobacter infection, although meningitis, 
septic arthritis and proctocolitis secondary to C. jejuni have been reported (Quinn et 
ah, 1984).
The manifestations of disease are different geographically. In developed countries, in 
the young adult population the infection is characterised by an inflammatory process 
(Blaser et a l, 1983b; Blaser et a l, 1979) and in developing countries, in the first two 
years of life most cases are likely to present with a profuse watery diarrhoea (Blaser 
et a l, 1983a; Glass et a l, 1983). The emergence of antimicrobial-resistance in 
general and, in particular, of fluoroquinolone-resistant C. jejuni infections in the 
United States and Europe, associated with the use of fluoroquinolones in veterinary 
medicine, is an important public health concern (Fields & Swerdlow, 1999). 
Gasteroenteritis by C. jejuni is primarily self-limiting and is usually treated by 
supportive therapy (fluid and electrolyte replacement) (Skirrow & Blaser, 2000). The 
drug of choice for treating severe clinical infection due to C. jejuni is erythromycin 
(Nachamkin et a l, 2000) and the prevelence of resistance to this dmg has remained 
low (Nachamkin et a l, 2002).
1.4 Epidemiology
Human disease due to food-borne pathogens remains a medical problem worldwide 
(Schlundt et a l, 2004). Infections caused by ingestion of C. jejuni are one of the 
main sources of severe gasteroentritis in humans and also there is recent evidence 
that infection by this microorganism may be linked to neurobiological disorders such 
as Guillain-Barré syndrome (GBS). C. jejuni survives in a wide range of 
environments, including water, milk, and meat products. Under some conditions the
11
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bacteria are exposed to a variety of stresses which they must be able to tolerate in 
order to permit their transmission to host environments suitable for growth. The 
association of Campylobacter with poultry (e.g. chickens, turkeys, ducks, and geese) 
as reservoirs has been known for over 30 years (Smith & Muldoon, 1974; 
Winkenwerder, 1967). Contamination of poultry meat by C. jejuni during processing 
has been reported (Berrang et a l, 2001; Chuma et a l, 1997; Chuma et a l, 1994; 
Hartnett et a l, 2001; Kazwala et a l, 1990). In recent years, the number of 
documented human food-borne outbreaks from raw fruits, vegetables and 
unpasteurized fruit juices has increased (Buck et a l, 2003). C. jejuni has been 
isolated from green onions, potato, mushroom, pepper, lettuce, spinach and parsley 
(Buck et a l, 2003).
C. jejuni is a food-borne pathogen, thus resistance to physiological stresses in water 
and food are important for successful transmission and production of infection and, 
therefore, it is possible that Campylobacters can enter a viable non-culturable (VNC) 
state and this may have a great significance (Jones et a l, 1991; Ketley, 1997; Rollins 
& Colwell, 1986). C. jejuni is unable to multiply at temperatures below 30°C, and is 
sensitive to various environmental stresses, including light, oxygen, heat, drying, 
high salt concentrations, and low pH values (Pai'k, 2002).
There are more than 60,000 notified cases of campylobacteriosis per annum in the 
United Kingdom (Fig. 1.3) of which 90% are caused by C. jejuni. A  peak incidence 
of disease is seen in children under one year old and in young adults in developed
12
Figure 1.3:
A- United Kingdom laboratory confirmed cases of gastrointestinal infections 
between the years 1992-2001
B- Seasonal incidence of confirmed cases of E. coli. Salmonella and 
Campylobacter in England and Wales (average of 1996-1998) (Jones, 2001)
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countries (Blaser et a l, 1983b; MacDonald et a l, 1988; Tauxe, 1992). In developing 
countries, where the organisms are endemic, disease occurs in young children and 
persistent carriage occurs in adults without symptomatic disease (Calva et a l, 1988; 
Taylor et a l, 1988). This indicates that a high level of endemic disease causes the 
development of specific immune responses and less severe disease (Blaser et a l, 
1986; Blaser et a l, 1985; Glass et a l, 1983). Following exposure, although 
recolonisation may occur, specific serum and secretory antibodies provide strain- 
specific immunity and protection against disease due to the homologus strain (Black 
e ta l ,  1985; Black ef a/., 1988).
1.5 Pathogenesis
Although C. jejuni was the first enteropathogen to have its complete genome 
sequence published (Parkhill et a l, 2000), the mechanisms by which it causes 
disease remain unclear. Several mechanisms may be involved in pathogenesis of 
infection (Smith, 1996). Possible virulence-associated factors are adherence, 
invasion, production of cytotoxins (Datta et a l, 2003) and motility (Florin & 
Antilion, 1992; Wassenaar, 1997). To cause gasteroenteritis, C. jejuni must adhere 
to, invade and destroy host cells; thus they must produce adhesion and invasion 
factors and toxins (Smith, 1996). van Vliet & Ketley (2001) indicated that when 
colonizing the intestines, Campylobacters are predicted to express several virulence 
factors include motility and chemotaxis, adhesion and invasion, secretion of toxins 
and lipopolysaccharide (LPS), iron acquisition, oxidative stress defence, and heat 
shock response which are summerized in Fig. 1.4. Recently, some genes have been
14
Figure 1.4: The different stages of Campylobacter invasion of the intestine.
1, motility
2, chemotaxis
3, oxidative stress defence
4, adhesion
5, invasion
6, toxin production
7, iron acquisition
8, temperature stress response
9, coccoid dormant stage
^  , viable Campylobacter cell
, coccoid dormant Campylobacter cell 
, epithelial cell
Diagram was taken from van Vliet & Ketley (2001).
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implicated in C. jejuni pathogenicity: flaA  (Nuijten et a l, 2000), dnaJ (Ziprin et a l,
2001), cadF (Ziprin et a l, 2001), and racR (Bras et a l, 1999), for the expression of 
adherence and colonization, virB ll (Bacon et a l, 2000), pldA (Ziprin et a l, 2001) 
and ciaB (Konkel et a l, 1999a; Rivera-Amill et a l, 2001) for the expression of 
invasion, wlaN (Linton et a l, 2000b) for the expression of Guillain-Barré syndrome 
and cdtA, cdtB and cdtC as genes responsible for the expression of cytolethal 
distending toxin (Lara-Tejero & Galan, 2001; Purdy et a l, 2000).
1.5.1 Motility and chemotaxis
C  jejuni requires motility and chemotaxis to colonize the intestinal tracts of humans 
and animals (Black et a l, 1988; Pavlovskis et a l, 1991) and for invasion in vitro 
(Grant et a l, 1993; Wassenaar et a l, 1991; Yao et a l, 1994). Campylobacters enter 
the stomach by the host consuming food or water, surviving the acid barrier, and then 
colonising the distal ileum and colon. This stage needs the production of the 
flagellum which is the best characterised virulence determinant of Campylobacter 
spp. Experiments with genetically undefined mutants of C. jejuni showed that this 
virulence determinant was required for adhesion and colonisation in a range of 
animals (Aguero-Rosenfeld et a l, 1990; Caldwell et a l, 1985; McSweegan & 
Walker, 1986; Morooka et a l, 1985; Newell et a l, 1985). The flagellin gene was 
cloned and characterised in C. jejuni and C. coli strains (Guerry et a l, 1992; Nuijten 
et a l, 1992). The locus consists of two g e n e s : m dflaB , which encode proteins 
with predicted molecular weights of 59.5 and 59.9 kDa, respectively. It was shown in 
a genetic study that flaA  and not flaB  is essential for colonization (Nachamkin et a l, 
1993; Wassenaai- et a l, 1991). Experiments with defined mutants showed that flaA  
was not required for adhesion but was essential for the invasion and transcytosis of
16
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intestinal epithelial cells (Grant et a l, 1993; Wassenaar et a l, 1991) and the 
flagellum was necessary for the colonisation of chicks (Nachamkin et a l, 1993; 
Wassenaar et a l, 1993). Due to the unusual ability of C. jejuni to remain highly 
motile in mucus, it has been suggested that adhesion to host cells may not actually be 
necessary as the C. jejuni cell is able to remain in the intestine by colonising the 
mucus blanket overlying the epithelium successfully. C. jejuni transcytose through 
the host cell (Everest et a l, 1992; Harvey et a l, 1999; Konkel et a l, 1992b), to 
emerge on the basolateral surface, allowing access to the lamina properia 
(MacCallum et a l, 2005a). Influx of neutrophils occurs at the site of bacterial 
invasion (basolateral surface) through interleukin-8 (IL8) release (Hickey et a l, 
1999; 2000) from infected cells (enterocytes) by activation of NF-kB (Mellits et a l,
2002). Secretion of cytokines and other mediators are involved in this natural 
immune response leading to an inflammatory response (MacCallum et a l, 2005a).
It is possible that the flagella structure may secrete virulence determinants in the 
absence of another type III secretion system (Pai’khill et a l, 2000; Rivera-Amill et 
a l, 2001).
1.5,2 Cell adherence and invasion
Humans are infected by C. jejuni, like other human enteric bacterial pathogens, by 
colonisation of the mucosal layer of the intestine followed by adherence and invasion 
of epithelial cells (Everest et a l, 1992; Harvey et a l, 1999; Ketley, 1997; Konkel et 
a l, 1992b; Konkel et a l, 2001; Kopecko et a l, 2001).
Up until recently, few of the determinants involved in pathogenesis were well 
characterized and some of them were rather controversial (Ketley, 1997). In
17
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volunteer studies, infection has been established by ingestion of as few as 500 
bacteria. The first sites to become colonized are the jejunum and ileum, although the 
infection extends distally to affect the terminal ileum and usually the colon and 
rectum. It has been suggested that ability to bind to epithelial or to other cells is an 
essential step to produce disease by C. jejuni as well as for a number of other 
intestinal bacterial pathogens. After colonization of the mucus membrane and 
adhesion to intestinal cell surfaces, the bacteria affect the normal absorptive capacity 
of the intestine by damaging epithelial cell function directly or indirectly, directly by 
cell invasion or the production of toxin(s), and indirectly pursuing the initiation of an 
inflammatory response. These are possible mechanisms that are not equally 
exclusive, and any combination may have a role depending on characteristics of the 
infecting strain and the host condition (Ketley, 1997).
C. jejuni is certainly able to adhere to tissue culture cells without subsequent 
invasion (Everest et a l, 1992), although it can be assumed that adhesion to the 
epithelial cell surface is essential for subsequent invasion of the cell. Although the 
production of fimbriae by Campylobacters has not been observed, a number of 
proteins such as outer-membrane proteins (DeMelo & Pechere, 1990; Fauchere et a l, 
1992; Kervella et a l, 1993), LPS (McSweegan & Walker, 1986) and a protein 
known as PEBl (Pei & Blaser, 1993) have been suggested as potential bacterial 
adhesins to bind eukaryotic cells; however, the specific role of these proteins in the 
binding capacity to host cells of Campylobacter is unknown. PEBl was shown to 
bind to cells and the gene encoding this potential adhesin has been cloned (Pei & 
Blaser, 1993). The predicted protein has homology to amino-acid transporter systems 
of other bacteria. It is not clear whether the cell binding of PEBl is an artifact or
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whether the protein may have the dual function of both amino-acid transport and 
intestinal cell binding (Ketley, 1995).
The only protein that has been shown to be involved in facilitating the binding of 
Campylobacter to fibronectin is CadF {Campylobacter adhesin to fibronectin), 
which aids in the binding of C. jejuni and C. coli to intestinal epithelial cells (Konkel 
et a l, 1999b). The involvement of the cadF gene product in Campylobacter 
colonization has been shown by in vivo colonization using a chicken model (Ziprin et 
a l,  1999).
The importance of host cell invasion in pathogenic mechanisms of Campylobacter 
were strongly suggested by inflammation and occasional bacteraemia (Ketley, 1995). 
Invasion of host cells in both experimentally-infected infant macaque monkeys 
(Russell et a l, 1993) and in the colon of patients (van Spreeuwel et a l, 1985) has 
been observed.
Caco-2 cells (human colonic carcinoma line) which differentiate to form polarised 
enterocyte-like microvilliated monolayers, have been used to study adhesion and 
invasion of C. jejuni (Everest et a l, 1992). Caco-2 cells have similar properties to 
colonic enterocytes, as they possess brush borders with microvilli and maintain tight 
junctions, therefore they exibit the properties of a polarized cell line (Delie & Rubas, 
1997). Two clinical groups of patients with either watery (non-inflammatory) 
diarrhoea or colitis were sources of the C. jejuni strains tested (Ketley, 1995). 
Although the strains adhered to Caco-2 cells, there was a significant correlation 
between the inability to invade the cells and isolation of the C. jejuni strain from 
patients with non-inflammatory disease. However, some strains classified as “non­
inflammatory” were able to invade Caco-2 cells. These strains may have been
19
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isolated from patients suffering from colitis but inflammatory cells were missed or 
absent in the stool at the time of diagnosis. Alternatively, progress of Campylobacter 
infection is critically influenced by host factors like a strong immune response. The 
range of symptoms in patients may be to some extent a reflection of strain 
differences which was suggested by isolation of non-invasive strains from patients 
with non-inflammatory diarrhoea. In addition, a role for invasion in pathogenesis is 
supported by a conelation between the ability to invade the cells and to cause colitis 
(Ketley, 1995).
Caco-2 cells have been used as a model of intestinal epithelium for other studies on 
the interaction of C. jejuni with host cells (Everest et a l, 1992; Harvey et a l, 1999; 
Konkel et a l, 1992b). MacCallum et a l (2005b) suggested that C. jejuni inhibits 
absorption in infected Caco-2 cells. They suggested that, fluid and electrolyte 
absorption are likely to be compromised, if tight junctional integrity of intestinal 
epithelium was lost.
Although invasion of intestinal epithelial cells is suggested to play a role in 
Campylobacter virulence, there is a very great range in the in vitro invasion level 
among strains of C. jejuni (Bacon et a l, 2000; Hu & Kopecko, 1999; Oelschlaeger et 
a l, 1993). C. jejuni has been reported to enter host cells via a microfilament- 
dependent process (De Melo et a l, 1989; Konkel & Joens, 1989; Konkel et a l, 
1992a), and in vivo observations suggested that cell entry is associated with 
accumulation of microfilament (Russell et a l, 1993). In contrast, other studies 
(Oelschlaeger et a l, 1993; Russell & Blake, 1994) indicated that invasion was not 
affected by microfilament inhibitors. Campylobacters, after entering the host cells, 
remain in the cytoplasm within membrane-bound vacuoles, although free C. jejuni
2 0
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bacteria associated with a cytopathic effect were observed in vivo within the 
cytoplasm of cells (Russell et a i, 1993). The flagellum is the only Campylobacter 
determinant which is consistently involved in the process of invasion (Grant et a l, 
1993; Russell & Blake, 1994; Wassenaar et a l, 1991).
The ability of Campylobacter spp. to translocate across an epithelial cell barrier was 
observed (Everest et a l, 1992; Grant et a l, 1993; Konkel et a l, 1992b); and such 
translocation was first observed in salmonellae (Finlay & Falkow, 1990; Finlay et a l, 
1988). This action has great potential significance for the pathophysiology of 
campylobacteriosis. Translocated Campylobacter were observed below the cell 
monolayer less than Ih after inoculation of cells above the monolayer (Konkel et a l, 
1992b) and at least for 6h continued to translocate. Transcytosis (i.e., translocation 
via a cytoplasmic pathway) may be the means to enable Campylobacters to cross the 
cell monolayer following initial invasion of the cell with the exit at the basolateral 
surface. Nevertheless, these bacteria may also be able to cross the cell monolayer via 
a paracellular path. The passage of Campylobacters between cells was indicated by 
electron microscopic observations (Konkel et a l, 1992b; Oelschlaeger et a l, 1993), 
and four different and reproducible phenotypes amongst clinical strains were 
identified; a. non-invasion; b. invasion; c. invasion with transcytosis; and d. 
transcytosis without invasion (Everest et a l, 1992). It would be predicted that the 
strains in the group d take a paracellular route between tight junctions.
1.5.3 Cytotoxins
Although tissue invasion by campylobacter and inflammatory changes could be 
responsible for the clinical manifestations of disease, toxins also probably contribute 
as well to the disease process. Toxin production is, however, an unclear area of
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pathogenesis (Ketley, 1997). Lipopolysaccharide (LPS) is a virulence determinant in 
many species of Gram-negative bacteria and it has been shown to contribute to 
several aspects of the pathogenesis, including resistance to phagocytic killing, serum 
resistance and cell toxicity. Sialylation of LPS by enhancing serum resistance was 
shown to play a role in virulence in some pathogens (e.g., Haemophilus and 
Neisseria spp.) (Demarco de Hormaeche et a l, 1991; Moxon & Masked, 1992). The 
biochemical characterisation of C. jejuni LPS has been progressed by several groups 
(Aspinall et a l, 1992a; 1993a; 1993b; 1992b; 1993c; Conard & Galanos, 1990; Mills 
et a l, 1992; Moran et a l, 1991) although most of them were concerned with the 
utilisation of LPS in serotyping. C  jejuni LPS can consist of a low mol. wt fraction 
(similar to the characteristic LPS in Haemophilus and Neisseria spp.) or it may also 
contain a high mol. wt fraction (Mills et a l, 1992). The role of LPS in the virulence 
of other Gram-negative bacteria gives a good foundation for the search for such a 
role in C. jejuni (Ketley, 1995). McSweegan & Walker (1986) reported a role for 
both LPS and flagellin as important adhesins in C. jejuni.
The major outer-membrane protein (MOMP) of C. jejuni is a porin which is present 
in 60% of pathogenic strains (Bolla et a l, 1995; Huyer, 1986; Kervella et a l, 1992). 
A cytotoxic porin-lipopolysaccharide (LPS) complex was isolated and characterised 
by Bacon et a l  (1999). The cytotoxic activity associated with this complex was heat 
labile at 70 °C and trypsin-resistant and this activity was neutralised by a polyclonal, 
homologous antiserum which reacted on a Wes ten blot with a 45-kDa protein 
(predicted iso-electric point of 4.35), but not by polyclonal antisera raised against a 
number of other bacterial toxins. Sequencing of the N-terminus of the protein
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component of this complex revealed that there was 91% homology with the major 
outer-membrane porin protein from C. jejuni (Bacon et a l, 1999).
Campylobacters have been reported to produce various toxic activities including a 
cholera-like toxin (CLT) and several cytotoxins, including cytotoxins with different 
patterns of cell specificity, a cytolethal distending toxin (CDT), a shiga-like toxin 
(SLT) and a haemolysin (Ketley, 1997; Wassenaar, 1997). Parkhill et a l (2000) 
reported that the genome of C. jejuni (NCTC 11168) does not contain a cholera-like 
toxin gene, although genes encoding a cytolethal distending toxin (cdtA, B and C) are 
present. A phospholipase (pldA), a putative integral membrane protein with a 
haemolysin domain (Cj0183), and a member of the family of contact-dependent 
haemolysins found in pathogenic Brachyspira (Serpulina) and Mycobacterium 
species (Cj0588) were also identified (Parkhill et a l, 2000). The cytotoxins may 
cause enteric cell damage which leads to an inflammatory diarrhoea together with 
bloody stools and leucocytes in the faeces (Wallace et a l, 1997).
Production of enterotoxin by C. jejuni was first described by Ruiz-Palacios et a l 
(1983). The evidence for a role and even the production of enterotoxin by 
campylobacter is not convincing. A toxin that elongated CHO cells like cholera toxin 
was detected with a GMl-based ELISA, and several groups described fluid 
accumulation in intestinal loops (McCaidell et a l, 1986b; Ruiz-Palacios et a l, 1985; 
Ruiz-Palacios et a l, 1983; Suzuki et a l, 1994). The production of CLT was reported 
to correlate with the watery diarrhoea observed in developing countries (Guenant et 
a l, 1992), but CLT-positive strains have been isolated from non-symptomatic 
carriers (Belbouri & Megraud, 1988; Mathan et a l, 1984). There are reports that, 
under low stringency hybridisation conditions, the C. jejuni chromosome contains
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nucleotide sequence similarities with cholera toxin and heat-labile toxin (Baig et a l, 
1986; Calva et a l, 1989). In contrast, even with similar strains, several other 
independent groups could not demonstrate the production of CLT, detect no antibody 
against it and could not demonstrate any DNA sequence similarity (Konkel, 1992; 
Mathan et a l, 1984; McFarland & Neill, 1992; Perez-Perez et a l, 1989; Perez-Perez, 
1992; Ruiz-Palacios et a l, 1992). It is probable that the nature of toxin production by 
campylobacter spp. is complex and may involve a range of different toxins expressed 
under various, as yet unknown, conditions.
On the basis of a weighed comparison of the data, the existence of six different 
cytotoxins was proposed (Wassenaar, 1997): (a) a 70-kDa cytotoxin active on Hela, 
CHO, and other cells except Vero cells (inactive on Vero cells); (b) a cytotoxin 
active on Vero and Hela cells; (c) CDT; (d) a cytotoxin neutralized by Stx antitoxin; 
(e) a cytotoxin(s) displaying haemolytic activity; and (f) a hepatotoxin.
1.5.3.1 70-kDa cytotoxin
A toxic activity against HeLa, MRC-5 and HEp-2 cells but not against Vero or other 
animal cell lines was described in an early study on the cytotoxicity of bacterial 
supernatants (Yeen et a l, 1983). A molecular weight of more than 30,000 was noted 
for the cytotoxin, and bacterial culture broth produced diarrhoea in the RITARD 
(The Removable Intestinal Tie-Adult Rabbit DiaiThoea) model (Pang et a l, 1987). 
The cytotoxin was sensitive to heat, and expression was lost upon bacterial 
subculturing. Possibly a similar or identical cytotoxin was described by Goossens 
(1985) as a cytotoxin active on CHO cells which could not be neutralized by Stx 
(shiga toxins) antitoxin, although the sensitivity for Vero cells was not tested. A 
cytotoxin that was specific for HeLa and CHO cells and inactive on Vero cells was
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detected by Johnson and Lior (1986), and they presumed that this was identical to the 
cytotoxin described by Goossens (1985). McCardell et al. (1986a) described a 
cytotoxin of 70-kDa that was toxic for CHO cells, although its trypsin resistance and 
heat stability were in contrast to other reports.
A cytotoxin for HeLa and CHO cells, but not for Vero cells was described by 
Guenant et al. (1987). This cytotoxin, with 50 to 70-kDa MW estimation, was 
trypsin- and heat-sensitive and was not neutralized by mli-Clostridium or Stx 
antitoxin (GueiTant et al., 1992; Guenant et al., 1987). In another study, Mahajan 
and Rodgers (1990) described a 68-kDa cytotoxin active against CHO and INT407 
cells, trypsin sensitive and heat labile, and also they suggested a possible (glyco) 
protein receptor on chicken embryo fibroblast cells and INT407 cells. Other 
researchers (Daikoku et a l, 1989; Kawaguchi, 1989; Mizuno et a l, 1994) described 
a cytotoxin which was also active on HeLa and CHO cells, trypsin sensitive, heat 
labile and may be the same 70-kDa toxin, but Vero cell specificity tests or 
neutralization studies were not canied out to confirm this similarity. It has been 
reported upon storage (Daikoku et a l, 1989; Florin & Antilion, 1992) or subculturing 
(Daikoku et a l, 1989; Pang et a l, 1987) of the Campylobacter strains, the expression 
of this cytotoxin was unstable and was lost. The protein was produced intracellularly 
in the early log phase, and released in the stationary phase (Daikoku et a l, 1989; 
Daikoku e ta l ,  1990; Kawaguchi, 1989).
Briefly, characterisation of this cytotoxin revealed a M.W. of approximately 70 kDa, 
trypsin sensitivity, heat lability, activity against HeLa, CHO, HEp-2, and INT407 
cells and no activity against Vero cells, and also toxic activity could not be
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neutralized by ?iX\Xi~Clostridium antitoxin or anti-Stx. The mechanism of action 
(intracellular versus membranolytic) of this cytotoxin is unknown.
1.5.3.2 Vero/HeLa cell cytotoxin
In most reports, Vero cells were found to be more susceptible and sensitive than 
HeLa cells (Florin & Antillon, 1992; Johnson & Lior, 1984; Johnson & Lior, 1986) 
against this cytotoxin and, in one study, MRC-5 cells were even more sensitive 
(Florin & Antillon, 1992). This cytotoxin could not be neutralizaed with anti- 
Clostridium or Stx antitoxin (Johnson & Lior, 1984; Johnson & Lior, 1986). The 
mechanism of action of this cytotoxin is unknown.
1.5.3.3 Cytolethal distending toxin
Cytolethal distending toxin (CDT) is perhaps the most widely studied cytotoxin and 
genes with similarity to those encoding E. coli CDT were identified in C. jejuni 
(Pickett et a l, 1996). CDT causes certain culture cells, including HeLa cells, to 
become slowly distended and finally to die (Fig. 1.5) (Johnson & Lior, 1987; 
Johnson & Lior, 1988a; Johnson & Lior, 1988b). CDT was first described by 
Johnson and Lior (1987) as a distinct and novel toxic entity. They discovered this 
new activity in certain E. coli strains which, during a five-day period, caused Chinese 
hamster ovary (CHO) cells to become distended. This activity was distinct from 
those of E. coli heat-stable toxin, heat-labile toxin, verotoxin and haemolysin 
(Johnson & Lior, 1988a; Pickett & Whitehouse, 1999). CDT production by 
Campylobacter spp was first described by Johnson and Lior (1988b) as CLDT. 
CDT’s represent an emerging family that are produced by a number of pathogens, 
including E, coli, Campylobacter spp,, Shigella dysenteriae, Actinobacillus 
actinomycetemcomitans, Haemophilus ducreyi (as a non-diarrhoeagenic pathogen)
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Figure 1.5: Genetics and action of CDT
Three adjacent genes, cdtA, cdtB and cdtC, encode CDT. The arrows underneath the 
line show the location and length of the genes, and the molecular weight of the 
translate products. Many sensitive cells become slowly distended and then die by this 
holotoxin. Diagram was taken from Pickett (2000).
Introduction
cdtA
cdtB
cdtC
21.1 kDiJU.I kUa 29.0 kDa
CITI H olo tox in  ?
Target Ceil Cell DeathCell D istension
27
Introduction
(Cope et a l, 1997; Elwell & Dreyfus, 2000) and Helicobacter spp. (Young et a l, 
2000). Eyigor et a l (1999a) demonstrated the widespread presence of genes 
encoding CDT amongst members of the Campylobacter genus, showing that CDT 
may be intimately involved in successful colonisation processes and in the ability of 
the bacteria to cause disease in man (Purdy et a l, 2000). In addition to C. jejuni, 
other diarrhoeagenic bacterial species, including the closely related C. coli and C. 
fetus can make CDT (Johnson & Lior, 1988b; Pickett et a l, 1996), as well as some 
E. coli strains (Johnson & Lior, 1988a) and Shigella spp. (Johnson & Lior, 1987) 
isolates.
The CDT produced by Shigella dysenteriae causes diarrhoeal symptoms in a 
suckling mouse model (Okuda et al., 1997). CDTs are described as cytotoxins which 
induce progressive cellular distension and death in a number of cultured and primary 
cells, including HeLa, Vero, CHO, HEp-2, Caco-2, human keratinocyte cell line 
(HaCat), Hamster lung (Don) fibroblasts and human T lymphocytes (Elwell & 
Dreyfus, 2000). NIH 3T3 fibroblasts and mouse Y-1 adrenal cells are apparently not 
sensitive to CDT (Elwell & Dreyfus, 2000; Pickett & Whitehouse, 1999). Some cell 
culture types, including HEp-2, CHO (Elwell & Dreyfus, 2000; Pickett & 
Whitehouse, 1999) and hamster lung (Don) fibroblasts (Pickett & Whitehouse, 1999) 
rearrange actin in response to CDT, but this does not occur in HeLa cells treated with 
CDT (Elwell & Dreyfus, 2000).
The cdt genes were cloned and sequenced from E. coli (Peres et a l, 1997; Pickett et 
a l, 1994; Scott & Kaper, 1994), C. jejuni (Pickett et a l, 1996), S. dysenteriae 
(Okuda et a l, 1995), and H  ducreyi (Cope et a l, 1997). CDT production depends 
upon the expression of three adjacent genes, cdtA, cdtB, and cdtC (Fig. 1.5 and 1.6),
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Figure 1.6: Suggested pattern for uptake, trafficking, and target activity of CDT.
The CDT operon consists of three adjacent genes, cdt ABC, and the products of these 
three genes interact to form the CDT holotoxin. Binding of CDT to an unidentified 
host cell receptor is mediated by CdtA and CdtC, after which the toxin is internalized 
via receptor-mediated endocytosis (Coites-Bratti et a l, 2001). CDT trafficking, and 
especially the movement of CdtB, is poorly described, although evidence suggests 
that the toxin undergoes retrograde transport through the Golgi complex, and that 
CdtB finally enters the nucleus. In the nucleus, CdtB seems to bind to DNA and 
causes double-stranded breaks, which lead to trigger the DNA damage checkpoint 
pathway and finally cell cycle arrest and cell death. The ultimate fate of CdtA and 
CdtC is unknown as is indicated by the question marks. Diagram was taken from 
Pickett & Lee (2005).
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and. expression of the cdt genes in non-toxic E, coli strains showed that the three 
genes were sufficient and required in order to produce CDT (Okuda et a l, 1997; 
Pickett et a l, 1994; Pickett et a l, 1996). It has been shown that CdtB acts as a 
nuclease (Elwell & Dreyfus, 2000; Hassane et a l, 2001; Lara-Tejero & Galan, 
2000), and it has been shown by two groups that CdtB apparently binds to DNA of 
the host cell and causes double-stranded cuts of the DNA (Fig. 1.6) (Hassane et a l, 
2003; Li et a l, 2002). Recent evidence shows that all three Cdt subunits are present 
in the CDT holotoxin (Figs. 1.5 and 1.6), in a 1:1:1 stoichiometry (Lara-Tejero & 
Galan, 2001). About 40% of the sequences of C  jejuni cdtA and cdtC genes are 
similar to each other (Pickett & Whitehouse, 1999). CDT is an AB2 toxin composed 
of CdtB which plays a role as the enzymatically active (A) subunit, and CdtA and 
CdtC, as the heterodimeric B subunit which is required for the delivery of CdtB into 
the target cell (Laia-Tejero & Galan, 2001). Lara-Tejero & Galan (2001) reported 
that toxic activity was not exibited by purified CdtA (29,919.36 Da), CdtB 
(28,972.97 Da), or CdtC (21,157 Da) when applied to cells individually. However, 
when CdtA, CdtB, and CdtC were combined, they interacted with one another to 
form an active tripaitite holotoxin. Mao & DiRienzo (2002) reported that the CdtA 
subunit binds to CHO cells, but they did not observe binding of CdtB and CdtC to 
these cells. Recently, it has been shown that both CdtA and CdtC bound with 
specificity to the surface of HeLa cells, but CdtB did not (Fig. 1.6) (Lee et a l, 2003). 
CDT arrests eukaryotic cells in the G2 phase of the cell cycle (Fig. 1.6) and induces 
interleukin-8 (IL-8) release from intestinal epithelial cells (Hickey et a l, 2000; Laia- 
Tejero & Galan, 2001; Pickett et a l, 1996; Whitehouse et a l, 1998).
AbuOun et a l  (2005) challenged one-day old chicks with wild-type and a CDT- 
negative mutant of C. jejuni 81-176 and the same level of colonisation (up to 10^
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CFU per gram of cecal contents) was achieved. This finding suggested that the 
absence of CDT expression did not affect colonisation potential. In spite of this high 
level of colonisation, clinical symptoms of disease were not perceived in challenged 
chicks with either the wild-type or the mutant strain (Abuoun et a l,  2005). Also the 
results showed that CDT was expressed during colonisation of the avian gut (Abuoun 
et a l,  2005). Even though CDT was apparently expressed in the chick, its absence 
did not interfer with colonisation.
In one study, Campylobacters were examined for cytotoxin formation in a CHO cell 
culture test. The reference strains were C. jejuni from persons suffering from 
diarrhoea, from organs of poultry, C. jejuni and C. fetus subsp. fetus from the 
gasterointestinal tract of calves and adult cattle. During evaluation, three 
morphologically different pictures were observed. In the first, there was a formation 
of rounded or polymorphic, strikingly large and elongated cells and this was 
associated with reduced growth. These progressive morphological changes 
coiTesponded to those described for the Cytolethal Distending Toxin (CDT). A 
second cytotoxin, that by analogy to CDT was termed Cytolethal Rounding Toxin 
(CRT), produced a rounding of cells without a change in their size while, at the same 
time, growth was reduced. A third morphological picture consisted of cell changes 
characterized by enlarged polymorphic cells as well as by small rounded cells. These 
cell changes were referred to as the CDT/CRT effect (Schulze et a l, 1998). Hanel et 
al{\99^) reported that C. jejuni strains were able to produce at least two different 
cytotoxins, corresponding to CDT and CRT.
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1.5.3.4 Shiga-like toxin
Discovery of the Shiga toxins was due to a need to know more about how gram- 
negative pathogenic bacteria cause disease (Konowalchuk et a l,  1977; O'Brien et a l, 
1992) . These toxins have been proven to be important in the pathogenicity of both 
Shigella dysenteriae type 1 and E. coli 0157:H7, The term verotoxin (VT) was 
suggested, due to the observation that E. coli-derived toxins were cytotoxic to Vero 
cells. The terminology has been unified: Stx is from Shigella dysenteriae type 1, and 
Stxl, Stx2, etc. from E. coli. The type 1 and 2 toxins from E. coli were previously 
called Shiga-like toxins. The Shiga toxins are responsible for the systemic 
complications of infections and aie not required for the initial colonization of the 
intestine (Obrig, 1997). Toxins in the Stx family are composed of a holotoxin 
consisting of one A-subunit (active) responsible for the inhibitory activity and five 
indentical B-subunits (A1B5) that determine specific binding to eukaryotic cells 
(Hoey et a l, 2003; Jackson, 1990; O'Brien et a l, 1992). Stx has been purified from 
Shigella dysenteriae type 1 as a 70 kDa multi-subunit complex comprised of a single 
32 kDa A-subunit and 5x7.7 kDa B-subunits (O'Brien et a l,  1980; Olsnes et a l, 
1981). Shiga-like toxins (Stxl, Stx2, Stx2c) have also been purified from E.coli and 
are similar' to Shiga toxin (O'Brien et a l, 1992). In spite of minor differences 
between the A-subunit amino acid sequences of the Stx subspecies (Stxl, Stx2, 
Stx2c, etc.), all exibit identical enzymatic activity. The neutral glycolipid, 
glycosphingolipid (Gb3) which is present on the cell surface of eukaryotic cells is the 
receptor for Stx, Stxl, Stx2, and Stx2c (Lingwood, 1993; Ling wood et a l, 1987).
The A-subunit inhibits protein synthesis by inactivating ribosomes. Enzymatically a 
purine base from the 28S rRNA within the 60S ribosomal subunit is removed by the
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A-subunit (Endo et a l,  1988). Interaction of peptide elongation factors (EF-1 and 
EF-2) with the ribosome is prevented by the modification of the ribosome and stops 
protein synthesis at the level of peptide elongation (Obrig, 1994; Obrig et a l, 1987).
It has been reported that Stx is cytotoxic to endothelial cells (Obrig et al., 1988). 
Glomerular vascular capillaries with swollen endothelial cells were revealed by a 
histopathological test of kidney samples from HUS (haemolytic uraemic syndrome) 
patients (Koster et a l, 1984; Richardson et a l, 1988). In all patients diagnosed with 
HUS and having an infection with E. coli (Stx producing), microvascular angiopathy 
was present. It has been concluded that the putative primary target cells for Stx are 
endothelial cells (Obrig, 1997). Boyd & Lingwood (1989) demonstrated that human 
kidney, particularly in young children, contains the Gb3 receptor for Shiga toxin. In 
another study, endothelial cells isolated from human kidney expressed Gb3 and were 
very sensitive to Shiga toxin (Obrig et a l, 1993). van Setten (1994) demonstrated 
that murine macrophages directly respond to Stxl with an increase in production of 
IL-1 and IL-6.
Due to presence of Gb3 receptor, significant targets for VT are microvascular 
endothelial cells of the kidney and gastrointestinal tract (Jacewicz et a l, 1999; Obrig 
et a l, 1993; Ohmi et a l, 1998), which correlate to HUS and haemorrhagic colitis 
(HC), respectively (Hoey et a l, 2003). It has been reported that VT can be detected 
in HUS patients in the kidney (Chaisri et a l, 2001; Uchida et a l, 1999), thus 
considerable levels of this cytotoxin may enter the circulation from the intestinal 
lumen (Hoey et a l, 2003).
Moore et a l (1988) detected a toxin activity in 11 of 36 bacterial lysates of C  jejuni 
and C. coli strains. This activity cross-reacted with anti-shiga toxin antibodies, but
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homology between the stxi gene of E. coli and the genome of cytotoxic C  jejuni 
strains was not detected (Moore et a l, 1988). The putative cell-associated SLT was 
produced in very low levels equivalent, in fact, to that found in enterotoxigenic E. 
coli. Vibrio cholerae, E. coli K12 and normal intestinal flora E. coli strains (Moore et 
a i, 1988). No SLT gene sequences were found and there was no correlation between 
production and the clinical background of the strain. Nevertheless, the clinical 
manifestation, which often involves intestinal tissue damage and an associated 
inflammatory response, is not inconsistent with the action of cytotoxins (Ketley, 
1995).
1.5.3.5 Haemolytic cytotoxins
It is recognized that some Campylobacter strains (i.e., C. jejuni and C. coli) are 
haemolytic. Haemolysis was described on blood agar plates that were cultivated at 42 
°C for 4 days (Arimi et a l, 1990). The haemolytic activity was observed only with 
ageing bacteria, and there is a suggestion that an intracellular component is released 
when bacteria die and lyse. This suggestion and most other observations describe 
cell-associated or contact haemolysis.
Alpha haemolysis was rarely observed and its appearance depends on the pH of the 
medium. The typical green zone around a colony appears within incubation for 48h 
at 37 °C on rabbit blood agar plates at pH 6.0 to 6.5, which is lower than that of most 
Campylobacter media (Misawa et a l, 1995b). Clear zones on blood plates were 
produced by beta haemolysis, and it was observed with the same strains that 
produced alpha haemolysis, but only after incubation for 6 days at 37 °C or 3 days at 
42 °C. The zone did not spread but remained in close proximity to the colonies 
(Misawa et a l, 1995b).
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To perform a contact haemolysin assay, a bacterial suspension was mixed with 
erythrocytes and was centrifuged to increase the contact between bacteria and cells, 
so that cell-bound haemolysins could be detected. Haemolytic activity was shown in 
six of eight C. jejuni strains by this assay (Pickett et al., 1992). A more sensitive 
microplate assay was developed to measure contact haemolysis, which showed 
moderate titers in some strains and low titers in 94% of C. jejuni strains (Tay et a l, 
1995). Bacterial lysates or culture supernates were always non haemolytic (Tay et 
a l, 1995).
C. jejuni strains were tested for their ability to acquire iron from different iron 
sources present in humans. The growth of C. jejuni strains was stimulated by 
haemoglobin, haemin, haemoglobin-haptoglobin and haemin-haemopexin in low- 
iron medium. Lactoferrin, transferrin and fenin were unable to provide iron to the 
strains (81-176, C31, and 1376) tested. The haemolytic activity shown to be 
produced by several C. jejuni strains did not appear to be iron regulated (Pickett et 
a l, 1992).
Parkhill et a l (2000) identified a member (Cj0588) of the family of contact- 
dependent haemolysins found in pathogenic Serpulina and Mycobacterium species, 
and a putative integral membrane protein with a haemolysin domain (Cj0183), in the 
genome of C. jejuni NCTC 11168.
McCardell et a l (1986a) reported secretion of haemolytic activity into the culture 
medium. A cytotoxin which was toxic to CHO cells and could be neutralized by the 
anti-haemolysin/cytolysin antitoxin of V. cholerae, displayed haemolytic activity. 27 
of 60 C. jejuni and C. coli were positive for the haemolytic phenotype and could be 
induced in non haemolytic strains by rabbit ligated ileal loop passage (McCardell et
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a l, 1986a). Hossain et a l (1993) reported presence of both heat-stable and heat- 
labile haemolytic activities in culture filtrates of C. jejuni isolated from patients with 
cholera-like and dysenteric diarrhoea, but neutralization with anti-cytolysin of V, 
cholerae was not performed (Hossain et a l, 1993). The haemolytic activity of two 
strains was trypsin sensitive and precipitation by ammonium sulphate indicated its 
proteinaceous nature. The haemolysins of these two strains differed in sensitivity to 
temperature, so that one culture filtrate was partially resistant to treatment for 30 min 
at 100 °C, and the other filtrate was inactivated (Hossain et a l, 1993).
More work on haemolytic cytotoxin production by C. jejuni is needed. With specific 
antisera, it could be determined how many different haemolytic cytotoxins exist. 
Whether haemolytic, membrane-damaging cytotoxins are represented by one or more 
of the other toxins produced by Campylobacter spp. is unknown.
1.5.3.6 Hepatotoxin
Kita et a l (1990) reported that some clinical isolates of C. jejuni that caused bloody 
and watery diaii'hoea and one strain isolated from an asymptomatic patient could 
cause hepatitis in mice. A bacterial sonicate fraction was isolated from such a C. 
jejuni strain that caused toxicity to hepatocytes but not to Y1 or CHO cells (Kita et 
a l, 1992; Kita et a l, 1990). When the crude sonicate fraction (but not culture 
filtrates) was applied intravenously to mice, liver lesions similar to the lesions seen 
after liver colonization by hepatotoxic C. jejuni strains were caused (Kita et a l, 
1992). These reports suggest that some strains have the potential to colonize the liver 
and express a hepatotoxin to cause hepatitis, although the mechanism of this factor is 
unknown.
36
Introduction
It is probable that the nature of toxin production by Campylobacter spp is complex 
and involves a range of different toxins expressed under a variety of conditions in 
vivo, which are as yet unknown.
1.5.4 Guillain-Barre syndrome (GBS)
Recently, an association between Campylobacter infection and GBS has been 
provided and campylobacteriosis is the most frequent infection associated with this 
form of neuromuscular paralysis (Fields & Swerdlow, 1999; Parkhill et a l, 2000). 
Unusually, C. jejuni has three sets of neu genes involved in sialic acid biosynthesis. 
Sialic acid is an uncommon constituent of bacterial surface structures and, through 
molecular mimicry, may be important for evasion of host immunity and in post­
infection autoimmune disases such as GBS (Parkhill et a l, 2000).
Molecular mimicry of gangliosides by lipo-oligosaccharide is in part dependent on 
the presence of V-acetylneuraminic acid of C. jejuni (sialic acid) in both structures. 
Within the lipo-oligosaccharide biosynthetic locus, one group of genes {neuA, neuB 
and neuC) potentially encode a complete pathway for the biosynthesis of activated 
V-acetylneuraminic acid from V-acetylmannosamine, and insertional mutagenesis of 
the neuB gene resulted in a lipo-oligosaccharide lacking V-acetylneuraminic acid 
(Linton et a l, 2000a). The biosynthesis of ganglioside-mimicking lipo- 
oligosaccharide also requires a number of glycosyItransferases, including one or 
more sialyItransferases. The C. jejuni NCTC 11168 genome sequence data was used 
by Gilbert et a l  (2000) to clone and sequence the lipo-oligosaccharide biosynthetic 
locus from a Guillain-Barre syndrome-associated C. jejuni strain (OH4384) known to 
synthesise ganglioside-mimicking lipo-oligosaccharide. Within this locus, they 
identified three genes encoding sugar transferases, including a sialyltransferase.
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involved in biosynthesis of ganglioside-mimicking lipo-oligosaccharide (Gilbert et 
al., 2000).
1.6 Current knowledge on genetics
Genome sequence data for C. jejuni are only available for a single strain, 11168, and 
this may not be representative of the species as a whole. Several studies have 
indicated that extensive genetic diversity exists between strains (Dorrell et al., 2001; 
Leonard et al., 2004; Salama et al., 2000). It would therefore be of considerable 
interest to have available the genome sequences of a variety of isolates for 
comparative purposes with regard to the different pathogenic phenotypes exhibited 
by strains.
In spite of years of research and a complete genome sequence (Parkhill et al., 2000), 
still there is remarkably little knowledge about the molecular pathogenesis of C. 
jejuni. The genome sequence failed to reveal any specific secretion systems (type HI 
or type IV) that are involved in pathogenesis of many other bacteria (Parkhill et al., 
2000). Manifestation of C. jejuni disease can range from a mild watery diairhoea to a 
dysenteric-like syndrome. This range of differences could be due to either 
differences in host response to bacteria or to differences in virulence amongst 
individual strains, or a combination of both. It is obvious that there are great 
differences amongst C. jejuni strains with regard to their ability to promote disease 
symptoms.
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1.6.1 Plasmids
C. jejuni 81-176 is a virulent clinical isolate that has become the predominant model 
in the study of infection mechanisms of C. jejuni. It was originally isolated in 1985 
from an outbreak of diarrhoeal disease in children who consumed raw milk during a 
visit to a dairy farm (Korlath et a l,  1985). Strain 81-176 has been chosen for most 
laboratory work due to the fact that it has been fed to volunteers on two occasions 
and in each case caused disease (Black et a l,  1988). The strain invaded intestinal 
epithelial cells at much higher levels than most other C. jejuni strains (Oelschlaeger 
et a l,  1993) and caused disease in a ferret diarrhoea model but strain NCTC 11168, 
for which the genome was sequenced, was avirulent (Bacon et a l,  2000). Moreover 
strain NCTC 11168 invaded INT407 cells at < 1% the level of 81-176 (Bacon et a l, 
2000). Thus, these important and significant differences in virulence phenotypes 
must have a genetic basis. D o itc I I  et a l  (2001) reported that about 5% of the genome 
of NCTC 11168 is missing in 81-176 using microarray hybridizations. However, the 
most clear genomic difference between these two strains is the presence of two large 
plasmids (pVir and pTet) in 81-176.
Until plasmid pVir in strain 81-176 was identified by Bacon et a l  (2000), there was 
no evidence for the involvement of plasmids in the virulence of C. jejuni. pVir is an 
-37.5 kb plasmid which contains components of a type IV secretion system (T4SS) 
(Bacon et a l,  2000; 2002) known to be important for virulence in a number of major 
bacterial pathogens (Christie, 2001). Bacon et a l  (2000) suggested that this plasmid 
is important in vitro for invasion and adherence of intestinal epithelial cells in 
culture.
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Tracz et a l (2005) reported that although the presence of the pVir virulence plasmid 
did not correlate with most clinical symptoms (diarrhoea, fever, abdominal pain, and 
vomiting), patients infected with pVir-positive C. jejuni strains were more likely to 
produce bloody stool than those infected with pVir-negative strains. 53% of patients 
infected with pVir-positive C. jejuni strains had bloody stools, as opposed to 21% of 
patients infected with pVir-negative C. jejuni sti'ains. Also, the presence of pVir in 
isolates was not associated with the patient’s sex, age, antimicrobial therapy, 
coexisting conditions, or travel (Tracz et a l, 2005). C. jejuni gasteroentritis with 
bloody stool indicated that progression of the infection into the tissue of the colon 
and rectum had occurred (Skiixow & Blaser, 2000). Bacon et a l (2000; 2002) 
reported that pVir was important for the in vitro invasion of intestinal epithelial cell 
lines. The association of pVir in C. jejuni infection with bloody diaixhoea in a 
clinical setting supported the role of this plasmid for in vivo epithelial cell invasion 
and stressed its potential as a marker for the risk of developing a more severe clinical 
infection (Tracz et a l, 2005).
Tetracycline resistance in C. jejuni is primarily mediated by plasmids which carry the 
tetO gene (Taylor et a l, 1981; 1987). Bacon et a l (2000) reported the presence of a 
35 kb plasmid (pTet) that encoded tetracycline resistance. Another study reported 
size of this plasmid 45.2 kb (Batchelor et a l, 2004). Tracz et a l (2005) reported that 
the presence of pVir plasmid in C. jejuni isolates was associated with the presence of 
the tetracycline-resistance plasmid (94% of pVir-positive C. jejuni isolates were 
found positive for the presence of the tetracycline-resistance plasmid). However, the 
results also showed that 66% of C. jejuni isolates that contained tetracycline- 
resistance plasmid did not contain pVir, which demonstrated that plasmid-mediated 
tetracycline resistance did not occur exclusively with pVir.
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1.7 Proteomics
The large and growing application of 2-dimensional electrophoresis (2-DE) is 
important for “proteome analysis”. Proteome analysis is “the analysis of the entire 
PROTEin complement expressed by a genOME”. Proteomics (Wasinger et a l, 1995) 
has become a key technology and also a method of choice for the investigation of 
expressed gene products. It has applications in the analysis of protein expression 
changes during cellular processes such as cell differentiation, exposure to adverse 
environments, host/pathogen interactions and the characterisation and validation of 
novel therapeutic targets with the investigation of the mode-of-action of drugs 
(Jungblut et a l, 1999). Proteomic techniques have evolved from established protein 
separation techniques such as 2-DE to include both the rapid identification of 
polypeptides by mass spectrometry (MS) and the development of bioinformatic 
techniques developed to correlate enzymatic peptide digest mass fingerprints and 
peptide fragmentation data with the genome sequence (Parker et a l, 1998). The 
combination of 2-DE along with mass spectrometry makes possible the identification 
of proteins on 2-DE patterns on a large scale (Shevchenko et a l, 1996).
Two-dimensional electrophoresis was first introduced by O'Farrell (1975) and is a 
widely used and powerful method for the analysis of complex protein mixtures 
extracted from tissues, cells, or other biological samples. Information on individual 
proteins such as pi and molecular mass, the number of expressed proteins and their 
level of expression may be obtained from analysis of gels. 2-DE of proteins allows 
10,000 protein species to be separated in one electrophoretic run (Klose & Kobalz, 
1995).
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Iron homeostasis and the role of the fenic uptake regulator (Fur) in iron acquisition 
in C. jejuni was investigated by a proteomic and transcriptome analysis (Holmes et 
al., 2005). A proteomic analysis of wild-type and fur  mutant of C. jejuni strain 111 68 
was done by comparing 2-DE gels of cell protein extracts from bacteria grown in 
iron-rich and iron-limited conditions. 595 spots on the iron-limited gel and 699 spots 
on the iron-rich gel (496 protein spots were common to both conditions) were 
identified by 2-DE gel analysis. The results showed that 30 genes were transcribed at 
lower levels in the fur  mutant than in the wild-type strain under iron-rich conditions. 
Several genes containing perR/Fur box consensus sequences, such as those coding 
for bacterioferritin {bfrldps, Cj 1534c), glutamyl-tRNA reductase (hemA, Cj0542), 
thioredoxin reductase (trxB, Cj0146c), cytochrome c peroxidase (ccp, Cj0358), 
superoxide dismutase {sodB, Cj0169) and the peroxide stress regulator perR 
(Cj0322) might be potentially derepressed in a /« r  mutant (Holmes et a l, 2005). The 
proteomics data supported the microaixay data by showing that the major protein 
spots induced under iron limitation were also components of known iron-uptake 
systems and components of two iron-regulated ABC transporter systems. In total, 13 
different proteins were shown to be regulated at the level of transcription in response 
to iron stress,
A comparative proteomic analysis was done on three strains (26695, SSI and J99) of 
H. pylori (a bacterium related to C. jejuni) on 2-DE gels (Jungblut et a l, 2000). The 
comparison of the three strains revealed a high genetic variability. Whereas several 
main spots were found at the same position, many positionally shifted and 
differentially present or absent spots were observed. 1863 spots were detected on the 
pattern of H. pylori 26695 of which 152 spots were identified by peptide mass 
fingerprinting using MALDI-MS. The 152 identified proteins spots represented 126
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genes which were 8% of the total number of 1590 gene predicted from the genome of 
H. pylori (Jungblut et ah, 2000).
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Aims of the research
Four major objectives were to be realised: Firstly, development of a reproducible 
cytotoxicity assay to evaluate and measure cytotoxic activity in different cell 
fractions of a range of C. jejuni strains. Secondly, to screen the isolates of C. jejuni 
from different sources for the presence of virulence plasmids (pVir and pTet) and to 
seek any correlation of plasmid presence with cytotoxic activity. Thirdly, purification 
and characterization of cytotoxic activity using column chromatography. Finally, a 
comparison, by proteomic analysis, of toxin-producing and non-producing C. jejuni 
strains.
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Materials and Methods
CHAPTER 2: MATERIALS AND METHODS
2.1 Bacterial strains and growth conditions
2.1.1 Bacterial strains
Campylobacter jejuni strains 11168, 11168 cdtB, 11168 cdtA, 11168 tlyA, 11168 
pldA mutants, 81-176, 81-176 cdtB mutant, and clinical isolates strains (COLl-30 
and RPHl-10) were used in this study (Table 2.1). C  jejuni cdtB mutant strains of 
11168 and 81-176 (kindly provided by Dr. D. Purdy, CAMR, Porton Down, UK) 
were created by insertion of a chloramphenicol resistance (Cm^ cassette in the cdtB 
gene. 11168 cdtA, 11168 tlyA, 11168 pldA mutants (kindly provided by Dr. P. 
Everest, Veterinary School, Glasgow University, UK) were created by insertion of a 
kanamycin resistance (Km'') cassette in cdtA, tlyA and pldA genes, respectively. C. 
jejuni 81-176 was kindly provided by Dr. D. Newell (Veterinary Laboratory Agency, 
Weybridge, Addlestone, Surrey, UK), COL 1-30 clinical isolates of C. jejuni were 
from Dr. R. Owen, Health Protection Agency (HPA), Colindale, London, UK and 
RPHl-10 from Dr. F. Bolton, Royal Preston Hospital, Preston, UK. E. coli strains 
E32511A, DH5a and JC3272 were also used in this study as controls. E. coli strain 
E32511A (Verotoxin-producing strain), kindly provided by Dr. G. Willshire, HPA, 
Colindale, London, UK and E. coli DH5a (a non-toxin-producing strain) (obtained 
from the local culture collection. Division of Infection and Immunity) were used in 
the cytotoxicity assays as positive and negative controls, respectively. E. coli JC3272 
strains (one strain containing plasmid pRK 2013 and another one without it) 
(obtained from the local culture collection. Division of Infection and Immunity) were
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Materials and Methods
used in the plasmid purification as a positive and negative control.
2.1.2 Growth of bacterial strains
2.1.2.1 Growth of C. jejuni strains
C. jejuni strains were grown on blood agar base (Difco) (Appendix 1) supplemented 
with 5% (v/v) defibrinated sheep blood (E&O Laboratories Ltd), 0.4% (v/v) 
Campylobacter selective supplement (Blaser-Wang) (Oxoid) containing: vancomycin 
10 pig/ml, polymyxin 2.5 I.U/ml, trimethoprim 5 fxg/ml, amphoteriein B 2 jag/ml, 
cephalothin 15 pg/ml, and 0.4% (v/v) Campylobacter growth supplement (Oxoid) 
containing: sodium pyruvate 0.25 mg/ml, sodium metabisulphite 0.25 mg/ml and 
ferrous sulphate 0.25 mg/ml. Strains were incubated at A2°C in anaerobic jars under 
microaerophilic conditions (0% 5%, CO2 10% and N2 85%, BOC Gases).
For growth in liquid medium, a starter culture was prepared from agar by 
emulsifying several loopfuls of Campylobacter growth in 5 ml of Brucella broth 
(Difco) (Appendix 2) and using this as inoculum for 100 ml of the same medium. 
The culture was incubated under microaerophilic conditions in an anaerobic jar 
secured on an orbital shaker running at 100 revolutions per minute (rpm) for 48h at 
42 °C. After putting plates or flasks into the jar, first the air of the jar was vacuumed 
and then the gas mixture above was injected into the jar to make a microaerophilic 
condition.
When required, antibiotics were added to these media at the following 
concentrations: tetracycline (20 pg/ml), kanamycin (50 |Lig/ml), chloramphenicol (20 
|ag/ml).
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2.1.2.2 Growth of E. coli strains
E. coli strains were grown overnight at 37 °C on Luria Bertani (LB) agai* (Appendix 
3), and were inoculated from such plates to LB broth, where necessary. Broths were 
incubated overnight at 37 °C with shaking at between 150 and 200 rpm.
2.1.3 Long-term storage of C. jejuni strains
Several loopfuls of the Campylobacter strain were removed from a BA plate and 
emulsified in 1.5ml of Brucella broth containing 40% (v/v) glycerol (Ridel-deHaën) 
and aliquots were immediately placed at -70 °C to act as a frozen stock. Cultures 
were grown from frozen stocks by thawing rapidly at 37 °C and spreading 50^1 of 
the bacterial suspension on a pre-warmed BA plate. Incubation was performed as 
above.
2.2 Characterisation of the strains
The isolates were identified by standard tests including API CAMPY test, Gram 
stain, colonial morphology, a selective medium for Campylobacter, oxidase and 
catalase tests.
2.2.1 API CAMPY test
API CAMPY (bioMerieux) is a system for the identification of Campylobacter 
which uses standardized and miniaturized tests with a specially adapted database. 
API CAMPY test was used to identify the clinical isolate strains. The API CAMPY 
strip consists of 20 microtubes containing dehydrated substrates, and it is made up of 
two parts: 1- enzymatic and conventional tests and 2- assimilation or inhibition tests.
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2.2.1.1 Enzymatic and conventional tests
The first part of the strip was inoculated with a dense suspension, which rehydrates 
the substrates. The metabolic end products produced during the incubation period 
(aerobic conditions) are revealed through colour changes that are either revealed 
spontaneously or by the addition of reagents.
2.2.1.2 Assimilation or inhibition tests
The second part was inoculated with bacterial cells suspended in a minimal medium 
and incubated in microaerophilic conditions. C. jejuni strains grow if they are 
capable of utilizing the coiTesponding substrate or if they are resistant to the 
antibiotic tests.
After incubation for 24h at 37 °C, the reactions were read visually as positive or 
negative according to the reading Table (Table 2.2) and identification was obtained 
by consulting the identification Table and using the identification software.
2.2.1.3 Procedure of API CAMPY test
A well-isolated colony was picked and was subcultured on BA agar. The plate was 
incubated for 24-48 h at 42 °C in microaerophilic conditions. All the growth from the 
subculture plate was harvested and suspended in 3 ml of 0.85% NaCl (w/v) in 
demineralised water (supplied with API kit) (Appendix 4) at a turbidity equivalent to 
6 McFarland unit’s (supplied with API kit). Approximately 80-100 |Lil of the bacterial 
suspension in 0.85% NaCl medium was distributed into the tests URE to PAL of the 
first strip and test HgS of the second strip. The cupule of the URE test was overlaid
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Table 2.2: API CAMPY reading table
Tests Reactions Results
Negative Positive
URE UREase yellow orange/red
NIT Reduction o f NITrates colorless pink/red
EST ESTerase colorless/pale blue turquoise
HIP HlPpurate colorless violet
GOT Gamma Glutamyl Transferase colorless dark orange
TTC Triphenyl Tétrazolium Chloride 
reduction
colorless/pale pink pink/red
PyrA Pyrrolidonyl Arylamidase colorless orange
ArgA L-Arginine Arylamidase colorless orange
AspA L-Aspartate Arylamidase colorless orange
PAL ALkaline Phosphatase colorless purple
H2S Production of H2S colorless black
GLU GLUcose (Assimilation) transpaient opaque
SUT SUccinaTe (Assimilation) transparent opaque
NAL NALidixic acid (Susceptibility) transparent opaque
CFZ CeFaZoline (Susceptibility) transparent opaque
ACE ACEtate (Assimilation) transparent opaque
PROP PROPionate (Assimilation) transparent opaque
MET MaLaTe (Assimilation) transparent opaque
CIT CltraTe (Assimilation) transparent opaque
ERG ERythrOmycin (Susceptibility) transparent opaque
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with mineral oil to form a slight convex meniscus. The strip was incubated for 24 hr 
at 35-37 °C in aerobic conditions.
150 pi of the bacterial suspension was also transferred into an ampoule of AUX 
medium (7 ml) (supplied with API kit) (Appendix 4), and was mixed well. This new 
suspension was distributed into the assimilation tubes and cupules, and the strip was 
incubated for 24-48 h at 42 °C in microaerophilic conditions.
2.2.1.3.4 Reading the strip
After the incubation time, reagents (NITl, NIT2, NIN and FB) (Appendix 4) were 
added to the strips according to the manufacturer’s instructions. After 10 minutes, the 
reactions were read by referring to the reading table. If the SUT test (a control for 
bacterial growth) was positive, all the assimilation tests were read. If it was negative, 
the second part of the strip was reincubated for a further 24 hr. If the SUT test was 
negative after 48 h, the other assimilation tests were not considered to provide the 
necessary information. Identification was obtained using the identification software 
by manually entering the 7-digital numerical profile via the keyboard.
2.2.2 Oxidase test
The principle of the oxidase test is based on the detection of an intracellular 
cytochrome oxidase enzyme, which activates the oxidation of reduced cytochrome 
by molecular oxygen. This in turn acts as an electron acceptor in the terminal stage 
of the electron transfer systems. Microorganism which produce the oxidase enzyme, 
in the presence of atmospheric oxygen, cytochrome c, and phenylenediamine oxidase
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reagent, oxidize this to the purple coloured indophenol. Ascorbic acid is incorporated 
in the reagent as a reducing agent to reduce autooxidation and to improve stability.
1-2 drops of reagent (Appendix 5) were dispensed onto a strip of Whatman No. 1 
filter paper, and then a colony from Campylobacter grown on blood agar was 
smeared onto the saturated filter paper. A positive test was indicated by the 
development of a violet to purple colour within 10-30 sec, and a negative test was 
indicated by delayed reactions or no colour development.
2.2.3 Catalase test
One drop of hydrogen peroxide (Sigma) was placed on a slide and was mixed with a 
colony of the strain. A positive test was indicated by the production of O2 gas.
catalase
H2O2 H2O + O2
2.3 Fractionation of C. jejuni cells
2.3.1 Preparation of bacterial culture supernatant, cell-free extracts 
and broken cell pellets
Broth cultures (100 ml) were centrifuged at 10,000 rpm for 10 min at 4 °C. The 
supernatant was used as bacterial culture supernatant in the assays. The bacterial 
pellet was resuspended in 1/50 volume of PBS and the bacteria were lysed by
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sonication using a cell sonicator (JENCONS Scientific Ltd) (4x30 sec bursts with 30 
sec intervals of cooling on ice between each burst). Cell debris and unlysed bacteria 
(broken cell pellets) were then produced using two different centrifugation speeds; 
3,600 xg for 10 min at 4 °C or 22,000 xg for 30 min at 4 °C in a Heraeus Biofuge 
and S or vail® ultracentrifuge, respectively. The cell-free extracts (supernatants) were 
divided into aliquots and stored at -70 °C. Broken cell pellets were resuspended to 
the original lysate volume in PBS and stored at -70 °C.
2.3.2 Preparation of cytoplasmic, inner-membrane protein (IMP) 
and outer-membrane protein (OMP) fractions of C. jejuni strains
A cell-free extract from the low speed centrifugation described above was re­
centrifuged at 100,000 Xg for 60 min at 4 °C in a Sorvall ultracentrifuge. The 
supernatant was used as a cytoplasmic fraction. The pellet was resuspended in 
envelope buffer (10 mM sodium phosphate, pH 7.2) (Appendix 7) containing 
sarcosyl 0.5% (w/v) (N-lauroyl-sarcosine) (Sigma) and left for 30 min to solubilise 
the proteins. After centrifugation at 100,000 xg for 60 min at 4 °C as described 
previously, the final supemate contained the sarcosyl-soluble inner membrane 
proteins and the final pellet contained the sarcosyl-insoluble outer membrane 
proteins preparations were obtained. The outer membrane fraction was resuspended 
in 0.5-1 ml of envelope buffer. All preparations were stored as aliquots at -70 '^ C.
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2.4 Protein estimations
Bradford’s assay and the modified Lowry method were used to estimate protein 
concentrations of bacterial culture supernatant, cell-free extract, broken cell pellets, 
cytoplasmic, IMP and OMP fractions of C. jejuni, C. coli and E, coli strains. After 
estimation, the protein concentrations of the various fractions were standardised to 
bring them to equal concentration per ml for use in cytotoxicity assays.
2.4,1 Bradford’s assay
The Bio-Rad Protein Assay is a dye-binding assay based on the differential colour 
change of a dye in response to various concentrations of protein (Bradford, 1976).
This is based on the observation that the absorbance maximum for an acidic solution 
of Coomassie Brilliant Blue G-250 shifts from 465 nm to 595 nm when binding to 
protein occurs (Reisner e ta l,  1975; Sedmak & Grossberg, 1977).
A concentration series in duplicate of bovine serum albumin (BSA) (Sigma) as 
standard was prepaied by diluting a stock of BSA (Sigma) (2mg/ml) in PBS. Also 
serial dilutions of samples were prepared in duplicate. 200 pi of the diluted Dye 
reagent (1 volume of Dye reagent concentrate diluted with 4 volumes of dHgO) was 
added to each sample dilution, and the absorbance value of samples, standard and 
blank (diluent) were read after 5 min at 595 nm on a spectrophotometer (Anthos). A i
standard curve was prepared by plotting the average Agggnm for each BSA 
concentration. The absorbance value of samples were then read off against the 
standar d curve to determine the protein concentration,
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2.4.2 Modified Lowry method
A sample volume of 1 ml containing test protein diluted in PBS, BSA concentrations 
(10, 20, 40, 80, 160, 320 and 640 pg/ml) in PBS as a standard and PBS as a blank as 
two fold serial dilutions in duplicate were prepared. 1 part of reagent B (Appendix 8) 
was added to 100 parts of reagent A (Appendix 8) to form Reagent C (Appendix 8).
3.0 ml of reagent C was added to the samples, which were incubated at room 
temperature for 45 min. The samples were then mixed vigorously with 0.3 ml of 
Folin & Ciocalteu’s Phenol reagent (Sigma) (Appendix 8) and were incubated for 45 
min at room temperature. Absorbance values of standards, samples and blank 
(diluent) were read at 660 nm. A standard curve was prepared by plotting the average 
Aeeonm for each BSA concentration. The absorbance value of samples were then read 
off against the standard curve to determine the protein concentration.
2.5 Sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE)
SDS-PAGE was performed according to the method of Laemmli (1970) in a vertical 
gel electrophoresis tank (Bio-Rad). Glass plates were assembled according to the 
manufacturer’s instructions. Resolving gels, containing 7.5, 10, 12.5 or 15% (w/v) 
acrylamide (Appendix 9.1), were poured between the assembled plates until the gel 
was approximately 2 cm below the top of the plates and then absolute (100%) 
ethanol was used as an overlay. The gel was left undisturbed for approximately 30 
min at room temperature until set, and then the overlay was poured off. The top of 
the separating gel was washed with distilled water and dried with the edge of a filter 
paper. A stacking gel containing 6% (w/v) acrylamide (Appendix 9.2) was poured
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directly onto the polymerised separating gel and a comb was placed into the gel 
solution and allowed to set. The gel was left undisturbed in a vertical position for 30 
min at room temperature until the stacking gel was set, and the comb was then 
carefully removed. The wells were filled with Ix electrode buffer (Appendix 9.4) 
and the gel was assembled into the electrophoresis tank containing the same buffer. 
Protein samples (16 jal) were loaded after mixing with 4 pi of 5x sample buffer 
(Appendix 9.3). The gel was run at 20 mA until the tracker dye entered the 
separating gel at which point the cuiTent was increased to 50 mA. The gel was 
removed when the tracker dye reached the bottom of the separating gel and stained 
for protein visualisation. Gels were stained with Coomassie Blue R-250 (Sigma) 
staining solution (Appendix 9.5) for a minimum of 2 h on a rotating platform and 
destained by several changes of destaining solution (Appendix 9.6) until the 
background was decolourised.
2.6 Tissue culture
2.6.1 Growth of mammalian target cells
2.6.1.1 Preparation of Vero cell line
African green monkey kidney (Vero) (ECACC) cells were grown to confluence at 37 
°C in 25cm^ tissue-culture flasks (Iwaki brand) in humidified conditions in an 
incubator with 5% CO% in Modified Eagle Medium (MEM) (Gibco) containing 5% 
(v/v) foetal calf serum (Labtech), 1% (w/v) penicillin/streptomycin (Gibco), 1% (v/v) 
fungizone (Gibco) and 1% (w/v) L-glutamine (Gibco). The cells were trypsinized 
with 3 ml trypsin EDTA solution (Gibco) before harvesting.
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2.6.1.2 Preparation of Caco-2 cell line
Human colon adenocarcinoma (Caco-2) (ECACC) cells were grown to confluence at 
37 °C as above in MEM culture medium containing 5% (v/v) foetal calf serum, 1% 
(w/v) penicillin/streptomycin, 1% (v/v) fungizone, 1% (w/v) L-glutamine, 1% (v/v) 
non-essential amino acid (NEAA) solution (Gibco) and 1% (v/v) insulin-transferrin- 
selenium (ITS) solution (Gibco) as growth promoters in 80cm^ tissue-culture flasks 
(Iwaki brand). The cells were trypsinized with 10 ml trypsin EDTA before 
harvesting.
2.6.1.3 Preparation of J774A.1 (murine macrophage)
Mouse macrophage-derived (J774A.1) (ECACC) cells were grown to confluence at 
37 °C in an incubator with 5% CO2 and in humidified conditions in phenol red-free 
Roswell Park Memorial Institute (RPMI 1640) medium (Gibco) containing 5% (v/v) 
foetal calf serum, 1% (w/v) penicillin/streptomycin, 1% (v/v) fungizone, 1% (w/v) L- 
glutamine in 25cm^ tissue-culture flasks. The cells were harvested by banging the 
flask to release the adhered cells.
2.6.2 Culture and treatment of mammalian cells
After harvesting, the cells were resuspended in the same tissue culture medium as 
they were grown in to a density of 5x10"*^  cells/ml (5x10^ cells/ml for J774A.1 cells). 
The trypan blue exclusion test was used to check the cell viability. For this, 50 pi of 
0.2% (w/v) trypan blue solution (Appendix 10) was added to 50 pi cell suspension 
and incubated at room temperature for 5 min. Cells that remained clear and had not
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taken up the blue stain were counted as viable cells using an improved Neubauer 
haemocytometer (Webber, UK).
Resuspended cells were added (as 100 pi for Vero and Caco-2 cells and 50 pi for 
J774A.1 cells) to the wells of a 96-well flat-bottomed tissue culture plate (Iwaki 
brand) and maintained at 37 °C. Serial two fold dilutions of fractions of C. jejuni 
(bacterial culture supernatant, cell-free extract, broken cell pellets, cytoplasmic, IMP 
or OMP preparations) were prepared in MEM or RPMI. After confluent growth of 
cells (18-24 h), 50 pi of each dilution was added in duplicate to the monolayers and 
the plates returned to the C02/air atmosphere at 37 °C. Cell-free extracts and broken 
cell pellets of Verotoxin-producing E. coli E32511A and a non-toxin producing 
strain, E. coli DH5a, were used as positive and negative controls for the presence of 
cytotoxin. Tissue culture medium and Triton X-100 (1%) (w/v) (Sigma) were also 
used as negative and positive controls in the assays to represent 0 and 100% killing, 
respectively (see formula below).
2.6.3 Cytotoxicity assays
2.6.3.1 MTT dye reduction assay
Cytotoxic activity was determined by the MTT assay as originally described by 
Mosmann (1983) using the CellTiter 96® non-radioactive cell proliferation assay 
(Promega) kit.
A tétrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tétrazolium bromide 
(MTT) is used as a quantitative colourimetric assay for mammalian cell survival. The
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assay detects living cells, which cleave by dehydrogenase activity in the 
mitochondria, the MTT tétrazolium ring to produce a dark blue formazan product.
After incubation of the tissue culture cell monolayers in the presence of sample for 
various times, 15pi of MTT dye solution was added to each well and the plates were 
incubated at 37 °C for 4 h in a humidified, 5% CO2 atmosphere. 100 pi of 
solubilization/stop solution was then added to each well and, after incubation 
overnight, the absorbance values of the samples were read at 570 nm using a 96 well 
plate reader (Anthos). The percentage of cell death was calculated using the formula 
below:
% Cell Death = 1 - [(Mean OD test - Mean OD +ve control) / (Mean OD „ve control -  
IVIean OD +ve control)] X  100
2.6.3.2 ATP-based assay
The Cell Titer-Glo™ luminescent cell viability assay (Promega) was also used to 
determine cytotoxic activity. This assay determines the number of viable cells in 
culture based on quantitation of the ATP present, used as an indicator of 
metabolically-active cells. The amount of ATP is directly proportional to the number 
of cells present in culture (Crouch et a l, 1993). Different cell types have different 
amounts of ATP, and values reported for the ATP level in cells vary considerably 
(Andreotti et a l, 1995; Beckers et a l, 1986; Crouch et a l, 1993; Kangas et a l, 1984; 
Stanley, 1986). Factors that affect the ATP content of cells may affect the 
relationship between cell number and luminescence. Factors that affect the 
cytoplasmic volume or physiology of cells will also have an effect on ATP content.
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One factor known to cause a rapid decrease in ATP content is depletion of oxygen 
(Crouch e ta l,  1993).
After incubation of the tissue culture cell monolayers in the presence of sample for 
various times in 96-well opaque-walled plates, 100 pi of the Cell Titer-Glo™ reagent 
was added to each well and the contents were mixed for 2 min on an orbital shaker to 
induce cell lysis. The plate was then incubated at room temperature for 10 min to 
stabilize luminescence signal. The luminescence was recorded with a luminometer 
(Anthos Lucy 1).
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2,7 Microscopy
Treated (test samples and positive controls) and untreated (negative control) tissue 
culture cells after different incubation times were examined with an inverted 
microscope (ZEISS, Axiovert 25) at magnifications of x20 and x40. Photographs 
were taken with a camera (Photometries) mounted on the microscope.
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2.8 Purification of Proteins
2.8.1 DEAE sepharose column chromatography
5 ml DEAE sepharose fast flow (Sigma) was applied to a glass Econo-column (1.5 
cm X 20 cm) (BioRad) and washed with 30 ml of water to remove excess ethanol. 
The column was equilibrated at 4 °C by washing with 25 ml of envelope buffer 10 
mM (Tris base, pH 7.2) (binding or starting buffer). A further 50 ml of envelope 
buffer was applied, followed by 25 ml of envelope buffer. Then 5 ml of low speed 
centrifugation cell-free extract (crude sample) (3.5 mg total protein) was applied to 
the column and left for 30 min and the flow-through was collected. The column was 
washed with 25 ml of envelope buffer and was collected as wash-through no. 1. Then 
5 ml of increasing concentrations of NaCl (0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.7, 0.9 and 
IM) in envelope buffer (pH 7.2) were eluted. Finally, 25 ml of envelope buffer was 
used to wash the column and was collected as wash-through no. 2. All the procedures 
were done at 4 °C.
2.8.1.1 Concentration of samples
Centricon (Millipore) centrifugal concentrators with a moleculai' weight cut-off 
(MWCO) value of 5,000 kDa were used to concentrate (10 times) some fractions 
from the DEAE sepharose purification. A 2 ml volume of sample was applied to the 
Centricon sample reservoir and the tube centrifuged at 2,000 xg for 20 min at 4 °C to 
concentrate the sample approximately 10 times as per the manufacturer’s 
instructions.
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2.8.2 Fractionation of proteins using Microcon tube
2.9 Characterisation (identification) of proteins 
(proteomics)
2.9.1 In-gel digestion after SDS-PAGE (1-dimensional)
The Coomassie-stained gels were destained as normal until the background was clear 
and bands were visible. Protein bands were then excised for in-gel digestion with 
trypsin. Usually a small portion from the middle of a gel band is enough rather than 
the whole band, particularly for stronger bands. This cuts down on the amount of 
acrylamide in the digest, and improves diffusion of reagents into and peptides out of 
the gel slice. For this experiment, proteins in the whole gel lane were analysed,
■'If
t :
To purify and separate proteins, MicroCon tubes (Millipore) were used. The protein 
sample was applied sequentially to MicroCon tubes of sizes 100,000, 50,000, 30,000,
10,000, and 5,000 MWCO, respectively. First, 3 ml of sample was applied to a
100,000 MWCO MicroCon tube and was centrifuged at 3,000 xg for about 15 min
■4until -50 pi of sample remained in the tube and 2950 p,l was filtered. The filtrate was
Iapplied to a 50,000 MWCO MicroCon tube and was centrifuged as above until 50 ql 
of sample remained on the tube and 2900 jiil was filtered. This procedure was 
repeated until the MicroCon 5,000 MWCO tube was reached and 6 fractions were 
collected.
Bradford’s assay was used to measure the protein concentrations of the fractions, and %
also the fractions were examined by SDS-PAGE.
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irrespective of mild or strong bands. After the gel pieces were excised, they were cut 
into several pieces and placed in 1.5 ml eppendorf tube. The gel pieces were then 
washed for 1 hour in 500 pi of 100 mM ammonium bicarbonate. A volume of 10 pi 
of 45 mM DTT in 150 pi of 100 mM ammonium bicarbonate sufficient to cover the 
gel pieces was added, and the proteins were reduced for 30 min at 60 °C. After 
cooling to room temperature, the DTT solution was replaced with 10 p i of 100 mM 
iodoacetamide. After 30 min incubation at ambient temperature in the dark with 
occasional voitexing, the gel pieces were then washed with 500 pi of 50% 
acetonitrile/ 100 mM ammonium bicarbonate. This step was aided by shaking for 1 
h. After discarding the wash, 50 pi of acetonitrile was added to shrink the gel pieces. 
The liquid phase was removed within 10 min, and the gel pieces were completely 
dried in a vacuum centrifuge (DNA Speedvac®). The gel pieces were reswollen in 
0.2 pg of trypsin (Sigma) in 10 p i of 25 mM ammonium bicarbonate. After 15 min, 
20 pi of 25 mM ammonium bicarbonate was added to cover gel pieces and to keep 
the gel pieces wet. For enzymic cleavage, the sample is then incubated at 37 °C for 
overnight in flatbed shaker.
After digestion, the remaining supernatant was removed and saved. The remaining 
peptides were extracted from the gel pieces by incubating in 5% (v/v) formic acid 
(enough to cover the pieces) for 15 min and then adding the same volume of 100% 
acetonitrile for a further incubation of 15 min. The extraction was repeated twice and 
all three fractions were pooled and dried down in a vacuum centrifuge and 
resuspended in 10 p i of 5% formic acid.
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2.9.2 Two-dimensional electrophoresis
2.9.2.1 Sample preparation (supl and sup2) for 2-DE gels
C. jejuni colonies were inoculated in 5 ml of Brucella broth, and were incubated for 
48 h under microaerophilic conditions at 42 °C. After 48 h, 5 ml of bacterial culture 
was added to 500 ml of Brucella broth and was incubated as above. After 48h, the 
ODgoonm was measured. Bacterial cultures were centrifuged at 10,000 rpm for 10 min, 
the supernatant was discarded and the pellets were resuspended in a small volume of 
Brucella broth medium (10 ml) and shell frozen in liquid nitrogen. They were then 
freeze dried overnight on a freeze-dryer (E-C, Modulyo).
ProteoPrep'^'^ Universal Extraction Kit (Sigma) was used to prepare material for 2- 
DE. After freeze drying, 20 mg of lyophilized C. jejuni was resuspended in 10 ml of 
soluble cytoplasmic extraction reagent (S2688, Sigma). The suspension was 
sonicated on ice using a cell sonicator (JENCONS Scientific Ltd) for 4x30 sec bursts 
with 30 sec intervals of cooling on ice between each burst to disrupt the cells and 
break down the DNA. The suspension was centrifuged at 14,000 xg for 45 min at 4 
°C to pellet cell debris and insoluble material. The supernatant was kept on ice. A 
further 10 ml of soluble cytoplasmic extraction reagent was added to the pellets and 
sonication and centrifugation were repeated as above. This yielded a supernatant and 
a pellet. This supernatant and that stored on ice were pooled for a total soluble 
protein extract of about 20 ml (supl). supl was lyophilized overnight using a freeze- 
dryer (E-C, Modulyo) and the lyophilized material resuspended in 2 ml of soluble 
protein resuspension reagent (S 3688, Sigma) and was stored on ice for the next step. 
The cell pellet was resuspended in 2 ml of cellular and organelle membrane
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solubilizing reagent (C0356, Sigma), and then was sonicated as above. The 
suspension was centrifuged at 14,000 Xg for 45 min at 15 °C to pellet cell debris and 
the supernatant (sup2) was decanted.
supl and sup2 were reduced by adding ti'ibutylphosphine (TBP) to each to a final 
concentration of 5 mM and were incubated for 1 h at room temperature, supl and 
sup2 were then alkylated by adding iodoacetamide to each to a final concentration of 
15 mM and were incubated for 1.5 h at room temperature. After the incubations, the 
reduced and alkylated samples were centrifuged at 20,000 xg for 5 min at room 
temperature to remove any insoluble material.
2.9.2.2 TCA precipitation
Due to the low protein concentrations of sup2, precipitation with TCA was 
performed. TCA was added to 10% (w/v) of the sample volume, and was kept on ice 
for 30 min. The sample was centrifuged at 13,000 rpm (microcentrifuge) for 30 min, 
the supernatant was discaided and the pellet was washed several times with acetone 
before being solubilised.
2.9.2.3 First dimension separation by lEF
Proteins were separated in the first dimension using the IPGPhor® isoelectric 
focusing system employing immobilised pH gradient (IPG) strips. The required 
number of strip holders were placed on to the IPGPhor® and 450 /rl of sample 
containing rehydration solution (Appendix 11) was evenly pipetted in the strip holder 
groove. The 24 cm Immobiline DryStrips® were lowered, gel side down on to the 
rehydration solution without trapping air bubbles. To minimize evaporation and urea 
crystallization, this strip was then oveiiayed with DryStrip Cover Fluid®
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(Amersham) before the plastic cover was applied. The proteins were then focused to 
their isoelectric points according to the programmed conditions in Table 2.3. 
Rehydration and isoelectric focusing were performed in this integrated system at 20 
°C. Following isoelectric focussing, the proteins were reduced and bound to sodium 
dodecyl sulphate (SDS) by equilibrating each strip for 15 min in 10 ml of SDS 
equilibration buffer (Appendix 12) containing 100 mg of dithiothreitol (added fresh 
before use). A second equilibration step in SDS equilibration buffer containing 250 
mg of alpha-iodoacetamide (added fresh before use) instead of dithiothreitol was 
performed in order to prevent protein re-oxidation and to minimise reactions of 
cysteine residues.
Table 2.3: Isoelectric focusing steps used to focus pH 3-10 nonlinear IPG 
strips
IPG Step Voltage Duration (hour)
3-10 nonlinear
Rehydration — 12
1 500 1
2 1000 1
3 8000 6
2.9.2.4 Second dimension separation by SDS-PAGE
After equilibration, the immobilised pH gradient strips were rinsed in electrophoresis 
buffer before being placed on to 12.5% (w/v) homogeneous polyacrylamide gels. 
Ettan DALT precast gels® (1 mm thickness x 255 mm width x 196 mm length) cast
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onto a plastic support film were used in conjunction with the Ettan T>AUYtwelve® 
system (Amersham). The Ettan DALT precast gel® was inserted into a previously 
cleaned and dried Ettan DALT precast gel cassette®. The gel side of the precast gel 
was placed over the glass plate of the gel cassette and the cathodic end (-) of the gel 
was placed on the cathodic end of the cassette. A roller was used against the plastic 
support film to press out any bubbles or liquid from between the gel and the glass. 
Thus the gel is adhered firmly to the glass and resists further movement. The cassette 
was then closed by pressing the plastic frame and the glass plate tightly together. To 
load the equilibrated IPG strip, the gel cassettes were placed in an upright position 
and then the IPG strip was inserted between the glass plates with a spatula or spacer 
and brought in close contact with the upper edge of the SDS gel. Then the area was 
sealed with molten 0.5% (w/v) agaiose in gel running buffer (supplied with Ettan 
DALT buffer kit®). After the agaiose had set, the loaded gel cassettes were ready to 
insert into different slots of the Ettan DPdJYtwelve® tank.
The Ettan DALT buffer kit® was used to make electrophoresis buffer. Two types of 
anode and cathode buffer were prepared according to the manufacturers instructions 
and used for all second dimension separations. The cathode buffer included in the 
Ettan DALT Buffer kit® was diluted in a separate container to working strength. This 
was done by adding both bottles of lOx cathode buffer (total volume 250 ml) to 2.25 
L of distilled deionised water. The DALT tank was filled to the 7.5 L fill line with 
distilled deionised water and the entire contents of the bottle of lOOx anode buffer 
(supplied with Ettan DALT Buffer kit®) was added carefully by spreading the tubing 
elements apart. The pump was switched on to start mixing the buffer with water at a 
set temperature of 15 °C. The gel cassettes loaded with IPG strips were inserted into 
different slots of the Ettan T>Ps\dïtwelve® tank. Blank cassettes were inserted into any
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unoccupied slots. When all 12 slots were occupied, the buffer level was adjusted (by 
adding distilled deionised water with the help of a pipette) to be slightly below the 
level of gaskets. The diluted cathode buffer (Ix) was then poured into the top of the 
tank to the fill line. After filling the tank with cathode and anode buffer, 
electrophoresis were run at 2 w/gel until the bromophenol blue front had completely 
migrated out of the SDS gel.
2.9.2.5 Visualization of proteins
Gels were stained overnight by incubating in a coomassie staining solution consisting 
of 0.5 g Coomassie Brilliant Blue G-250 (Sigma), 100 ml glacial acetic acid, 125 ml 
isopropanol, and ddHzO up to 1 L. Then the gels were destained by multiple washes 
in a solution of 10% glacial acetic acid with 20% methanol until background of the 
gel was clear.
2.9.3 Image analysis
Images of gels were acquired at 300 dots per inch (dpi) using Labscan v3.0 software 
(Amersham Pharmacia Biotech) on a Umax flatbed scanner (OD maximum 3.4) with 
integrated transparency adapter and/or Typhoon® scanner 9400 (variable mode 
imager). The tiff images generated were analysed using ImageMaster® 2D Elite 
V3.01 software. The authenticity and outline of each spot were validated by visual 
inspection and edited where necessary. The volume values for each spot were 
acquired using no-subtraction mode and normalized against the total intensity of the 
detected spots.
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2.9.4 Mass spectrometry
2.9.4.1 Processing of protein for mass spectrometry
A number of spots were selected from different gels with the help of image analysis 
software and then subjected to the robotic Ettan Spot Handling Workstation® 
(Amersham Pharmacia Biotech) where the excision of each spot and subsequent 
digestion with sequencing grade modified porcine trypsin (Promega, Madison, WI, 
USA), were done automatically.
The spot picking, destaining, digestion, extraction, MALDI sample preparation and 
spotting on MALDI target slides were carried out robotically in this enclosed, fully- 
automated, spot-handling workstation. Briefly, each picked gel plug was rinsed by 
three wash cycles in which 150 (jlI of 50% methanol/50% water, containing 25 mM 
ammonium bicarbonate was applied, left to stand for 15 min, and then removed. The 
plugs were dehydrated in 75% acetonitrile for 20 min, the solution removed, and the 
trays placed into a heated, air circulating drying module and dried for 10 min. To the 
dried plugs was added 7 jul of digestion solution (containing 40 ng/(Jl\ of sequencing 
grade trypsin in 25 mM ammonium bicarbonate), and the plate was robotically 
transferred to the digestion station where it was covered and maintained at 37 ”C for 
4 h. Eighty microliters of extraction solution (50% acetonitrile containing 0.1% 
trifluoroacetic acid, TEA) were then added to each well and left to stand for 20 min. 
The extract solutions were transferred to a clean 96-well plate, and the extraction 
repeated. The plate containing the combined extracts was then evaporated to dryness. 
MALDI samples were prepared by reconstituting the dried peptides in 3 (jlI of 50% 
acetonitrile containing 0.5% TEA. An aliquot of 0.3 (à\ was then applied to the clean
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MALDI target slide surface and allowed to dry. The spots were redissolved by the 
addition of 0.3 (xl of matrix solution (a-cyano-4-hydroxycinnamic acid saturated 
solution in 50% acetonitrile containing 0.5% TEA) and finally allowed to dry before 
MALDI-TOE mass spectrometry. The plate containing the remaining peptides was 
stored at -20 °C until LC-MS/MS analyses could be performed.
2.9.4.2 MALDI-TOF mass spectrometry
MALDI peptide mass fingerprinting was carried out using the Applied Biosystems 
Voyager-DE instrument operating in reflectron mode and equipped with a nitrogen 
laser (337 nm, 3 ns pulse width, 3 Hz repetition rate). Internal calibration was 
performed using the porcine trypsin autodigestion peaks at m/z 842.510 and 
2211.1046. Each spectrum conesponded to the sum of 200 acquisitions, in which the 
threshold signal-to-noise exceeded a set value. Protein identification by peptide mass 
fingerprinting was performed using the MASCOT® search engine (Matrix Science, 
London, UK) and database described later in this chapter.
2.9.4.3 Tandem mass spectrometry
Proteins that were not resolved by MALDI-TOE MS were subjected to LC-MS/MS 
using a capillary HPLC system and a Q-TOE mass spectrometer. Eor protein 
identification, the files containing all the MS and MS/MS data obtained during each 
run were searched against the National Center for Biotechnology Information 
(NCBInr) protein database (www.ncbi.nlm.nih.gov) using MASCOT®software 
(www.matrixscience.com).
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2.9.5 Database search
Peptide mass fingerprint data from MALDI-TOF and peptide fragmentation data 
from Q-STAR-MS/MS were used to search genomic and protein databases including 
NCBInr database ('http://www.ncbi.nlm.nih.gov). and Mass spectrometry database 
(MSDB).
2.9.5.1 The MASCOT® search tool
The MASCOT® search engine (http://www.matrixscience.com) is based on a 
modified MOWSE computer programme using a probability-based scoring system 
(Pappin et a l, 1993). The probability that the observed match between the 
experimental data and a protein sequence is random is calculated for each protein 
sequence in the database. The proteins are classified with increasing probability of 
being a random match to the experimental data. This probability is based on the size 
of the database and the frequency of each peptide mass in the database. The search 
tool guidelines state that if the probability based score is higher than the database’s 
probability (p) then the match is significant within 95% confidence limits. This 
search engine supports all three types of searches: peptide mass fingerprint, sequence 
query, and MS/MS ion search. The results are displayed as a histogram showing the 
distribution of the scores and the 95% confidence limits.
2.9.5.2 The NCBInr database
This database contains the translated protein sequences from the entire collection of 
annotated DNA sequences kept at GenBank, and also protein sequences in the 
protein Data Bank (PDB), CDS translations, covering most of the publicly available
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data. The NCBI also provide BLAST (Basic Local Alignment Search Tool) 
programme support for database sequence similarity searching.
2.9.6 Difference gel electrophoresis (DIGE)
The difference gel electrophoresis (DIGE) method allows multiplexing of samples 
and the use of an internal standaid, which is created by using one of the labels for a 
pooled mixtures of all samples. The method is based upon the specific properties of 
the three CyDye''''^ DIGE Fluor minimal dyes which enable multiplexing of up to 
three separate protein mixtures on the same 2D gel. Cy™2, Cy3 and Cy5 are three 
spectrally resolvable dyes (CyDye DIGE Fluor minimal dyes) mached for mass and 
charge. Because gel-to-gel variations are eliminated, this method leads to highly 
accurate qualitative and quantitative results. Samples for DIGE experiments were 
submitted to the Functional Genomics Facility (University of Glasgow). Fig. 2.1 
shows the workflow of the DIGE system.
2.10 DNA techniques
2.10.1 Polymerase chain reaction (PCR) techniques
2.10.1.1 Preparation of boiled extract for PCR (DNA extraction)
Bacterial cell DNA was isolated by the boiling method from cultures grown on blood 
agar. Several loops of bacterial growth were resuspended in 250 pi of nuclease-free 
water in microfuge tubes. These were placed in a heating block at 99 °C for 10 min. 
The tubes were then placed at -20 °C for 5 min to ‘snap-freeze’ them. Suspensions
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Figure 2.1: Schematic workflow of DIGE system.
Diagram was taken from Westermeier & Marouga (2005).
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were then centrifuged at 13,000 rpm for 10 min in a Heraeus microfuge after which 
the supernatant containing DNA was removed and stored at -20 °C.
2.10.1.2 PCR amplîfîcation
The sources of the primer sequences and reaction conditions used in this study are 
listed in Table 2.4. PCR amplifications were performed in a 50 pi volume containing 
45 pi of PCR ReddyMix"^^ master mix (ABgene®), 1 pi (20 pmole) of each primer 
(Invitrogen) and 3 pi of template.
PCR products were analysed by agarose gel electrophoresis (see section 2.10.3).
Composition of PCR ReddyMix™ master mix:
Taq DNA Polymerase 1.25 units
Tris-HCl (pH 8.8 at 25 °C) 75 mM
(NH4)2S0 4  20 mM
MgClz 1.5 mM
Tween® 20 0.01% (v/v)
Each of dATP, dCTP, dGTP and dTTP 0.2 mM
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2.10.2 Plasmid purification
2.10.2.1 Small-scale isolation of plasmid DNA
The QIAprep® miniprep kit (Qiagen) was used to purify plasmids from C. jejuni 
strains. E. coli JC3272 (containing plasmid pRK 2013) and E. coli JC3272 were used 
as positive and negative controls, respectively.
10 ml of bacterial culture was centrifuged at 4,000 rpm for 10 min and the pelleted 
bacterial cells were resuspended in 250 pi of buffer PI (resuspension buffer, 
containing RNase A) and then 250 pi of buffer P2 (lysis buffer) was added and the 
tube inverted gently 4-6 times to mix (the solution became viscous and slightly clear 
after inverting). Then 350 pi of buffer N3 was added and the tube gently inverted 4-6 
times after which the solution became cloudy. The tube was centrifuged for 10 min at 
maximum speed (13,000 rpm) in a tabletop microcentrifuge (Heraeus, Biofuge). 
After centrifugation, a compact white pellet formed and the supernatant was 
transferred to the QIAprep spin column by decanting or pipetting and this was 
centrifuged for 30-60 s and the flowthrough was discarded. The QIA prep spin 
column was washed by adding 0.5 ml of buffer PB (to remove traces of nuclease 
activity) and then was centrifuged for 30-60 s and the flowthrough was discarded. 
The column was washed again by adding 0,75 ml of buffer PE (containing ethanol) 
and was centrifuged for 30-60 s, the flowthrough was discarded and the column was 
centrifuged for an additional 1 min to remove residual wash buffer. The QIAprep 
column was placed in a clean 1.5 ml microcentrifuge tube and, to elute DNA, 20 pi 
of buffer EB (10 mM Tris-HCl, pH 8.5) was added to the centre of each QIAprep
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column and, after standing for 1 min, was centrifuged for 1 min. The flowthrough 
was stored at -20 °C.
2.10.2.2 Large-scale isolation of plasmid DNA
QIAGEN® large-construct kit was also used to purify plasmids from C. jejuni strains. 
A single colony from a freshly-streaked selective plate was inoculated as a starter 
culture into 2-5 ml Brucella broth containing the appropriate selective antibiotic. The 
medium was incubated for 48 h at 42 °C with vigorous shaking in a flask with a 
volume at least 4 times greater than the volume of the culture. 0.5-1.0 ml of the 
starter culture was diluted into 500 ml Brucella broth and was grown at 42 °C for 48 
h with vigorous shaking. The bacterial cells were haivested by centrifugation at
6,000 X g  for 15 min at 4 °C. The bacterial pellet was resuspended in 20 ml of buffer 
PI (which had Rnase A added, resuspension buffer) (Appendix 15), and then 20 ml 
of buffer P2 (lysis buffer) (Appendix 15) was added and mixed gently but thoroughly 
by inverting 4-6 times, and was then incubated at room temperature for 5 min. Then 
20 ml of chilled buffer P3 (neutralization buffer) (Appendix 15) was added, mixed 
immediately by gentle inversion 4-6 times, and was incubated on ice for 10 min, and 
after that it was centrifuged at 20,000 xg for 30 min at 4 °C, and the supernatant 
containing DNA was removed promptly. The lysate was filtered through a folded 
filter pre-wetted with distilled water. DNA was precipitated at room temperature by 
adding 0.6 volume (approximately 36 ml) of isopropanol to the cleared lysate, mixed 
and centrifuged immediately at 15,000 xg for 30 min at 4 °C, and then the 
supernatant was decanted carefully. The DNA pellet was washed with 5 ml of 70% 
(v/v) ethanol at room temperature, and was centrifuged at 15,000 xg for 15 min, and 
the supernatant was decanted carefully without disturbing the pellet. The 70%
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ethanol removed precipitated salt and replaced isopropanol with the more volatile 
ethanol, making the DNA easier to redissolve. The tube containing the DNA was 
placed upside down on a paper towel and the DNA was allowed to air-dry for 2-3 
min, any additional liquid visible was removed carefully and the DNA was mixed 
gently in 9.5 ml buffer EX until the DNA was completely dissolved. Then 200 pi of 
ATP-dependent exonuclease and 300 pi ATP solution (lOOmM) were added to the 
dissolved DNA, mixed gently but thoroughly, and incubation continued in a water 
bath or heating block at 37 °C for 60 min. During this step genomic DNA and nicked 
plasmid were digested by exonuclease, and only supercolied DNA remained for 
further purification. A QIAGEN-tip 500 was equilibrated by applying 10 ml of buffer 
QBT (equilibration buffer) (Appendix 15), and the column was allowed to empty by 
gravity flow. 10 ml of buffer QS was added to the DNA sample, and the whole 
sample was applied to the QIAGEN-tip, and was allowed to enter the resin by gravity 
flow. The QIAGEN-tip was washed with 2x30 ml of buffer QC (wash buffer) 
(Appendix 15). DNA was eluted with 15 ml of buffer QF (elution buffer) pre 
warmed to 65 °C (Appendix 15). DNA was precipitated by adding 10.5 ml (0.7 
volume) of isopropanol room-temperature to the eluted DNA, mixed and centrifuged 
immediately at 15,000 Xg for 30 min at 4 °C, and the supernatant was decanted 
carefully. The DNA pellet was washed with 5 ml of 70% (v/v) ethanol at room- 
temperature, was centrifuged at 15,000 xg for 15 min, and the supernatant was 
decanted carefully without disturbing the pellet. The pellet was air-dried for 5-10 
min, and the DNA was redissolved in a suitable volume of TE buffer, pH 8,0 
(Appendix 15).
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2.10.2.3 Restriction endonuclease digestion of supercoiled plasmid DNA
Bglll (Promega) enzyme was used to digest the supercoiled plasmid purified by 
QIAGEN® Large-Construct Kit. A mixture of 5 pi of supercoiled DNA, 1 pi of J5g/II 
enzyme, 5 pi of enzyme buffer and 19 pi of dH20 were incubated at 37 °C overnight.
2.10.3 Agarose gel electrophoresis
5-20 pi of the sample DNA were mixed with 6x DNA loading buffer (Appendix 13) 
in a ratio of 5:1 prior to loading into the wells. Molecular weight markers were 
utilised according to manufacturer’s instructions.
Agarose Type II-A (Sigma) was suspended in 0.5x Tris boric EDTA (TBE) 
(Appendix 14) to the required concentration and heated until the agarose was 
completely dissolved. The solution was allowed to cool, and ethidium bromide was 
added to a final concentration of 1.0 pg/ml, after which the agarose was poured into 
an appropriate gel tray. Upon setting, the gel was immersed in 0.5x TBE in a 
horizontal gel electrophoresis tank (Bio-Rad). Samples were loaded and a current of 
100 mA was passed through the agarose gel using a powerpack (Bio-Rad). 
Electrophoresis was carried out until the marker dye had migrated an appropriate 
distance.
A high performance ultraviolet transilluminator (Ultra Violet Products, Cambridge, 
UK) coupled to an image acquisition system was used to store images of the 
ethidium bromide-stained DNA electronically using analysis software package 
(LabWorks). A video graphic printer (model UP-860, Sony) was used to print the 
images which were edited using Adobe Photoshop Version 4.
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CHAPTER 3: RESULTS
3.1 Growth curve of C. jejuni
C. jejuni strain 81-176 was inoculated in Brucella broth and incubated 
microaerophilically as described in section 2.1.2.1. Every 6h, the absorbance value of 
the culture was measured at 600 nm and a typical growth curve showed that 
maximum absorbance (Agoonm) was obtained after 48h incubation (Fig.3.1). Thus, 
cultures of C. jejuni for cytotoxicity assays were used after incubation for 48h.
3.2 Characterization of the strains
3.2.1 Growth of C. jejuni strains on blood agar containing Blaser- 
Wang selective supplements
All C. jejuni strains that were used in this study grew on Blood agar (BA) containing 
Blaser-Wang selective supplements and had formed visible colonies after incubation 
for 36h under microaerophilic condition, indicating that all strains behaved as 
expected for C. jejuni.
3.2.2 API CAMPY identification test
The identity of the 39 clinical isolates was confirmed using the API CAMPY 
identification kit. Reference strains 11168 (C. jejuni) and WA 585 (C. coli) were 
used as positive and negative controls. The results confirmed that all clinical isolates 
used in further tests were C. jejuni jejuni. According to the manufacturer’s 
instructions, it is normal to experience a lack of uniformity between strains in some
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Figure 3.1: Growth curve of C. jejuni strain 81-176
The organism was grown in Brucella broth medium under microaerophilic conditions 
in an anaerobic jar secured on an orbital shaker running at 100 rpm at 42 °C. Every 
6h, the absorbance value of the culture was measured at 600 nm.
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test results. Details of API CAMPY test results are shown in Tables 3.1 and 3.2. 
They show that not all strains produced uniform results, but all were placed as C. 
jejuni jejuni. 37 of the 39 clinical isolates were identified as C. jejuni jejuni 1 or 2 
with ID score > 98.3%; and two isolates were also identified as C. jejuni jejuni 1 
with 88.3% ID scores. 19 (48.72%) of the isolates were identified as C. jejuni jejuni 
1 and 20 (51.28%) of them as C. jejuni jejuni 2 (Table 3.2). According to Table 3.1, 
GOT (Gamma Glutamyl Transferase) test is the most important test to differentiate 
between C. jejuni jejuni 1 and 2 which showed negative and positive results, 
respectively.
3.2.3 PCR for hippuricase (hipO) gene
Differentiation of C. jejuni from other Campylobacter spp. depends on its ability to 
hydrolyse hippurate (Wallace et al., 1997) and hippuricase is the product of the hipO 
gene (Hani & Chan, 1995). All Campylobacter strains listed in Table 3.1 were tested 
for the presence of hipO gene. C. jejuni gave a positive amplimer in all cases, but no 
PCR product was detected for C. coli WA585. Some examples are shown in Fig. 3.2.
3.2.4 Catalase test
The catalase test was used in parallel with API CAMPY test to diagnose the strains. 
All Campylobacter isolates were positive for the catalase test.
3.3 SDS-PAGE analysis of culture supernatants and cell- 
free extracts
SDS-PAGE showed that less protein was present in culture supernatant than in cell- 
free extracts (Fig. 3.3). Distortion of the gel was apparent with lanes containing
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Table 3.2: Results of API CAMPY test
Results
strain Identified strain 
(substrain)
Percentage of 
identiRcation 
(ID score)
Test againsP"
C O L l C. jejun i je ju n i 1 99.4 —
C 0L 2 C. jejun i je jun i 2 99.9 PyrA 15%
COL3 C. jejun i je jun i 1 98.4 PyiA 10%
COL4 C. jejun i je jun i 1 99.3 —
COLS C. jejun i je jun i 1 99 —
COL6 C. je ju n i je ju n i 2 99.7 PyrA 15%, CFZ 93%, CITa 25%
COL7 C. je ju n i je ju n i 1 99.6 PyrA 10%, CFZ 84%,
COL8 C. je ju n i je ju n i 1 99.4 —
COL9 C. je ju n i je ju n i 1 99.4 MLTa 84%
COLIO C. je ju n i je ju n i 2 99.8 PyrA 15%, CITa 25%
C O L ll C. je ju n i je ju n i 2 99.8 PyrA 15%, CITa 25%
C 0L 12 C. je ju n i je ju n i 2 99.8 CITa 25%
COL13 C. je ju n i je ju n i 2 99.9 PyrA 15%
COL14 C. je ju n i je ju n i 2 99.8 PyrA 15%, CITa 25%
COL15 C. je ju n i je ju n i 2 99.9 PyrA 15%, CITa 25%
COL16 C. je ju n i je ju n i 2 99.8 PyrA 15%, CITa 25%
C 0L 17 C. je ju n i je jun i 2 99.8 PyrA 15%, CITa 25%
COL18 C. je ju n i je ju n i 2 99.8 PyrA 15%, CFZ 93%,
COL19 C  je jun i je ju n i 2 99.9 PyrA 15%, ArgA 9%, CITa 25%
COL20 C. je ju n i je ju n i 2 99.8 PyrA 15%, CITa 25%
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Table 3.2: (continued)
Results
strain Identified strain 
(substrain)
Percentage of 
identification 
(ID score)
Test against
COL21 C. je ju n i je ju n i 2 99.8 PyrA 15%, CITa 25%
COL22 C. je ju n i je jun i 1 98.7 PyrA 10%
COL23 C. je ju n i je jun i 2 99.8 PyrA 15%, SUT 96%
COL24 C. je ju n i je jun i 1 98.7 PyrA 10%
COL25 C. je ju n i je jun i 1 99.1 PyrA 10%, MLTa 84%
COL26 C. je ju n i je jun i 1 99.6 PyrA 10%, CFZ 84%
COL27 C. je ju n i je jun i 1 98.9 PyrA 10%
COL28 C. je ju n i je jun i 1 98.7 PyrA 10%
COL29 C. je ju n i je jun i 1 88.3 NIT 98%, PyrA 10%, CFZ 84%
COL30 C. je ju n i je jun i 1 88.3 NIT 98%, PyrA 10%, CFZ 84%
RPHl C. je ju n i je jun i 2 99.9 PyrA 15%, MLTa 84%
RPH2 C. je ju n i je ju n i 2 99.9 PyrA 15%
RPH3 C. je ju n i je ju n i 2 99.8 -
RPH4 C. je ju n i je ju n i 1 99.4 -
RPH5 C. je ju n i je ju n i 1 99.4 -
RPH6 C. je ju n i jejun i 1 98.7 PyrA 10%
RPH7 C. je jun i jejun i 2 99.8 PyrA 15%, CITa 25%
RPH8 C. je ju n i je ju n i 1 99.1 PyrA 10%
RPHIO C. je ju n i je ju n i 2 99.9 PyrA 15%
‘^Test against, tests not compatible with given identity.
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Figure 3.2: PCR to confirm the presence of hippuricase {hipO) gene in C. jejuni
strains.
DMA was extracted from whole bacterial cells and used as a template for PCR using 
primers for hipO gene (see section 2.10.1.2).
M; 1 kb DNA ladder
Lane 1; C. jejuni 81-176
Lane 2: C. jejuni 81-176 cdtB mutant
Lane 3: C. jejuni 11168
Lane 4: C. jejuni 11168 cdtB mutant
Lane 5: C. jejuni 11168 cdtA mutant
Lane 6: C. jejuni COL7
Lane 7: C. coli WA 585
hipO gene amplicon: 1130 bp (indicated with the arrow)
Results
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Figure 3.3: SDS-PAGE of cell-free extracts and culture supernatants from C.
jejuni strains and control strains
Cell-free extracts (with two different centrifugation speeds and times) and culture 
supernatants of C. jejuni clinical isolates (COLl and COL7) and two E. coli strains 
(E32511 and DH5a) as controls were subjected to electrophoresis on a 10% (w/v) 
polyacrylamide gel and stained with 0.1% (w/v) Coomassie blue solution (section 
2.5).
Lane 1: C. jejuni COLl, cell-free extract, after centrifugation at 3,600 xg/10 min 
Lane 2: C. jejuni COLl, cell-free extract, after centrifugation at 22,000 xg/30 min 
Lane 3: C. jejuni COL7, cell-free extract, after centrifugation at 3,600 xg/10 min 
Lane 4: C. jejuni COLl, cell-free extract, after centrifugation at 22,000 xg/30 min 
Lane 5: C. jejuni COLl, culture supernatant 
Lane 6: C. jejuni COL7, culture supernatant
Lane 7: Protein marker (covers a molecular weight range of 10-250 kDa)
Lane 8: E. coli E32511, culture supernatant 
Lane 9: E. coli DH5a, culture supernatant
Lane 10; E. coli E32511, cell-free extract, after centrifugation at 3,600 xg/10 min 
Lane 11: E. coli E32511, cell-free extract, after centrifugation at 22,000 xg/30 min 
Lane 12: E. coli DH5oc, cell-free extract, after centrifugation at 3,600 xg/10 min 
Lane 13: E. coli DH5a, cell-free extract, after centrifugation at 22,000 xg/30 min
Results
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Results
culture supernatant, presumely due to the salt content of the growth medium. 
Differences were apparent between protein bands present in E. coli and C. jejuni 
extracts, but no noticeable difference could be seen between high-speed and low- 
speed centrifugation extracts.
3.4 Cytotoxicity assay
3.4.1 Cytotoxicity assay of C. jejuni culture supernatant
After protein estimation, filtered and concentrated culture supernates were tested on 
Vero cells for cytotoxicity. Some low cytotoxic activity after incubation for 16h was 
noted, but it was much less than that obtained with cell-free extracts. This result 
suggests that although some cytotoxin activity may be secreted into the culture 
medium, it was too little to warrant further investigation.
3.4.2 Cytotoxicity assay of cell-free extracts of C. jejuni strains on 
Vero cells
Cell-free extracts obtained after two different centrifugation speeds and time were 
tested in the cytotoxicity assay. Cell-free extracts from high-speed centrifugation 
(22,000 xg) for 30 min and low-speed centrifugation (3,600 xg) for 10 min of 
clinical isolates strains COLl and C0L7 were tested for cytotoxicity on Vero cells 
with different incubation times; Ih, 4h, 8h, 16h, and 24h (Fig. 3.4 to 3.8). Clinical 
isolates COLl and C0L7 were chosen for cytotoxicity based on previous preliminary 
data (D. Stewart-Tull, personal communication), which had indicated that COLl and 
COL7 had clear cytotoxic activity against Vero cells.
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Figure 3.4: Comparison of cytotoxicity of cell-free extracts, obtained after
different centrifugation speeds and time on Vero cells after incubation for Ih.
The cytotoxic activities of cell-free extracts of two C. jejuni clinical isolates (COLl 
and C0L7) and two E. coli strains (E32511 and DH5a), as positive and negative 
controls, were determined by MTT assay using two-fold serial dilutions of the 
extracts.
A. Cytotoxicity of cell-free extracts (low-speed centrifugation) on Vero cells after Ih
B. Cytotoxicity of cell-free extracts (high-speed centrifugation) on Vero cells after Ih
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Figure 3.5: Comparison of cytotoxicity of cell-free extracts, obtained after
different centrifugation speeds and time on Vero cells after incubation for 4h.
The cytotoxic activities of cell-free extracts of two C  jejuni clinical isolates (COLl 
and COL7) and two E. coli strains (E32511 and DH 5a), as positive and negative 
controls, were determined by MTT assay using two-fold serial dilutions of the 
extracts.
A. Cytotoxicity of cell-free extracts (low-speed centrifugation) on Vero cells after 4h
B. Cytotoxicity of cell-free extracts (high-speed centrifugation) on Vero cells after 4h
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Figure 3.6: Comparison of cytotoxicity of cell-free extracts, obtained after
different centrifugation speeds and time on Vero cells after incubation for 8h.
The cytotoxic activities of cell-free extracts of two C. jejuni clinical isolates (COLl 
and COL7) and two E. coli strains (E32511 and DH5a), as positive and negative 
controls, were determined by MTT assay using two-fold serial dilutions of the 
extracts.
A. Cytotoxicity of cell-free extracts (low-speed centrifugation) on Vero cells after 8h
B. Cytotoxicity of cell-free extracts (high-speed centrifugation) on Vero cells after 8h
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Figure 3.7: Comparison of cytotoxicity of cell-free extracts, obtained after
different centrifugation speeds and time on Vero cells after incubation for 16h.
The cytotoxic activities of cell-free extracts of two C. jejuni clinical isolates (COLl 
and COL7) and two E. coli strains (E32511 and DH5a), as positive and negative 
controls, were determined by MTT assay using two-fold serial dilutions of the 
extracts.
A. Cytotoxicity of cell-free extracts (low-speed centrifugation) on Vero cells after 16h
B. Cytotoxicity of cell-free extracts (high-speed centrifugation) on Vero cells after 
16h
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Figure 3.8: Comparison of cytotoxicity of cell-free extracts, obtained after
différent centrifugation speeds and time on Vero cells after incubation for 24h.
The cytotoxic activities of cell-free extracts of two C. jejuni clinical isolates (COLl 
and COL7) and two E. coli strains (E32511 and DH5a), as positive and negative 
controls, were determined by MTT assay using two-fold serial dilutions of the 
extracts.
A. Cytotoxicity of cell-free extracts (low-speed centrifugation) on Vero cells after 24h
B. Cytotoxicity of cell-free extracts (high-speed centrifugation) on Vero cells after 
24h
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The results showed that the cytotoxicity was at maximum after 16h incubation and 
also that the cytotoxicity caused by the cell-free extract from low-speed 
centrifugation was greater (-50% cell death at the high concentration of COL7 
extract) than that of the cell-free extract from high-speed centrifugation (30% cell 
death at high concentration of COLl extract). For this reason, the extract prepared by 
low-speed centrifugation was chosen for subsequent assays. At this time point, E. 
coli DH5a (a non-toxin-producing strain) showed little or no cytotoxicity while the
C. jejuni strains and E. coli E32511 (Verotoxin producer) showed obvious 
cytotoxicity. The low speed cell extract of COL7 had greater cytotoxin activity than 
that of E. coli E32511 where as the high speed cell extract of this E. coli strain had a 
greater effect.
3.4.3 PCR results to confirm genotype of CDT  ^and CDT
A cytolethal distending toxin (CDT) has been described in C. jejuni (see section 
1.5.2.3). This toxin has been reported to show clear cytotoxic effects only after 
incubation for about 72h. However, it was important to discount any contribution 
that CDT might have to the cytotoxicity noted here at 16-24h. For this purpose, 
cytotoxic activity of cell-free extracts from CDT” mutants were compared with those 
from the wild-type C. jejuni strains. PCR was performed to confirm the genotypes of 
the CDT” mutants in the type strains 81-176 and 11168 using primers for the cdtB 
gene (Fig. 3.9) and for strain 11168 using primers for the cdtA gene (Fig. 3.10). The 
results for cdtB gene showed an amplimer of 495 bp from each of the wild-type 
strains and larger amplimer of 1200 bp from each of the cdtB mutant strains (Fig. 
3.9). The increased sizes of the amplimers from the mutant strains were consistent
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Figure 3.9: Agarose gel electrophoresis of PCR products to confirm the genotype
of CDT+ and CDT strains of C. jejuni
DNA was extracted from whole bacterial cells and used as a template. PCR was 
performed according to section 2.10.1.2 using primers CJCF and CJCR for cdtB gene 
(Table 2.4).
Lane M: 1 kb DNA Ladder
Lane 1: C. jejuni 11168 (CDT^, wild-type)
Lane 2: C. jejuni 11168 (CDT”, cdtB mutant)
Lane 3; C. jejuni 81-176 (CDT^, wild-type)
Lane 4: C. jejuni 81-176 (CDT”, cdtB mutant) 
cdtB gene amplimer: 495bp
Results
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Figure 3.10; Agarose gel electrophoresis of PCR products to confirm the
genotype of CDT+ and CDT“ strains
DNA was extracted from whole bacterial cells and used as a template. PCR was 
performed according to section 2.10.1.2 using primers CDTAF and CDTAR for cdtA 
gene (Table 2.4).
Lane M: 1 kb DNA ladder
Lane 1 : C. jejuni 11168
Lane 2: C. jejuni 11168 {cdtA mutant)
cdtA gene amplimer: 779bp
Results
M 1 2
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1,000
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with the incorporation of a 700 bp chloramphenicol-resistance cassette within the 
cdtB gene. A larger amplimer of 2100 bp was obtained from the cdtA mutant, 
consistent with incoiporation of a kanamycin resistance cassette (1300 bp) into this 
gene which produced a 779 bp amplimer from the wild-type strain (Fig. 3.10).
3.4.4 Cytotoxicity assay on Vero ceils with wild-type and cdt mutant 
strains
The previous results (section 3.4.2) suggested that the cytotoxic activity may be 
membrane-associated and therefore retained more in the supernatant (cell-free 
extract) after low-speed centrifugation. For this reason broken cell pellets were also 
retained for assay as well as the supernatant cell-free extract after low-speed 
centrifugation. Cell-free extracts and broken cell-pellets were prepared by low-speed 
centrifugation of wild-type strain 81-176, the cdtB mutant of strain 81-176, wild-type 
strain 11168, and the cdtB and cdtA mutants of 11168 and these were tested for 
cytotoxicity on Vero cells after incubation for 16h and 72h. The longer incubation 
time was chosen because of the report that the cytotoxic effects of cytolethal 
distending toxin only become apparent after incubation for 72h. Figs. 3.11 A and B 
show that the cytotoxicity of cell-free extracts and broken cell pellets of the wild type 
and CDT-mutant strains of 81-176 and 11168 after 16h incubation were similar. The 
cytotoxicity of the broken cell pellets after low-speed centrifugation was noticeably 
higher than that of the cell-free extracts. After incubation for 16h or 72h, cell-free 
extracts of 81-176 wild-type and cdtB mutant were more active on Vero cells than 
the extracts from strains 11168 wild-type and cdtB mutant (Fig. 3.12). These results 
indicated that the cell-free extracts and broken cell pellets of the CDT’ mutants still 
retained cytotoxic activity to approximately similar levels to that of the wild type
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Figure 3.11: Cytotoxicity of cell-free extracts and broken cell pellets of C. jejuni
strains on Vero cells after incubation for 16h.
The cytotoxic activities of cell-free extracts and broken cell pellets from low-speed 
centrifugation of (A) C. jejuni NCTC 11168 wild-type and cdtB mutant and (B) 81- 
176 wild-type and cdtB mutant strains were determined by MTT assay in two-fold 
serial dilutions using Vero cells. Cell death was assessed after incubation for 16h.
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Figure 3.12: Cytotoxicity of cell-free extracts of C. je juni strains on Vero cells
after incubation for 72h.
The cytotoxic activities of cell-free extracts (low-speed centrifugation) of C  jejuni 
81-176 (wild-type and cdtB mutant), 11168 (wild-type and cdtB mutant) and two E. 
colt strains (E32511 and DH5a) as positive and negative controls were determined by 
MTT assay in two-fold serial dilutions using Vero cells. Cell death was assessed after 
incubation for 72h.
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strains, indicating that cytotoxicity was not caused by CDT, Also Fig. 3.12 showed 
that positive control E. coli E32511 had greatest effect.
Microscope images of Vero cells after incubation for 72h showed that distension of 
cells was apparent with extracts from the wild type strain, but not with the CDT” 
mutant or control cells (Figs. 3.13 to 3.15).
The trypan blue exclusion dye test was used to differentiate and count the living and 
dead Vero cells after incubation with the bacterial preparations. The results are 
expressed as the percentage of dead cells compared to the total number of cells. This 
test was performed on the Vero cells after incubation for 48, 72 and 96h (Table 3.3). 
The trypan blue data essentially agreed with the data obtained from the MTT 
cytotoxicity assay. Broken cell pellets had greater activity than cell-free extracts and 
C. jejuni strain 81-176 exhibited greater activity than strain 11168. The cdtA mutant 
of strain 11168 was included in this analysis and gave similar results to the cdtB 
mutant and the wild-type strain. Morphological changes, including cell rounding, 
were accompanied by cell death after incubation for 16h.
3.4.5 Use of PCR to identify the presence of virBll and tetO genes in 
C, jejuni strains
PCR was performed to detect the presence of the virB ll and tetO genes in clinical 
isolates and type strains of C. jejuni, and cdtA and cdtB mutants. It has been reported 
that C. jejuni strain 81-176 contains two plasmids, each of which is approximately 35 
kb in size. pTet cames the tetO gene, and four open reading frames have been 
identified in the second plasmid, pVir, one of which is virB ll, thought to be involved 
in the virulence (adhesion and invasion) of C. jejuni 81-176 (see section 1.5.1).
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Figure 3.13: Untreated Vero cells (control) after incubation for 72h
Note the normal, spindle-shaped appearance of the cells. Photograph was taken at a 
magnification of x40.
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Figure 3.14: Vero cells treated with cell-free extract (low-speed centrifugation) of
C. jejuni 11168
Vero cell monolayer incubated with 62.5 p,g/ml protein cell-free extract (low-speed 
centrifugation) of C. jejuni 11168 for 72h. The arrows show (A) the grossly distended 
cells (CDT-treated) and (B) rounded-up dead cells. Photograph was taken at a 
magnification of x40.
Results
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Figure 3.15: Vero cells treated with cell-free extract (low-speed centrifugation) of
C. jejuni 11168 cdtB mutant
Vero cell monolayer incubated with 62.5 p,g/ml protein of cell-free extract (low speed 
centrifugation) of C  jejuni 11168 cdtB mutant for 72h. Note that the majority of cells 
had the normal spindle-shaped appearance but some rounded-up dead cells (arrow) 
were visible. Photograph was taken at a magnification of x40.
Results
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Table 3.3: Trypan blue exclusion dye test for the effects of C. jejuni low-speed 
cell-free extracts on Vero cells after incubation for 48, 72 and 96h with 60 pg/ml 
protein.
Trypan blue was added to the cells at the times shown and the percentage of cells 
taking up the dye was taken as the percentage of non-viable cells.
Fractions 48h 72h 96h
C  jejun i 81-176, cell-free extract 48 55 58
C. je ju n i 81-176, broken cell pellets 49.5 70 75
C. je ju n i 81-176 cdtB  mutant, cell-free extract 35 40 42
C. je ju n i 81-176 cdtB  mutant, broken cell pellets 41.5 56 55
C. je ju n i 11168, cell-free extract 22.5 45 47
C. jejun i 11168, broken cell pellets 35 61 58
C. je jun i 11168 cdtB  mutant, cell-free extract 34.5 37 40
C, je jun i 11168 cdtB  mutant, broken cell pellets 46 51.5 54
C, je jun i 11168 cdtA  mutant, cell-free extract 30 34 35
C. je ju n i 11168 cdtA  mutant, broken cell pellets 41.5 49 50
C. je jun i C0L7, cell-free extract 24 45.5 46
C. je ju n i C0L7, broken cell pellets 30 59 60
E, coli E32511, cell-free extract 51.66 60 65
E. coli E32511, broken cell pellets 60 67.5 74
E. coli DH5a, cell-free extract 16 22 21.5
E. coli DH5a, broken cell pellets 18 27 29
Tissue culture medium 4 4 13
Triton-X 100 100 100 100
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DNAs extracted (using the boiling method, section 2.10.1.1) from clinical isolates 
(COLl-30, RPHl-8 and 10), wild-type (81-176 and 11168), cdt mutants (81-176 
cdtB, 11168 cdtB and 11168 cdtA), tlyA mutant (11168 tlyA) and pldA mutant (11168 
pldA) were used as templates in the PCR reactions.
A PCR amplimer for virB ll was obtained for 11 out of 39 (28.2%) of the clinical 
isolates (Table 3.4). Representative amplimers from some isolates are shown in Fig. 
3.16 and 3.17. PCR products showed the presence of the tetO gene in 5 out of 39 
(12.8%) of the clinical isolates (Table 3.4). Representative amplimers from some 
isolates aie shown in Fig. 3.18 and 3.19. The tetO gene was identified in 3 (12%) of 
25 human isolates and found in 3 (27.27%) of 11 vfrBi7-positive C. jejuni clinical 
isolates compared with 2 (7.14%) of 28 vfrRi7-negative isolates. The virB ll gene 
was found in 3 (60%) of 5 ^efO-positive isolates. It should be noted in particular that 
the strain 81-176 was positive and type strain 11168 was negative for both virB ll 
and tetO.
C. jejuni strains were grown on blood agar containing tetracycline (20 pg/ml). The 
results showed that 12.8% of the clinical isolates strains were resistant to this 
concentration of tetracycline (Table 3.4) which was in agreement with the results 
obtained by PCR for the presence of the tetO gene (i. e. all tetracycline-resistant 
isolates carried the tetO gene). Table 3.5 summarises the distribution of the virB ll 
and tetO genes in isolates from various sources. Results of v irB ll and tetO genes in 
Table 3.5 indicate the similar percentage distribution in human and chicken strains, 
and there is too few bovine and ovine sti'ains to judge their distribution.
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Figure 3.16: PCR results to determine the presence of v irB ll and tetO  genes in C
jejuni 81-176 and 81-176 cdtB strains
DNA was extracted from bacterial cells by boiling (see section 2.10.1.1) and used as a 
template. PCR was performed according to section 2.10.1.2 using primers VIR BF, 
VIR BR, TFT OF and TET OR for virB ll and tetO genes, respectively (Table 2.4).
M: 1 kb DNA ladder
Lane 1: virB ll in C. jejuni 81-176
Lane 2: virB ll in C. jejuni 81-176 cdtB mutant
Lane 3: tetO in C. jejuni 81-176
Lane 4: tetO in C. jejuni 81-176 cdtB mutant
virB ll gene amplicon: 708bp 
tetO gene amplicon: 559 bp
M 1
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Figure 3.17: PCR results to determine the presence of the v irB ll  gene in C. jejuni
strains
DNA was extracted from bacterial cells using boiling (see section 2.10.1.1) and used 
as a template. PCR was performed according to section 2.10.1.2 using primers VIR 
BF and VIR BR for virB ll gene (Table 2.4).
M: 1 kb DNA ladder
Lane 1: C. jejuni 81-176 cdtB mutant
Lane 2: C. jejuni RPHl
Lane 3: C. jejuni RPH2
Lane 4: C. jejuni RPH3
Lane 5: C. jejuni RPH4
Lane 6: C. jejuni RPH5
Lane 7: C. jejuni RPH6
Lane 8: C. jejuni RPH7
Lane 9: C. jejuni RPH8
Lane 10: C. jejuni RPHIO
virB ll gene amplicon: 708bp
Results
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Figure 3.18: PCR results to determine the presence of the tetO  gene in C. jejuni
strains
DNA was extracted from bacterial cells using boiling (see section 2.10.1.1) and used 
as a template. PCR was performed according to section 2-10-1-2 using primers TET 
OF and TET OR for tetO gene (Table 2.4).
M: 1 kb DNA ladder 
Lane 1: C. jejuni COL21 
Lane 2: C. jejuni COL22 
Lane 3: C. jejuni COL23 
Lane 4; C. jejuni COL24 
Lane 5; C. jejuni COL25 
Lane 6: C. jejuni COL26 
Lane 7: C. jejuni COL27 
Lane 8: C. jejuni COL28 
Lane 9: C. jejuni COL29 
Lane 10: C. jejuni COL30 
Lane 11: C. jejuni 81-176
tetO gene amplicon; 559 bp
Results
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Figure 3,19: PCR results to determine the presence of the tetO  gene in C. jejuni
strains
DNA was extracted from bacterial cells using boiling (see section 2.10.1.1) and used 
as a template. PCR was performed according to section 2-10-1-2 using primers TET 
OF and TET OR for tetO gene (Table 2.4).
M: 1 kb DNA ladder
Line 1: C. jejuni 81-176 cdtB mutant
Line 2: C. jejuni RPHl
Line 3: C. jejuni RPH2
Line 4: C. jejuni RPH3
Line 5: C. jejuni RPH4
Line 6: C. jejuni RPH5
Line 7 : C. jejuni RPH6
Line 8: C. jejuni RPH7
Line 9: C. jejuni RPH8
Line 10: C. jejuni RPHIO
tetO gene amplicon; 559 bp
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Table 3.4: Presence of virB ll gene and tetracycline-resistance locus tetO in C. 
jejuni strains
VirBll 
(PCR result)
tetO
PCR result phenotype"^
81-176 + + +
81-176 cdtB mutant + + +
11168 — — —
11168 cdtB - - —
11168 cdtA - — —
11168 tlyA — — —
11168 pldA - — —
COLI — —
COL2 - - —
COL3 — - —
COL4 - - —
COL5 - - —
COL6 - — —
COL7 - - —
COL8 + — —
COL9 + — —
COLIO + - —
COLll + - —
COL12 + - —
COL13 + — —
C0L14 + - —
COL15 - - -
COL16 - — “
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Table 3.4: (continued)
y irB ll  
(P C R  result)
tetO
P C R  result phenotype"*'
COL17 — — —
COL18 - — —
COL19 - — —
COL20 + — —
COL21 - - -
COL22 - — —
COL23 - — -
COL24 — - —
COL25 — - —
COL26 — — —
COL27 — + -h
COL28 — - -
COL29 “ - —
COL30 - + +
RPHl + + +
RPH2 + + +
RPH3 — - —
RPH4 - - —
RPH5 + + +
RPH6 - — —
RPH7 - - -
RPH8 ~ - -
RPHIO — — —
* determined on blood agar containing tetracycline (20 p.g/ral).
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Table 3.5: Presence of virB ll and tetO genes in C jejuni from various sources
Gene Human Chicken Bovine Ovine Total
{n = 25) (« = 8) (n = 5) (n = 1) {n = 39)
virB ll 7 (28%) 3 (37.5%) 1 (20%) 0 11 (28.2%)
tetO 3 (12%) 2 (25%) 0 0 5 (12.82%)
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3.4.6 Plasmid isolation from strain 81-176
It was noted from Table 3.4 that some strains (81-176, RPHl, 2 ,5) were positive for 
both the virB ll and tetO genes which indicated that they might possess the 2 
plasmids pVir and pTet. Some strains were positive for virB ll only (COLS-14, 20) 
or tetO only (COL27, 30) which indicated they may have contained either pVir or 
pTet, respectively. Attempts were made to purify plasmid DNA from some of these 
strains, but this was successful only for strain 81-176 when the QIAGEN® Large- 
Construct Kit was used (see section 2.10.2.2). The lack of success in plasmid 
isolation may have been due to the low copy number of these large plasmids. A 
representative gel of plasmid DNA isolated from the 81-176 strain is shown in Fig. 
3.20. This shows a high molecular size band which, on digestion with BglJl, 
produced 11 bands totalling approx. 70 kb. This is consistent with the presence of the 
two 35 kb pVir and pTet plasmids. It can not be confirmed if digestion continued to 
completion. However the pattern of DNA fragments very similar to that shown by 
Bacon et a l (2000) who also analysed plasmid DNA from strain 81-176. Analysis of 
the sequences of pVir (GenBank accession number NC 005012) and pTet (GenBank 
accession number NC 007141) was carried out using restriction mapping tools at 
New England Biolabs website. The results were consistent with Fig. 3.20 suggesting 
the presence of pVir and pTet in strain 81-176.
3.4.7 Cytotoxicity on Vero cells of clinical isolates possessing the 
virB ll or tetO genes
There was the possibility that one or other of the pVir or pTet plasmids, particularly 
pVir, coded for the cytotoxic activity identified earlier. In section 3.4.2 only COLl 
and C0L7 were investigated, but these strains were found to be negative for pVir or
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Figure 3.20: Supercoiled and BglW. digestion patterns of plasmids isolated from 
C jejuni 81-176 cdtB mutant
Supercoiled DNA was extracted from whole bacterial cells using QIAGEN® Large- 
Construct Kit (see section 2.10.2.2) and digested by Bglll enzyme. Both forms were 
run on 0.4% agarose gel.
Lane 1: Supercoiled DNA ladder (Invitrogen)
Lane 2: C. jejuni 81-176 {cdtB mutant), supercoiled
Lane 3: C. jejuni 81-176 {cdtB mutant), Bglll digestion pattern
Lane 4: 1 kb DNA ladder
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pTet, although they both possessed cytotoxic activity, particularly C0L7. In section 
3.4.4, strains 11168 and 81-176 both possessed cytotoxic activity which was 
particularly strong in strain 81-176 (Fig. 3.12). Strain 81-176 possessed both the pVir 
or pTet plasmids. Representative clinical isolates were therefore chosen which 
possessed either pVir (COLl 2, 20) or pTet (COL27, 30) and their cytotoxic 
capacities compared with COLl which possessed neither plasmid. Cell-free extracts 
of clinical isolates COLl, COL12 (virBll+), COL20 (virBll+), COL27 (tetO+) and 
COL30 (tetO+) were tested for cytotoxicity on Vero cells after incubation for 72h. 
Extracts from strains COL20, COLl and COL30 were cleaiiy toxic, particularly 
COL20 giving >50% cell death at the highest concentration but strains COL 12 and 
COL27 were only slightly more toxic that the E. colt DH5a extract (Fig. 3.21). 
Microscopic images showed that cell distensions were caused by strain COL20 and 
perhaps COLl (Figs. 3.22 to 3.24) and these strains showed the greatest cytotoxicity 
after 72h incubation. Thus, no clear correlation between cytotoxicity and carriage of 
either the virB ll and tetO genes was apparent from these results.
3.4.8 Tissue culture cell number correlates with luminescent output
The MTT assay for cell cytotoxicity was time-consuming and gave poor results at the 
higher toxicity level; a toxic activity of 100% was not achieved and maximum 
cytotoxicity appeared to plateau at 60-70% cell death. For this reason an alternative 
assay, which used intracellular ATP as a measure of cell viability, was used.
A direct relationship existed between luminescence measured with the CellTiter- 
Glo™ assay and the number of cells in tissue culture. The results show (Fig. 3.25) 
that there was a linear relationship (from 0-10,000 cells per well) between the
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Figure 3.21: Cytotoxicity of cell-free extracts from low-speed centrifugation of
different clinical isolates on Vero cells.
The cytotoxic activities of cell-free extracts (low-speed centrifugation) of C. jejuni 
clinical isolates COLl, COL12 { v ir B l t \  COL20 { v i r B l t \  COL27 {tetO") and 
COL30 {tetO^) and two E. coli strains (E32511 and DH5cx) as positive and negative 
controls were determined by MTT assay. Two-fold serial dilutions of the extracts 
were applied to Vero cells which were then incubated for 72h.
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Figure 3.22:
A, Untreated Vero cells after incubation for 72h
Note the normal, spindle-shaped appearance of the cells.
B, Vero cells treated with cell-free extract (low-speed centrifugation) of C. jejuni 
COLl
Vero cell monolayer incubated with 62.5 p-g/ml protein cell-free extract (low-speed 
centrifugation) of C. jejuni COLl for 72h.
Both photographs were taken at a magnification of x40.
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Figure 3.23:
A. Vero cells treated with cell-free extract (low-speed centrifugation) of C. jejuni 
COL12
Vero cell monolayer incubated with 62.5 jig /ml protein cell-free extract (low-speed 
centrifugation) of C. jejuni COL 12 for 72h.
B. Vero cells treated with cell-free extract (low-speed centrifugation) of C. jejuni 
COL20
Vero cell monolayer incubated with 62.5 jig/ml protein cell-free extract (low-speed 
centrifugation) of C. jejuni COL20 for 72h.
The arrow shows the grossly distended cells (CDT-treated).
Both photographs were taken at a magnification of x40.
Results
126
Figure 3.24;
A. Vero cells treated with cell-free extract (low-speed centrifugation) of C. jejuni 
COL27
Vero cell monolayer incubated with 62.5 fxg/ml protein cell-free extract (low-speed 
centrifugation) of C. jejuni COL27 for 72h.
B. Vero cells treated with cell-free extract (low-speed centrifugation) of C. jejuni 
COL30
Vero cell monolayer incubated with 62.5 pg/ml protein cell-free extract (low-speed 
centrifugation) of C. jejuni COL30 for 72h.
Both photographs were taken at a magnification of x40.
Results
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Figure 3,25: Correlation of tissue culture cell number with luminescent output 
(CellTiter-Glo™ Luminescent Cell Viability Assay).
Correlation of Vero (A) and J774A.1 (B) cell number with luminescent output were 
determined in two-fold serial dilutions using CellTiter-Glo^" Luminescent Cell 
Viability Assay (ATP-based assay).
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luminescent signal (a measurement of the ATP content of cells) and the number of 
tissue culture cells for both Vero cells and the J774A.1 mouse macrophage cell line.
3.4.9 Comparative cytotoxicity of cell-free extracts of strains 11168 
(wild type), 11168 cdtB, 11168 tlyA, and 11168 pldA mutants
These experiments were done to test the possibility that the putative haemolysin or 
phospholipase present in C. jejuni was contributing to the cytotoxicity of the strains 
noted here. Cell-free extracts (low speed centrifugation) of C. jejuni strains 11168 
(wild type), 11168 cdtB (CDT“), 11168 tlyA (haemolysin”), and 11168 pldA 
(phospholipase ) were incubated with Vero cells for 16h and tested for cytotoxicity 
using the MTT assay (see sections 2.6.3.1). After incubation of Vero cells for 16h 
with the cell-free extracts, the cytotoxicity of the four strains were similar (no 
significant difference) when tested by either assay (Fig.3.26). This suggested that the 
cytotoxicity measured in the assay was not due to CDT, haemolysin or 
phospholipase.
3.4.10 Cytotoxicity assay of supl, sup2 and reagents of the kit used 
to prepare materials for 2-D electrophoresis
supl and sup2 were prepared for use in comparative proteomic analysis of different
C.jejui strains. Therefore supl (cytoplasmic fraction), sup2 (membrane fraction) and 
reagents (which were used in the kit to prepare material for 2-DE gels) (see section 
2.9.2.1) were tested in the cytotoxicity assay on Vero cells using serial dilutions. 
Reagent 1 (used to prepare supl) and reagent 2 (used to prepare sup2) were used as 
controls, but they were toxic for Vero cells. Based on the results with reagent 1 and
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Figure 3. 26: Cytotoxicity of cell-free extracts of C. je juni NCTC 11168 wild-type,
11168 cdtB, tlyA and pldA  mutant strains on Vero cells after incubation for 16h.
The cytotoxic activities of cell-free extracts from low-speed centrifugation of C. jejuni 
NCTC 11168 wild-type, cdtB, tlyA and pldA mutant strains were determined by MTT 
assay. Two-fold serial dilutions of the extracts were applied to Vero cells which were 
then incubated for 16h.
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reagent 2, the results of cytotoxicity assay of supl and sup2 did not show the real 
cytotoxic activity of cytoplasmic and membrane fractions.
3.4.11 Effect of trypsin on Vero cells
As a prelude to further characterisation of the cytotoxic activity, tests were done to 
check if the activity was likely to be caused by a protein. One way to do this would 
be to use trypsin to digest the proteins in a cell-free extract. However, when the 
cytotoxic activities of two-fold serial dilutions of trypsin (0.25%) were determined 
using Vero cells, it was shown that trypsin alone was toxic (Fig. 3.27). Thus, trypsin 
was not used. Instead, the heat stability of the cytotoxicity of the cell-free extract was 
measured (Fig. 3.28).
3.4.12 Effect of heating on cytotoxic activity of C. jejuni
Aliquots of cell-free extract (low-speed centrifugation) of C. jejuni 81-176 cdtB 
mutant were heated at different temperatures: 50 °C, 60 °C, 70 °C, 80 °C and 90 °C 
for 30 min. The cdtB mutant strain was chosen to avoid any cytotoxicity due to 
CDT. The heated cell-free extracts were tested for cytotoxicity on Vero cells. The 
results showed that heating the extract to 50 °C for 30 min had little effect on its 
cytotoxicity, but the cytotoxic activity was lost at 60 °C and above (Fig. 3.28). The 
result indicated that cytotoxic activity was probably due to a protein(s).
3.4.13 Effect of using different temperatures of incubation of C. 
jejuni on cytotoxic activity
C. jejuni 81-176 was grown in Brucella broth at different temperatures (37 °C and 42 
°C) for 48h. After growth of the bacteria, cell-free extracts (low speed centrifugation)
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Figure 3.27: Effect of trypsin on Vero cells
The cytotoxic activities of two-fold serial dilutions of trypsin (0.25%) were 
determined on Vero cells after incubation for 16h using the ATP-based assay.
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Figure 3.28: Heat stability of cytotoxic activity of a cell-free extract from low
speed centrifugation of strain 81-176 cdtB using the ATP-based assay.
A cell-free extract (low-speed centrifugation) of C. jejuni 81-176 cdtB mutant was 
heated at different temperatures for 30 min. Activities were determined using two fold 
serial dilutions on Vero cells after incubation for 24h by ATP-based assay.
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were prepared and used in two different cytotoxicity assays (MTT and ATP-based) 
(Fig.3.29). Results showed that there was no difference between the two cell-free 
extracts prepared from cells grown at the two temperatures.
3.4.14 Cytotoxicity of cell-free extracts on Caco-2 cell line
A cell-free extract from low-speed centrifugation of C. jejuni 81-176 was tested for 
cytotoxicity on Caco-2 cells after incubation for 16h (Fig. 3.30). The activity of the 
strain 81-176 extract on Caco-2 cells was noticeably higher than that of E. coli 
E32511. The activity measured on Caco-2 cells here was similar to the activity of the 
cell-free extract of 81-176 on Vero cells (Fig.3.11B) (e.g. 40% killing with 40 
jag/ml).
3.4.15 Comparison of cytoplasmic, IMP and OMP fractions for 
cytotoxic activities
From the previous cytotoxicity tests, strains 81-176 and COL 12 were chosen as 
strongest and weakest strains for cytotoxic activity, respectively. Cytoplasmic, IMP 
and OMP fractions (see section 2.3.2) of the strains were prepared. Portions of these 
fractions were analysed by SDS-PAGE (Fig. 3.31). The results showed that more 
clearly discernible protein bands were found in the OMP and cytoplasmic fractions 
than in the IMP fraction. Some slight differences in protein bands were visible 
between strains 81-176 and COL 12. This might perhaps be expected as the strains 
were sourced from widely different locations. The various extracts were incubated 
with Vero cells for 16h (using confluent Vero cells) and 72h (using non-confluent 
Vero cells) and were tested for cytotoxicity using the CellTiter-Glo™
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Figure 3.29: Effect of incubation temperature of culture medium of C jejuni 
strain 81-176 on cytotoxicity of cell extract after incubation for 72h with Vero 
cells.
The cytotoxic activities of cell-free extracts of C. jejuni 81-176 (grown in Brucella 
broth at different temperatures, 37 °C and 42 °C) were determined by two different 
cytotoxicity assays (MTT and ATP-based) using two-fold serial dilutions of the 
extracts.
A. MTT assay
B. ATP-based assay
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Figure 3.30: Cytotoxicity of a cell-free extract of C. jejuni 81-176 on Caco-2 cells
A cell-free extract from low-speed centrifugation of C. jejuni 81-176 was tested for 
cytotoxicity on Caco-2 cells after incubation for 16h using the MTT assay. E. colt 
E32511 and DH5a strains were used as a positive and negative controls, respectively.
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Figure 3,31: SDS-PAGE analysis to compare cell fractions of C. jejuni 81-176 
and COL12.
IMP, OMP and cytoplasmic fractions of C  jejuni 81-176 and COL 12 (20 pi) were 
subjected to electrophoresis on a 12.5% (w/v) polyacrylamide gel and stained with 
0.1% (w/v) Coomassie blue solution (section 2.5).
M: Protein Marker (molecular weight range as indicated)
Lane 1: IMP fraction from C  jejuni 81-176
Lane 2: IMP fraction from C. jejuni COLI2
Lane 3: OMP fraction from C. jejuni 81-176
Lane 4: OMP fraction from C. jejuni COL 12
Lane 5: Cytoplasmic fraction from C. jejuni 81-176
Lane 6: Cytoplasmic fraction from C. jejuni COLI2
Results
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Luminescent Cell Viability assay (Figs. 3.32, 3.33 and 3.34). Summarised data of 
these figures are shown in Table 3.6. The results showed that all fractions of strain 
81-176 had greater activity than those of COLI2. Cytotoxic activity of IMP 
preparations were apparent at quite low protein concentrations, particularly after 72h 
when >50% killing of cells was achieved by the IMP fraction of 81-176 at 20 pg/ml 
(Fig. 3.32). OMP fractions were far less active at low protein concentrations with 
-50% killing at 250 pg/ml of the OMP fraction of 81-176 (Fig. 3.33) The 
cytoplasmic fractions also showed little cytotoxicity at low protein concentrations. 
That of strain 81-176 showed some activity after incubation for 16h, and this activity 
was noticeably greater after incubation for 72h (approxt. 50% killing at 100 pl/ml), 
which may have reflected cell death due to the slower, acting CDT toxin.
3.5 Cytotoxin purification
3.5.1 DEAE sepharose column chromatography
3.5.1.1 SDS-PAGE of column chromatography fractions
Purification of a protein fraction with cytotoxic activity was attempted using cell-free 
extracts. Althought the IMP preparation clearly had greater activity, it was later 
shown that proteins in this preparation could not be easily fractionated (section 
3.5.2). DEAE column chromatography fractions (see section 2.8.1) of cell-free 
extract of C. jejuni strains 81-176 and COL 12 were run on SDS-PAGE to find out in 
which fractions proteins were located. The results showed that some protein bands 
could be seen in the flowthrough, but most proteins were eluted in fractions
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Figure 3.32: Cytotoxicity (ATP-based assay) comparison between IMP fractions
of C. je juni 81-176 and COL12.
The cytotoxic activities of IMP fractions from C. jejuni 81-176 and COL 12 were 
determined in two-fold serial dilutions on Vero cells using ATP-based assay after 
incubation for (A) 16h and (B) 72h.
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Figure 3.33: Cytotoxicity (ATP-based assay) comparison between OMP fractions
of C. jejuni 81-176 and COL12.
The cytotoxic activities of OMP fractions from C. jejuni 81-176 and COL12 were 
determined in two-fold serial dilutions on Vero cells using ATP-based assay after 
incubation for (A) 16h and (B) 72h.
Results
100 -j
90 i 
80 H
60 1I
C, jejuni 81-176 
C, jejuni COL 12u
0 100 200 300 400 500
Protein Concentration (fig/ml)
100
52
2  50 -
U 40 -
^  30 -
20 -  
10 -,
60 -
0 100 200 300 400 500
•C. jejuni 81-176 
■C. jejuni COL 12
Protein Concentration (pg/ml)
140
Figure 3.34: Cytotoxicity (ATP-based assay) comparison between cytoplasmic
fractions of C. je juni 81-176 and COL12.
The cytotoxic activities of cytoplasmic fractions from C. jejuni 81-176 and COL12 
were determined in two-fold serial dilutions on Vero cells using ATP-based assay 
after incubation for (A) 16h and (B) 72h.
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Results
containing O.IM, 0.2M and 0.3M NaCl for both strains (Fig. 3.35 to 3.38),
3.5.1.2 Concentration of the fractions
A Microcon system with MW cut-off of 5000 Da was used to concentrate (10 times) 
some of the column chromatography fractions (flow- through, wash through, 0.05M, 
O.IM, 0.2M, and 0.3M NaCl) of both 81-176 and COLI2 strains. After 
centrifugation, the supernatant from the Microcon filtration was run on SDS-PAGE 
(Fig. 3.39). These data showed that little protein was apparent in the concentrated 
flow-through, wash through and 0.05M NaCl fractions. Many protein bands were, 
however, visible from the concentrated O.IM, 0.2M and 0.3M fractions. Some of the 
bands (no.l, no.2 and no.3) were then identified by Mass spectrometry and the 
results are shown in Table 3.7. Protein bands 1 and 2 were shown to be the same and 
were each made up of two identical proteins. Band 3 appeared to contain a number of 
different proteins, pi values of the identified proteins in bands no.l, no.2 and no.3 
(Table 3.7) showed these values in the proteins in band no.l which eluted first are 
higher than that in band no.3 which eluted later in DEAE-Sepharose column 
chromatography (Fig 3.39). This finding confirms the nature of ion-exchange column 
chromatography.
3.5.1.3 Cytotoxicity of DEAE sepharose column chromatography fractions
Cytotoxicity of fractions of strain 81-176 from DEAE sepharose column 
chromatography was tested after incubation with Vero cells for 16h. To take account 
of any toxicity of increased NaCl in the elution buffer, concentrations of 0.05-IM 
NaCl in buffer were tested in the MTT assay for toxicity (Fig. 3.40). Toxicity was 
marginal at low NaCl concentrations, but increased significantly at a concentration of 
0.4M NaCl and above. According to Figure 3.41 and Fig. 3.42, the most cytotoxic
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Figure 3.35: SDS-PAGE analysis of column fractions of cell-free extract of C.
jejuni 81-176 prepared by DEAE sepharose column chromatography.
Aliquots (20 jil) of column washes and elutions from 0.05 and O.IM NaCl were 
subjected to electrophoresis on a 10% (w/v) polyacrylamide gel and stained with 
0.1% (w/v) Coomassie blue solution (section 2.5).
M: Protein marker (molecular weight range as indicated) 
Lane 1: Crude cell-free extract from 81-176 
Lane 2; Flow-thr ough 
Lane 3: Wash through (first)
Lane 4: Wash through (second)
Lane 5: First fraction eluted with 0.05 M NaCl 
Lane 6: Second fraction eluted with 0.05 M NaCl 
Lane 7: First fraction eluted with 0.1 M NaCl 
Lane 8: Second fraction eluted with 0.1 M NaCl
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Figure 3.36: SDS-PAGE analysis of column fractions of cell-free extract of C.
jejuni 81-176 prepared by DEAE sepharose column chromatography.
Aliquots (20 pi) of elutions up to 0.5 M NaCl were subjected to electrophoresis on a 
10% (w/v) polyacrylamide gel and stained with 0.1% (w/v) Coomassie blue solution 
(section 2.5).
Lane 1: First fraction eluted with 0.2 M NaCl 
Lane 2: Second fraction eluted with 0.2 M NaCl 
Lane 3: First fraction eluted with 0.3 M NaCl 
Lane 4; Second fraction eluted with 0.3 M NaCl 
Lane 5: First fraction eluted with 0.4 M NaCl 
Lane 6: Second fraction eluted with 0.4 M NaCl 
Lane 7: First fraction eluted with 0.5 M NaCl 
Lane 8: Second fraction eluted with 0.5 M NaCl
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Figure 3.37: SDS-PAGE analysis of column fractions of cell-free extract of C.
jejuni COL12 prepared by DEAE sepharose column chromatography.
Aliquots (20 pi) of column washes and elutions from 0.05 and O.IM NaCl were 
subjected to electrophoresis on a 10% (w/v) polyacrylamide gel and stained with 
0.1% (w/v) Coomassie blue solution (section 2.5).
M: Protein Marker (molecular weight range as indicated)
Lane 1: Crude cell-free extract from C. jejuni COL 12 
Lane 2: Flow- through 
Lane 3: Wash through (first)
Lane 4: Wash through (second)
Lane 5: First fraction eluted with 0.05 M NaCl 
Lane 6: Second fraction eluted with 0.05 M NaCl 
Lane 7: First fraction eluted with 0.1 M NaCl 
Lane 8: Second fraction eluted with 0.1 M NaCl
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Figure 3.38: SDS-PAGE analysis of column fractions of cell-free extract of C.
jejuni COL12 prepared by DEAE sepharose column chromatography.
Aliquots (20 pi) of elutions up to 0.5 M NaCl were subjected to electrophoresis on a 
10% (w/v) polyacrylamide gel and stained with 0.1% (w/v) Coomassie blue solution 
(section 2.5).
Lane 1 : First fraction eluted with 0.2 M NaCl 
Lane 2; Second fraction eluted with 0.2 M NaCl 
Lane 3: First fraction eluted with 0.3 M NaCl 
Lane 4: Second fraction eluted with 0.3 M NaCl 
Lane 5: First fraction eluted with 0.4 M NaCl 
Lane 6: Second fraction eluted with 0.4 M NaCl 
Lane 7: First fraction eluted with 0.5 M NaCl 
Lane 8: Second fraction eluted with 0.5 M NaCl
Results
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Figure 3.39: SDS-PAGE analysis of concentrated fractions of C. jejuni 81-176
and COL12 prepared by DEAE sepharose column chromatography.
Aliquots (20 pi) were subjected to electrophoresis on a 10% (w/v) polyacrylamide gel 
and stained with 0.1% (w/v) Coomassie blue solution (section 2.5). Marked bands (1- 
3) which were not found in strain COL 12 were identified by mass spectrometry 
(Table 3.7).
M: Protein Marker (molecular weight range as indicated)
Lane 1: Flow- through, strain 81-176
Lane 2: Flow- through, strain COL 12
Lane 3: Wash through (pooled), strain 81-176
Lane 4: Wash through (pooled), strain COL 12
Lane 5: Eluted with 0.05 M NaCl (pooled), strain 81-176
Lane 6: Eluted with 0.05 M NaCl (pooled), strain C0L12
Lane 7: Eluted with 0.1 M NaCl (pooled), strain 81-176
Lane 8: Eluted with 0.1 M NaCl (pooled), strain C0L12
Lane 9: Eluted with 0.2 M NaCl (pooled), strain 81-176
Lane 10: Eluted with 0.2 M NaCl (pooled), strain COL 12
Lane 11: Eluted with 0.3 M NaCl (pooled), strain 81-176
Lane 12: Eluted with 0.3 M NaCl (pooled), strain COL12
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Figure 3.40: Cytotoxicity of different concentrations of NaCl on Vero cells
The cytotoxic activities of fractions containing the different concentrations of NaCl 
where proteins were eluted were determined on Vero cells after incubation for 16h 
using the ATP-based assay.
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Figure 3.41: Cytotoxicity on Vero cells of fractions of C. je juni 81-176 cell-free
extract prepared by DEAE sepharose column chromatography.
A crude cell-free extract (low speed centrifugation) from C  jejuni 81-176 was 
purified using DEAE sepharose (section 2.8.1). The cytotoxic activities of flow- 
through (F.T), wash-through (aliquots from the column washes) (W.T), and different 
elutions were determined in two-fold serial dilutions on Vero cells after incubation for 
16h using the ATP-based assay.
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Figure 3.42: Cytotoxicity on Vero cells of fractions of C je juni COL12 cell-free
extract prepared by DEAE sepharose column chromatography.
A crude cell-free extract (low speed centrifugation) from C  jejuni COL 12 was 
purified using DEAE sepharose (section 2.8.1). The cytotoxic activities of flow- 
through (F.T), wash-through (aliquots from the column washes) (W.T), and different 
elutions were determined in two-fold serial dilutions on Vero cells after incubation for 
16h using the ATP-based assay.
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activities were found in the fractions flow-through, wash-through, 50mM, O.IM and 
0.2M NaCL From the results of testing 1/8 dilutions of the samples (Fig. 3.41) the 
most toxicity was detected in wash-through, 50mM, O.IM and 0.2M NaCl fractions. 
Considerable activity at this dilution was also detected in 0.4M and 0.5M NaCl 
fractions, but this was discounted because of the effect of NaCl alone at this 
concentration. If these experiments were to be repeated, NaCl in the fractions could 
be removed by using dialysis or MicroCon.
It was hoped that certain fractions from strain 81-176 would show an obviously 
greater cytotoxicity than the equivalent fractions from COL 12 as proteins from each 
strain eluted from the DEAE-Sepharose in a similar way. At 1/8 dilution there was 
some indication that fractions at O.IM NaCl had greater activity in strain 81-176 than 
COL 12, but the flow-through and wash-through fractions also had greater activity. 
Comparison of the pooled O.IM NaCl fractions in Fig. 3.39 showed that, aside from 
the proteins identified in band 3 (Table 3.7) it would be difficult to distinguish clear 
differences between strains 81-176 and COL12.
3.5.2 SDS-PAGE results of IMP proteins fractionated using 
Microcon tube
An attempt was made to fractionate the proteins by size from the IMP fraction of 81- 
176 cdtB. It was hoped that if the extract was fractionated, then the proteins present 
in the fractions might be analysed by column chromatography.
The IMP fraction of 81-176 cdtB strain was applied to Microcon filters with different 
size molecular weight cut offs (MWCO). The Microcon with sizes 100,000, 50,000, 
30,000, 10,000 and 5,000 MWCO were used, respectively (Fig. 3.43). Apart from the
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Figure 3.43: SDS-PAGE analysis of fractions of IMP from C. je juni 81-176 cdtB
using microcon
IMP fractions from C. jejuni 81-176 cdtB were separated using different sizes 
(MWCO) of microcon filter (section 2.8.2) and subjected in a 20 (xl volume, to 
electrophoresis on a 12.5% (w/v) polyacrylamide gel and stained with 0.1% (w/v) 
Coomassie blue solution (section 2.5).
M: Protein Marker (molecular weight range as indicated)
Lane 1 : IMP Crude
Lane 2: First fraction >100,000 MW
Lane 3: Second fraction 50,000-100,000 MW
Lane 4: Third fraction 30,000-50,000 MW
Lane 5; Fourth fraction 10,000-30,000 MW
Lane 6: Fifth fraction 5,000-10,000 MW
Lane 7: Sixth fraction <5,000 MW
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first fraction, no protein bands were visible in the other fractions. It is likely that the 
starting material for fractionation comprised detergent micelles, each containing a 
mixture of proteins. When analysed by SDS-PAGE, the proteins would have been 
freed from the micelles. This would explain the appeaiance of proteins of modest 
molecular weight in that fraction held back on the 100 kDa cut-off filter (lane 2, Fig. 
3.43).
The results of SDS-PAGE were confirmed by protein assay results which showed 
that all of the protein content was in the first fraction retained by the filter with a 
MWCO of 100,000. It was not therefore considered feasible to attempt to purify 
proteins from the IMP fraction at this stage.
3 .6  Identification of proteins (proteomics)
Attempts to identify individual proteins from the DEAE-Sephai'ose chromatography 
proved difficult, probably due to insufficient protein in each protein band detected 
after one-dimensional SDS-PAGE electrophoresis and insufficient separation of the 
bands into individual proteins. Thus, it was decided to compare protein profiles after 
2-DE gel electrophoresis to obtain better resolution of the individual protein 
components of the cytotoxic extracts. Different strains of C. jejuni were chosen, 81- 
176, 81-176 cdtB, 11168 and COL12, which were known to possess different 
cytotoxic activities. It was assumed that these differences in cytotoxicity arose from 
differences in the levels of expression of particular proteins. The simplest 
explanation for the cytotoxicity of the strains was that one produced a protein with
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3.6.1 TCA precipitation of sup2 preparation
Due to the low protein concentration of sup2 in each of the strains, TCA was used to 
precipitate proteins in an attempt to concentrate the sup2 preparation. After 
precipitation, the concentrated sup2 was run on SDS-PAGE. As the SDS-PAGE 
results show, even after precipitation, the concentration of sup2 was still very low 
(Fig. 3.44). Even after concentration of sup2 there were no obvious protein bands in 
any strain, but a lot of proteins were seen in supl without any concentration. 
However, the separation was poor, presumbly because of some of the components of 
the reagents of the kit used in preparation of the extracts.
156
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biological activity (e.g. a toxin) and other did not. However, differences could also 
arise from the levels of protein synthesis. These possibilities were considered when 
analysing the data from 2-DE gel electrophoresis. Protein profiles from supl 
(cytoplasmic fraction) and sup2 (membrane fraction) extracts of the strains were 
therefore prepared according to the procedures given in section 2.9.2.1. The 
cytoplasmic fraction (supl) was prepared using the ProteoPrep’^ '^  Universal 
Extraction Kit (Sigma) as the supernatant following sonication in the Soluble 
cytoplasmic extraction reagent (S2688, Sigma). The membrane fraction was prepared 
after solubilisation in the Cellular' and organelle membrane solubilizing reagent 
(C0356, Sigma).
_
Figure 3.44: SDS-PAGE analysis of supl and sup2 prepared by ProteoPrep "^  ^
Universal Extraction Kit
Non-concentrated supl and concentrated sup2 (using TCA precipitation method) from 
C. jejuni strains 81-176, 81-176 cdtB, 11168, and COL 12 (section 2.9.2.1) in a 20 pi 
volume, were subjected to electrophoresis on a 10% (w/v) polyacrylamide gel and 
stained with 0.1% (w/v) Coomassie blue solution (section 2.5).
M: Protein Marker (molecular weight range as indicated)
Lane 1: supl from C. jejuni 81-176
Lane 2: sup2 from C. jejuni 81-176
Lane 3: supl from C. jejuni 81-176 cdtB mutant
Lane 4: sup2 from C. jejuni 81-176 cdtB mutant
Lane 5: supl from C. jejuni 11168
Lane 6: sup2 from C. jejuni 11168
Lane 7: supl from C. jejuni COL 12
Lane 8: sup2 from C. jejuni C0L12
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3.6.2 Two-dimensional electrophoresis and characterization of 
separated proteins
Successful 2-DE gels were obtained for the supl fractions of strains 81-176, 81-176 
cdtB and 11168 (Fig. 3.45, 3.46 and 3.47). Insufficient protein was present on the 2- 
DE gel for strain COL 12 to allow protein identification, but the gel did show good 
resolution (Fig. 3.48). Nevertheless, the quality of gel was adequate to compare with 
different strains. Spot numbering on each 2-DE gel was independent and therefore a 
spot with the same number on different gels need not represent the same proteins. 33 
proteins were identified from the supl sample of strain 81-176, although no obvious 
toxin-like proteins were among them (Table 3.8). 22 proteins were identified from 
strain 81-176 cdtB and 24 proteins from strain 11168 (Tables 3.9 and 3.10). A 
worked example of identification of spot no. 19 from 81-176 is shown in Appendices 
16, 17 and 18. Proteins identified with a MOWSE score of less than 46 were 
excluded from Tables 3.8, 3.9 and 3.10. A putative oxidoreductase subunit 
(gi|15791781 or gi|15791782) appeared in all 3 gels (81-176, 81-176 cdtB and 
11168). In fact, a striking number of oxidoreductase enzymes and other enzymes 
associated with central metabolic pathways e.g. phosphoenol pyruvate 
carboxykinase, citrate synthase and aconitate hydratase were identified. Spot no. 20 
in the gel of 11168 was identified as a two-component regulator (Cj0355c) and, 
while it did not appear in the gels of 81-176 or 81-176 cdtB, the spot appeared in the 
gel of COL12. Comparison by eye of 2-DE gels of 81-176 and COL 12 showed that 
spots no. 16 (Cj0772c, putative periplasmic protein), 17 (Cj 1420c, hypothetical 
protein), 19 (CJ0169, superoxide dismutase, Fe), 23 (CJ0414, putative oxidoreductase 
subunit), 25 (CJ0779, probable thiol peroxidase), 26 (CJ0779, probable thiol
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Figure 3.45: Two-dimensional electrophoresis (2-DE) gels of supl from C. jejuni 
81-176
Supl of C. jejuni 81-176 (section 2.9.2.1) was focused on a pH3-10 IPG strip. SDS- 
PAGE was performed on a 12.5% (w/v) gel and stained with Coomassie blue 
solution. To avoid confusion with spots to be picked for identification, molecular 
weight and pl standards were omitted from the 2-DE gels. The spots labelled 35 and 
36 on this gel, visible on subsequent gels, are non-biological markers used for 
reference in spot picking.
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Figure 3.46: Two-dimensional electrophoresis (2-DE) gels of supl from C. jejuni 
81-176 cdtB
Supl of C. jejuni 81-176 cdtB (section 2.9.2.1) was focused on a pH3-10 IPG strip. 
SDS-PAGE was performed on a 12.5% (w/v) gel and stained with Coomassie blue 
solution. The spots labelled 23 and 24 are non-biological markers used for reference 
in spot picking.
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Figure 3.47: Two-dimensional electrophoresis (2-DE) gels of supl from C. jejuni 
11168
Supl of C. jejuni 11168 (section 2.9.2.1) was focused on a pH3-10 IPG strip. SDS- 
PAGE was performed on a 12.5% (w/v) gel and stained with Coomassie blue 
solution. The spots labelled 33 and 34 are non-biological markers used for reference 
in spot picking.
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Figure 3.48: Two-dimensional electrophoresis (2-DE) gels of supl from C. jejuni 
COL12
Supl of C. jejuni COL 12 (section 2.9.2.1) was focused on a pH3-10 IPG strip. SDS- 
PAGE was performed on a 12.5% (w/v) gel and stained with Coomassie blue 
solution.
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Discussion
peroxidase), 27 (CJ0779, probable thiol peroxidase), 29 (Cj 1382c, flavodoxin), and 
30 (Cj0835c, aconitate hydratase) which were identified in the gel of strain 81-176, 
did not appear in the gel of strain C0L12. Spots no. 25 (Cj0779, probable thiol 
peroxidase) in strain 81-176, did not appear in strain 11168. However, multiple spots 
were identified as probable thiol peroxidase (spots 25, 26 and 27; Fig. 3.45). This 
observation suggests that probable thiol peroxidase is processed to produce 
fragments with lower MW than the predicted mature protein. Fibronectin binding 
protein (Cj 1478c, CadF) was identified in strain 81-176, but was not present in strain 
11168. Spots no. 32 in strain 81-176 (Fig 3.45) and 20 in 81-176 cdtB (Fig. 3.46) 
both identified as CadF are located in different places on the 2-DE gels and appear to 
possess different MW. N-liked glycosylation in C. jejuni has been reported by 
Wacker et al. (2002). It is speculated that glycosylation of outer membrane 
protein/peripheral protein can increase MW. Therefore spot no. 32 in Fig 3.45 may 
be a glycosylated form of CadF and spot no. 20 in Fig. 3.46 may be an unmodified 
form of the same protein.
Strains 81-176 and 81-176 cdtB were chosen to run on 2-DE to check that the 2-DE 
procedure was reproducible because, apart from the absence of CDT in the cdtB 
strain, it was expected that the profiles of these strains should be similar. Comparison 
by eye of Figs. 3.45 and 3.46 indicates that this was the case. The most important 
differences should be CDT subunits (sizes 29.9, 29.0 and 21.2 kDa), which should be 
present in 81-176 and absent in 81-176 cdtB. However, none of the CDT subunits 
were identified among the 81-176 spots. The reason why 81-176 and 11168 were 
chosen to run on 2-DE gels was that 11168 was less cytotoxic on Vero cells than 81- 
176, so it was hoped that there might be some differences in proteins responsible for 
cytotoxicity when these strains were run on 2-DE gels. This, however, proved to be
1 6 8
Discussion
too difficult as many differences in spot intensity and position were manifest 
between the gels. C0L12 was chosen because it was less cytotoxic on Vero cells 
than other strains, and it was also negative for the presence of CDT (aecording to the 
microscopic pictures taken after incubation for 72h).
3.6.3 Difference gel electrophoresis (DIGE)
Difference gel electrophoresis (DIGE) analysis was done for the supl fractions of 
strains 81-176 and 81-176 cdtB (Fig. 3.49 and 3.50). The results showed that in strain 
81-176 cdtB, proteins Cpn60 (60 kDa chaperonin) and elongation factor Tu were 
down regulated 4 and 2-fold compared with 81-176, respectively. Surprisingly, again 
the absence of CDT subunits in 81-176 cdtB was not found by this technique. 
Unfortunately, time restraints prevented a DIGE comparison of 81-176 and 11168 or 
COL12.
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Figure 3.49: DIGE (Difference gel electrophoresis) of supl of C. jejuni 81-176 and 
81-176 cdtB.
DIGE analysis indicates that the spot arrowed was down regulated -4-fold in C. jejuni 
81-176 cdtB mutant (right picture), compared with C. jejuni 81-176 (left picture). The 
spot was identified as Cpn60 (60 kDa chaperonin).
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Figure 3.50: DiGE (Difference gel electrophoresis) of supl of C. jejuni 81-176 and 
81-176 cdtB.
DIGE analysis indicates that the spot arrowed was down regulated -2-fold in C. jejuni 
81-176 cdtB mutant (right picture), compared with C. jejuni 81-176 (left picture). The 
spot was identified as elongation factor Tu (Cj0470).
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Chapter Four 
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Discussion
CHAPTER 4: DISCUSSION
4.1 Presence of hipO  gene in clinical isolates
Diagnostic tests based on the polymerase chain reaction (PCR) are attractive due to 
their relatively low cost in terms of laboratory manpower, rapid turnaround time, 
their ease of use, potential to be fully automated (Houng et a l, 2001; Linton et a l, 
1997; Maher et a l, 2003; On & Jordan, 2003), high sensitivity and specificity 
(Dickins et a l, 2002; Matsuda et a l, 1995; Ragimbeau et a l, 1998). A number of 
conventional PCR assays have been described for the identification and 
characterization of Campylobacters from a spectrum of sample types, including 
culture (Fermer & Engvall, 1999; Wang et a l, 2002), food products (Bang et a l, 
2002; Burnett et a l, 2002; Sails et a l, 2003) and stools (Houng et a l,  2001; Linton 
et a l, 1997; Maher et a l, 2003; On & Jordan, 2003) and using a variety of gene 
targets e.g. hipO, 23S rRNA, glyA, mapA, and ceuE (On & Jordan, 2003).
Harvey (1980) reported that the hippurate hydrolysis test allows clear differentiation 
between the species C. jejuni and C. coli and simplifies the bioehemical 
identification of these species. The N-benzoyIglycine amidohydrolase (hippuricase), 
the product of the hipO gene (Hani & Chan, 1995), acts to cleave N-benzoy Igly cine 
(hippuric acid or hippurate) into the constituent products glycine and benzoic acid.
Glycine formation is detected by using a ninhydrin-based system (Harvey, 1980).
In this study, the presence of the hipO gene and hippuricase were confirmed in 
clinical isolates by using a PCR technique and the API CAMPY test, respectively.
All C. jejuni isolates were tested by PCR for the presence of hipO and all were ,,
confirmed positive. The C. coli strain gave a negative result. This test was therefore ‘
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confirmed as accurate and very useful for rapid diagnosis of C. jejuni. The PCR 
technique and API CAMPY test results showed that 100% of the clinical isolates 
were positive for the presence of the hipO gene and hippuricase. This was a greater 
success rate than that reported by On who gave values of 91% (Table 1.2; On, 2005) 
(derived from various reports) and 99% (On, 1996) respectively, for hippurate 
hydrolysis.
4.2 Cytotoxic activities of C. jejuni strains
4.2.1 Cytotoxicity of cell-free extracts from C. jejuni clinical isolates 
with different incubation times on Vero cells
Misawa et al. (1994) reported that the expression of their cytotoxin was elevated 
when the C. jejuni was grown in Brucella broth and that this medium was excellent 
for cytotoxin production. In the present study. Brucella broth was used to grow C. 
jejuni for all purposes including cytotoxin production. The absorbance value of the 
culture at 600 nm after incubation for 48h reached a suitable level to provide enough 
cells for the cytotoxin assay and thus was in agreement with the finding of Misawa et 
al. (1994).
Vero and HeLa cells have been shown to be extremely sensitive to toxins that inhibit 
protein synthesis due to the presence of Gb3 sphingoglycolipid receptor on their 
surfaces (Obrig, 1994). The cytotoxicity towards Vero cells of cell-free extracts 
produced by low and high centrifugation speeds of C. jejuni clinical isolates COLI 
and C0L7 increased with an increase in incubation time of the extract with the tar get 
cells, from l-24h. This indicated that cytotoxin (s) in the cell-free extract needed
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time to affect the Vero cells. Good activity occured after incubation for 16h. Thus, 
incubation time of 16h was used for other cytotoxicity assays in this study. The 
cytotoxic activities of cell-free extracts from the low speed centrifugation were 
always higher than those from the high speed centrifugation at all incubation times 
(1, 4, 8, 16, and 24h) and with either of the two C. jejuni strains (COLI and COL7). 
Due to the higher activities in the low speed centrifugation fraction, this fraction was 
used for further cytotoxicity assays. It suggested that part or all of the cytotoxic 
activity may be membrane-associated, rather than completely soluble.
Data for the cytotoxicity assay were calculated according to the formula mentioned 
in the section 2.6.3.1, by comparison of the OD of the test sample with those of 
negative and positive controls, cells grown in tissue culture medium alone (assumed 
to be no cell death) or treated with Triton-X 100 (100% killing), respectively. In 
some graphs, there is no clear dose-response evident e.g. Fig. 3.6 and, even at the 
lowest doses of sample tested, there was significant cytotoxicity, compared to the 
controls cells. It would have been of interest to have tested lower concentration of 
samples for a more accurate comparison of their cytotoxic effects.
4.2.2 Cytotoxicity assay on Vero cells with wild type and cdt mutant 
strains
The frequency of cdtB genes among Campylobacter isolates obtained from different 
sources has been reported (Bang et a l, 2001; Eyigor et a l, 1999a; Eyigor et a l, 
1999b; Pickett et a l, 1996). In general, C. jejuni produced much higher CDT in 
• comparison with C. coli (Bang et a l,  2001; Eyigor et a l, 1999a; Eyigor et a l, 
1999b; Pickett et a l, 1996).
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Skirrow (1977) originally isolated C. jejuni NCTC 11168 from the faeces of a 
dianhoeic patient. Results of the effects of cell-free extracts and broken cell pellets 
of NCTC 11168 wild-type and the cdtB mutant on Vero cell after 16h incubation 
(Fig. 3.11) showed that the cytotoxicity of wild type and cdtB mutant were very 
similar. Microscopic images (Fig. 3.14, 3.15) of both strains after incubation for 72h 
revealed that distension of Vero cells was apparent with the wild type strain, and not 
with the CDT" mutant. This suggested that cytotoxic activity measured after 
incubation for 16h with wild-type or CDT" mutant extracts was not due to CDT, and 
that some other cytotoxin(s) may have been responsible for this activity. Also Fig. 
3.11 indicates that cytotoxicity was probably more cell-associated, due to the fact 
that more activity was found in broken cell pellets. Thus, some cytotoxic activities 
appear to be present in the broken cell pellet fractions (3.6 and 22K) which are 
membrane-associated and insoluble proteins.
Lee et al. (2000) examined fractions derived from the culture supernatant fluid (CS), 
sonicated cell supernatant fluid (SCS), pellet wash (PW) and washed cell sonicate 
(WCS) for cytotoxic activity after incubation for 12 and 24h. They found most 
activity was located within the bacterial cell (SCS and WCS). Guerrant et a l (1987) 
found cytotoxic activity in sonicated whole bacterial cell preparations. Bacon et a l 
(1999) detected cytotoxic activity in both culture supernatant and supernatants of 
sonicated C. jejuni strain 2483.
It was also found in this study that the cytotoxic effects after incubation for 16h were 
most prominent in Vero cells grown to a monolayer (confluent) as compared to 
freshly seeded Vero cells (non-confluent), but for assays that required incubation for
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72h, freshly seeded Vero cells produced better results, again indicating that the 
cytotoxic activities took some time to act.
The cytotoxie activities of Campylobacter strains have been classified into those of 
cytolethal distending toxin (CDT) and non-CDT toxins (Wassenaar, 1997), but due 
to the confusion concerning Campylobacter cytotoxins, compaiison of these 
cytotoxic activities among different studies is difficult (Nadeau et a l, 2003). CDT 
activities have been observed by using sonicated cells or supernatants of 
Campylobacter cultures (Eyigor et a l, 1999b; Johnson & Lior, 1988b; Schulze et a l,
1998). Non-CDT activities were observed by Nadeau et a l  (2003) who reported that 
poultry isolates were generally not toxic for Vero cells or, if so, had weak titres, but 
four of the five human isolates that were cytotoxic for CHO cells were also cytotoxic 
for Vero cells. Pickett (2000) reported more than one cytotoxin activity and, since the 
results obtained for a Vero cell assay by Nadeau et a l (2003) were variable among 
CHO cell-cytotoxic isolates, they could not eliminate the possibility of multiple 
cytotoxin activities for the tested Campylobacter isolates. Thus, there is the 
possibility that C. jejuni strains produce several different cytotoxins.
Previously reported cytotoxicity assays showed that C. jejuni 81-176 cdtB mutants 
appeared to retain a low level of toxic activity against HeLa cells or INT407 cells, 
apparently unrelated to the action of CDT. In contrast, C. jejuni 11168 cdtB mutants 
produced no residual toxicity (Purdy et a l, 2000). The authors suggested that this 
weak residual toxicity for HeLa monolayers in C. jejuni 81-176 cdtB mutants may 
account for an as yet uncharacterized toxin (s) previously associated by others with 
Campylobacters (Wassenaar, 1997) and suggested that some Campylobacters may 
indeed produce more than one toxin (Purdy et a l, 2000).
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Lee et al. (2000) examined cytotoxicity of sonicated cell supernatant fluid of C. 
jejuni strains against Vero cells by phase-contrast microscopy and reported that wells 
in which > 30% of the cells showed rounding were considered to be a positive result. 
Cytotoxicity of cell-free extracts of C. jejuni strains examined against Vero cells in 
the present study never reached 100% cell death even at high protein concentrations, 
which is keeping with the finding of Lee et al. (2000) that maximum dead cells 
(rounded cells) was 80%.
As different procedures have been used for preparing samples of cytotoxins by 
different researchers, it is difficult to determine the characteristics of the cytotoxins 
and it is possible that each (different) assay system for C. jejuni cytotoxin might 
detect a different type of cytotoxin (Misawa et al., 1994).
The activities of Verotoxins (VTs or Shiga-like toxin) are influenced by the presence 
or absence of its receptor (B-subunits of VT bind to the receptor) and, typically, 
expression of the Gb3 receptor corresponds with sensitivity to VT (Hoey et a l, 
2003). Gb3 is present on the cell surface of many eukaryotic cells (Lingwood et a l, 
1987) such as endothelial cells of kidney (Obrig et a l, 1993), bovine colonic 
epithelial cells (Hoey et a l, 2003) and both small and lai'ge intestinal mucosa of 
cattle (Hoey et a l, 2002). The Vero cell line was employed for cytotoxicity assays in 
the present study due to its ease of culture and since these cells have been used 
extensively by other researchers (Coote & Arain, 1996; Guerrant et a l, 1987; 
Johnson & Lior, 1986; McCardell et a l, 1986a; Misawa et a l, 1995a; Moore et a l, 
1988; Yeen et a l, 1983). Also, the receptor Gb3 is present on this cell line. Caco-2 
cells were used as they are epithelial cells from the human colon and as a result they 
are related to those cells targeted during natural infection by C. jejuni. Different
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observations on cytotoxic activities with the different cell lines may be due to the 
relative amounts of the receptor required for binding of the cytotoxin(s). In this 
study, cell-free extracts of strain 81-176 showed similar activity on Caco-2 and Vero 
cells, but identification of a possible receptor requires further study.
4.2.3 The presence of virBll and tetO genes and relation to 
cytotoxicity of C. jejuni strains
4.2.3.1 Presence of virB ll and tetO genes in C. jejuni strains
Bacon et al. (2000) reported the absence of virB ll in strain 11168 which was 
confirmed here (Table 3.4). They also reported that the v/rBiigene was present in i
10.3% of isolates from military personel with diarrhoeal disease. In the present study, 
the percentage of human clinical C. jejuni isolates containing the virB ll gene was 
28%, which is more than that reported above and by others (10.7%) (Datta et a l,
2003). The gene was also present in 37.5% of chicken isolates in the present study, 
which is more than that (9.5%) reported by Datta et a l (2003). The detection rate of 
the virB ll gene in the present study was 20% for bovine isolates (Table 3.5) while 
Datta et a l (2003) reported 15.4%.
The tetO gene was detected only from human (12%) and chicken (25%) sources. The 
data may reflect the use of tetracycline in treating human infections and also its use 
in the poultry industry (Avrain et a l, 2004). In this study, tetO gene was found in all 
tetracycline-resistant isolates, a result in keeping with the finding of Pratt & Korolik 
(2005) with Australian C. jejuni isolates. However, Tracz et a l  (2005) reported 
tetracycline resistance plasmids in only 79% of tetracycline-resistant isolates in 
Canada. In this study, the prevalence of tetracycline-resistance in human isolates was
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12%, compared with 60% in Alberta, Canada (Tracz et a l, 2005) which might 
indicate a contribution to resistance by a means other than expression of the tetO 
gene.
In the present study tetO gene was found in 27.3% of virBf 7-positive C. jejuni 
clinical isolates compared with 7.14% of v/rB77-negative isolates. The virB ll gene 
was found in 60% of rgfO-positive isolates. This is in agreement with Tracz et a l 
(2005) who had previously reported that the presence of pVir plasmid was associated 
with the presence of a tetracycline-resistance plasmid. Apart from strain 81-176, only 
three strains (RPHl, RPH2 and RPH5) had both virB ll and tetO genes. RPHl and 
RPH2 came from chickens and RPH5 was a human isolate.
4.2.3.2 Plasmid purification
Strain 81-176 is one of the best-characterized strains of C. jejuni (Black et a l, 1988). 
It was isolated from an outbreak associated with the consumption of unpasteurized 
milk (Korlath et a l, 1985) and has been shown to cause inflammatory diarrhoea in 
two human volunteer studies as well as disease symptoms in experimental infection 
models using primates and fen'ets (Black et a l, 1988). It has been shown that strain 
81-176 contains two large (-35 kb) plasmids, pVir and a Tc^ plasmid designated 
pTet. pVir is involved in invasion of cells by 81-176 (Bacon et a l, 2000; 2002), and 
DNA sequencing of this plasmid revealed the presence of four genes which encode 
homologues of a type IV secretion system (Bacon et a l, 2002). Type IV secretion 
systems are present in many bacteria and are involved in DNA export, bacterial 
conjugation, and protein secretion (Christie & Vogel, 2000; Covacci et a l, 1999). 
None of the four genes on the pVir was found to be present in the genome of C.
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jejuni NCTC 11168 nor in a number of Campylobacter reference strains (Bacon et 
a l, 2000).
The presence of pVir genes in a subset of fresh clinical isolates (Bacon et a l, 2000) 
and the absence of this plasmid from other strains of C. jejuni, noticeably the type 
strain, NCTC 11168, suggests that there may be differences in pathogenic 
mechanisms among strains of C  jejuni. In this study, plasmid isolation and |
subsequent restriction enzyme digestion indicated that strain 81-176 possessed pVir 
and pTet, in agreement with the positive PCR results obtained for virB ll and tetO.
4.2.3.3 Cytotoxicity assay of isolates of C. jejuni possessing the virB ll and tetO 
genes i
Cytotoxicity results on Vero cells using cell-free extracts of C. jejuni isolates COLI,
C0L12, COL20, COL27, and COL30 with different distributions of the virB ll and 
tetO genes, showed that COL20 was the most active of the strains tested. This strain 
was positive for the presence of the virB ll gene (Table 3.4). Cytotoxicity result of 
strain COL30 which was toxic on Vero cells, but was negative for the presence of j
CDT showed that the cytotoxicity measured in the assay was not necessarily due to 
CDT. Some activity of COL20 may have been due to the presence of CDT. All C  
jejuni strains appear to possess the cdt genes (Eyigor et a l, 1999a; 1999b; Pickett et 
a l, 1996), but the levels of cytotoxic activities expressed were strain dependent 
(Bang et a l, 2001; Eyigor et a l, 1999b). AbuOun et a l (2005) observed that the 
majority of C. jejuni strains express detectable CDT activity, while some strains 
expressed no detectable activity. Indeed, AbuOun et a l (2005) reported the isolation 
of CDT-negative faecal C. jejuni strains from patients suffering from enteric disease
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which indicated that CDT expression was not essential for the production of human 
enteric disease.
It has been reported by some authors that there is more non-CDT cytotoxic activity 
in human isolates than in animal and avian isolates (Akhtar & Huq, 1989; Lee et a l, 
2000; Prasad et a l, 1996; Schulze et a l, 1998), although some reported no difference 
(Lindblom & Kaijser, 1995; Misawa et a l, 1995a). Nadeau et a l  (2003) reported that 
poultry isolates were generally not toxic for Vero cells or, if so, had weaker titres 
than against CHO or HeLa cells, but four of the five CHO cell cytotoxic human 
isolates were also cytotoxic for Vero cells. C0L12 was isolated from a chicken and 
other strains (COLI, COL20, COL27, and COL30) were isolated from human 
subjects, so low activity of strain COL 12 on Vero cells is in keeping with the report 
of Nadeau et a l  (2003). The present study indicated that not all C. jejuni strains 
tested produced cytotoxin (s) and that cytotoxin producers seem to be predominantly 
human strains.
There was no apparent correlation between the clinical findings on the patients from 
whom the C. jejuni isolates were obtained and the presence of cytotoxin produced by 
the isolates, which is in keeping with the reports from other researchers (Mizuno et 
a l, 1994; Moore et a l, 1988). Strain COLI was isolated from a human with 
dianhoeal illness but showed low cytotoxicity compared to COL7 which was from 
human faeces. This was also confirmed when cytotoxicity results of strains COLI, 
COL20, COL27, and COL30 were considered (Fig. 3.21). The results were markedly 
different, although all of the strains were isolated from humans with diarrhoeal 
illnesses (same manifestation). One explanation for the lack of correlation between 
the phenotype of the C. jejuni isolates and characterisation of disease is that
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'differences in host immunity factors (Blaser et a l, 1986) instead of vaifability in 
toxin production among C. jejuni isolates may be responsible for the range of 
clinical manifestations. From observations during outbreaks of food-borne 
Campylobacter enteritis due to a single strain, infected persons manifested different 
signs and symptoms (Blaser et a l, 1987) which supports the above hypothesis. 
Another possible explanation is the presence of other virulence factors produced by 
the isolates which were not detected by the assay systems utilized.
4.2.4 Cytotoxicity of cytoplasmic, IMP and OMP fractions of C, 
jejuni 81-176 and COL12
C. jejuni 81-176 was selected for characterization due to its consistency in 
production of cytotoxin in sufficient quantity to give a good cytotoxic response. As 
the source of C. jejuni 81-176 was a human subject, it would probably have been 
through several passages. Retaining the ability to produce the cytotoxin suggests that 
the cytotoxin(s) produced by C. jejuni 81-176 is stable, and this stability might 
suggest that the gene (s) which encode the cytotoxin (s) is (are) located in a stable 
area of the C. jejuni 81-176 genome.
Cytotoxicity of cytoplasmic, IMP and OMP fractions from two C. jejuni strains, 81- 
176 and COL 12, on Vero cells showed that the fractions from 81-176 were more 
active than those from the isolate C0L12. As strain 81-176 was isolated from a 
human (Korlath et a l, 1985) and COL 12 from chicken caecum (Table 2.1), results of 
cytotoxic activity of 81-176 and COLI2 on Vero cells are in agreement with the 
report of Nadeau et al. (2003). Strain 81-176, a good cytotoxin producer, and 
COLI2, a poor cytotoxin producer, were chosen to use for further experiments
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involving protein purification and proteomic analysis. Cytotoxicity of cytoplasmic, 
IMP and OMP fractions on Vero cells (Figs. 3.32, 3.33 and 3.34; Table 3.6) showed 
that most of the cytotoxic activity was in the IMP, suggesting that most cytotoxic 
activity in the cell-free extract is membrane associated.
Results of the analysis of the three fractions of COL 12 on Vero cells after incubation 
for 16h and 72h, indicated that although after 16h, little cytotoxin activity was 
apparent in the fractions, more activity was noted with increased incubation time 
(72h) (Figs. 3.32, 3.33 and 3.34). This difference in activities between 16h and 72h 
may be due to CDT. However as mentioned before, microscopic images indicated 
that COL 12 was negative for the presence of CDT, so it can be speculated that some 
strains of C. jejuni produce both cytotoxin (s) and CDT in low titre.
4.2.5 Comparison of the cytotoxicity assays used
Three cytotoxicity assay systems were utilised to determine which method (MTT, 
ATP-based and trypan blue exclusion dye assays) would be the best for monitoring 
cytotoxicity. The trypan blue exclusion assay was the cheapest and quickest to set up 
but it relied on the operator correctly distinguishing dead cells, making a significant 
degree of error possible. The MTT dye reduction assay does require a lengthy 
incubation but the results are easily and accurately read by mechanical means. The 
Cell Titer-Glo™ Assay (ATP-based assay) is faster than the MTT assay as it requires 
less prolonged incubation steps. Results obtained in this study indicated that the 
MTT assay was more sensitive than the ATP-based assay, but suffered from a 
plateau effect at higher protein concentrations, whereby 100% killing was not
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achieved. The reason for this is not clear, but may be related to residual cell death in 
controls on prolonged incubation.
4.3 Characterization of cytotoxin in this study
Reports to date have shown a confusing and complex picture of C. jejuni 
cytotoxin(s). The varied and different properties of reported cytotoxin (s) could be 
due partly to variations in the C. jejuni strains used in the assays, growth of cultures 
and the different assay systems used to detect cytotoxins (Lee et a l, 2000). As there 
has been no correlation between different research groups with regard to the 
cytotoxins detected, therefore it is not yet known whether C. jejuni produce more 
than one type of cytotoxin (Lee et a l, 2000).
Apart from CDT, other cytotoxins have been described (Guerrant et a l, 1987; 
Johnson & Lior, 1986; Kawaguchi, 1989; Mahajan & Rodgers, 1989; Mahajan & 
Rodgers, 1990) and some of them have been partially characterised (Mahajan & 
Rodgers, 1990), but little is known about the function and structure of these 
cytotoxins. Yeen et a l  (1983) first documented a cytotoxin from C. jejuni strains that 
was heat-labile, trypsin-sensitive and induced characteristic rounding of cells. Also a 
cytotoxic component which was heat-labile at 60 °C, was partially sensitive to 
trypsin (0.25%) and had a mol.wt > 14 kDa was described by Guerrant et a l (1987). 
This cytotoxic component identified by these researchers could not be neutralised 
with antisera raised against E. coli verotoxins or C. difficile toxin B (Guerrant et a l , 
1987). Moore et a l (1988) indicated the presence of a Shiga-like toxin from C. jejuni 
which could be neutralised with monoclonal antibodies directed against the B- 
subunit of the mature Shiga-toxin, although they also detected a cytotoxin which 
could not be neutralised by the same monoclonal antibody.
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Vero cells, which were used for cytotoxic activity in this study, are sensitive to 
toxins that inhibit protein synthesis due to the presence of Gb3 sphingoglycolipid on 
their surface (Obrig, 1994). Thus, the presence or absence of the Gb3 
sphingoglycolipid receptor can be used to enable differentiation of toxins that inhibit 
protein synthesis, like Shigella dysenteriae and related E. coli Shiga toxins, from 
other toxins (Obrig, 1994). The rounding of Vero cells by cell-free extracts of C. 
jejuni strains (after incubation for 16h) in the present study indicates the presence of 
a toxin that inhibits actin filament formation and suggests that the cytotoxin 
produced (detected) may be more analogous to Clostridium difficile toxins A and B 
than to the Sh. dysenteriae and E. coli Stx toxins (Lyerly et a l, 1988). Morphological 
cell changes, including cell rounding, were accompanied by cell death after 
incubation for 16h.
The sensitivity of cell-free extracts of C. jejuni 81-176 cdtB mutant to heat (60 °C 
and above for 30 min) indicated that the cytotoxic factor(s) was protein in nature and 
this is in agreement with the finding of Guerrant et al. (1987) where heating the C. 
jejuni C31 filtrates to 60 °C or above for 30 min consistently and progressively 
abolished the cytotoxicity.
4.4 Proteomics (Protein identifîcation)
One-dimentional SDS-PAGE allowed the identification of several proteins (Table 
3.7) which were preferentially present in the cell-free extract of 81-176 compared to 
that of COL12. It is of interest to note that one of these proteins Cj0559 (an 
oxidoreductase) was also identified in the 2-DE analysis of 81-176 (Table 3.8). 
Results of identified proteins from one-dimentional SDS-PAGE by MS showed that
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there was more than one protein in the identified bands (Table 3.7), therefore it was 
decided to do 2-DE to better separate the proteins. It was anticipated that 2-DE 
analysis would provide additional information on proteins preferentially expressed in 
strain 81-176, a high toxin producer and a virulent strain.
Two-dimensional electrophoresis (2-DE) is one of the most widely accepted methods 
for the separation and comparison of complex protein mixtures and has become the 
main platform for proteomic studies. 2-DE presents greater protein resolution 
potential than any other current separation technique and has recently been used to 
map large numbers of proteins from different tissues and organisms, and also to 
identify changes in protein expression.
The development of an infectious disease in the body involves complex interactions "
between the microorganism and the host. The important events during infeetion %
include entry of the bacteria, invasion and colonization of host tissues, evasion from 
host immunity and, finally, tissue injury or functional impairment of host tissues.
Some microbes, without extensive colonization of host tissues, produce disease by 
liberating toxins (Abbas & Lichtman, 2003).
In the present study, strains 81-176 (high cytotoxic human strain), 81-176 cdtB 
mutant (cytotoxic but negative for the presence of CDT), 11168 (less cytotoxic strain 
than strain 81-176 but positive for the presence of CDT) and COL 12 (less cytotoxic 
strain than other strains, also negative for the presence of CDT, isolated from 
chicken) were chosen to run on 2-DE for a comparative proteomic analysis.
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Comparison of 2-DE gels of strains 81-176 and 81-176 cdtB showed that the profiles 
of these strains were similar, as expected, and therefore that the procedure was 
reproducible.
Comparison of 2-DE gels of C. jejuni strains 81-176 and COL 12 showed that spots 
no. 16 (Cj0772c, putative periplasmic protein), 17 (Cj 1420c, hypothetical protein), 
19 (Cj0169, superoxide dismutase, Fe), 23 (Cj0414, putative oxidoreductase 
subunit), 25 (Cj0779, probable thiol peroxidase), 26 (Cj0779, probable thiol 
peroxidase), 27 (Cj0779, probable thiol peroxidase), 29 (Cj 1382c, flavodoxin), and 
30 (Cj0835c, aconitate hydratase) which were identified in the gel of strain 81-176 
did not appear in strain COLI2 (Figs 3. 45 and 3.48). Spot no. 25 (Cj0779, probable 
thiol peroxidase) in strain 81-176 did not appeal' in the gel of strain 11168. 
Fibronectin binding protein (Cj 1478c) was identified in strains 81-176 and 81-176 
cdtB mutant, but not in 11168. The results of the 2-DE gels showed that 
oxidoreductases were amongst the most frequently identified proteins in strains 81- 
176 compared to NCTC 11168. Some protein differences between 81-176 and 11168 
may be due to proteins coded by plasmid pVir or pTet in 81-176 which were not 
present in 11168. Gaynor et al. (2004) noted that the expression of several 
oxidoreductase enzymes was down-regulated under severe 0 2 -depletion.
The oxidoreductases identified in the present study may be involved in the ability of 
C. jejuni to adapt to its environment in host body, or in the ability of these bacteria to 
escape from host defences (immune response). Colonization mechanisms of C. jejuni 
in the intestinal tract are poorly understood. A model of colonization in orally- 
challenged chickens has enabled some colonization factors to be identified by using 
defined mutants; these factors include superoxide dismutase (SOD) (Purdy et a l,
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1999), flagellin (Wassenaar et ah, 1993), and GalE (Fry et al., 2000). In addition, 
signature-tagged transposon mutagenesis has identified 22 different genes involved 
in colonisation of the chicken gastrointestinal tract by strain 81-176 (Hendrixson & 
DiRita, 2004).
In an important study, gene expression and animal work data suggested that the 
ability of C. jejuni to shift its metabolism and respiration strategies to accommodate 
the lower-oxygen microaerobic and largely anaerobic environments encountered in 
the gut was likely to be very important for in vivo survival and colonization (Gaynor 
et a l, 2004). Although to respire, C. jejuni requires oxygen as a terminal electron 
acceptor, it grows poorly if at all in the concentration of oxygen present in air, and so 
is classified as microaerophilic (Hoffman et a l, 1979a; 1979b). However, it has been 
reported that some Campylobacters are able to adapt to an aerobic metabolism and so 
grow in the presence of air in a humid environment (Jones et a l, 1993).
The oxidative stress imposed upon bacteria surviving under aerobic conditions is 
significantly higher than that survived in microaerophilic conditions. C. jejuni can 
survive in diverse environments including external environments, often aerobic, and 
in vivo environments such as the intestinal tract which will be largely anaerobic. A 
number of enzymes have been suggested to provide the primary protection against 
toxicity of oxygen in bacteria, including superoxidase dismutases (SODs), 
peroxidase, catalases, glutathione reductase, and glutathione synthetase (Farr & 
Kogoma, 1991). It is suggested that oxidoreductase enzymes have two main 
protective effects against the toxicity of oxidative reactions for some bacteria:
Firstly, the reaction of an organism to oxygen in its environment depends upon the 
occurrence and distribution of different enzymes which react with O2 and various
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oxygen radicals that are constantly produced by cells in the presence of O2. All cells 
contain enzymes able to react with O2. The potential for lethal accumulation of 
superoxide in aerobes and aerotolerant anaerobes is prevented by the enzyme 
superoxide dismutase (Imlay, 2002). All organisms which can live in the presence of 
O2, contain superoxide dismutase (whether or not they use O2 in their metabolism). 
Almost all organisms contain catalase which breaks H2O2 (Bergamini et a l, 2004; 
Rocha et a l, 1996). Even certain aerotolerant bacteria such as the lactic acid bacteria 
lack catalase, they break H2O2 by means of peroxidase enzymes which derive 
electrons from NADH2 to reduce peroxide to H2O. Obligate anaerobes bacteria lack 
superoxide dismutase and catalase and/or peroxidase, and therefore when they are 
exposed to O2 undergo lethal oxidations by various oxygen radicals. Recent work has 
uncovered adaptive strategies by which obligate anaerobes seek to minimize the 
damage done by hydrogen peroxide and superoxide (Imlay, 2002; Rocha et a l, 
1996). In enteric bacteria, expression of numerous pathways is induced by exposure 
to oxidative or nitrosative stress that allow the organism to resist the toxic effects of 
these compounds during growth in the host. Among food-borne bacterial pathogens, 
C. jejuni and C. coli have the unique attribute of being microaerophilic, which 
require at least 3% oxygen for growth, but 5 to 7% is optimal (Luechtefeld et a l, 
1982). C. jejuni has a single catalase activity, encoded by the katA gene, which 
protects against oxidative stress by changing H2O2 to H2O and O2 (Grant & Park, 
1995) and a superoxide dismutase (SOD) which is important for C  jejuni survival 
and colonisation (Purdy et a l, 1999). SOD is a metalloenzyme and has been isolated 
from many prokaryotic and eukaryotic organisms (Fridovich, 1986). SOD provides 
the first line of defence against the toxic effects of reactive oxygen derivatives, by 
conversion of oxygen radicals (0 2 ~) to hydrogen peroxide and dioxygen, and as a
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al. (2004) where oxidoreductases were among the most frequently identified proteins 
in the 2-DE analysis.
Secondly, phagocytes (neutrophil and monocytes), which are the first line of cell- 
mediated innate immunity, generate reactive oxygen and reactive nitrogen 
intermediates as an intracellular killing mechanism for phagocytosed microbes. 
Therefore, the production of these agents is an important host defence mechanism 
mediated in response to infection by bacterial pathogens. It is not surprising that 
pathogens have evolved numerous defence strategies to protect themselves against 
the toxic effects of these agents. The use of specific oxygen radical scavengers and 
inhibitors, such as superoxide dismutase and catalase, as well as the myeloperoxidase 
inhibitors, are examples of these evasion strategies (Janssen et a l,  2003; Marrack & 
Kappler, 1994). One of the initial and most crucial responses to infection is the 
recruitment of leukocytes (primarily neutrophils) from the blood to the site of
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result, has a protective role against the effects of oxidative stress. If superoxide
Îradicals are not efficiently scavenged, almost all known biological molecules, 
including DNA, membrane lipids, and other essential cellular components can be
:
damaged (Carlioz & Touati, 1986; Nakayama, 1992; 1994). E. coli expresses three 
types of superoxide dismutase, whereas in C. jejuni and C. coli, SOD (Fe) is the only 
SOD which plays a critical role in defence against oxidative stress, especially when 
growth has ceased during survival (Purdy et a l, 1999). In the present study, the 
results of 2-DE gels showed the present of a high number of enzymes including 
oxidoreductases, SOD (Fe), and peroxidases which, together with catalase, were 
present in all C. jejuni isolates (Section 3.2.4) but were particularly prominent in the 
virulent strain 81-176. They may well be involved in protection against toxicity of
oxygen (Tables 3.8-3.10). These results are in keeping with the finding of Gaynor et •A
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infection (Burg & Pillinger, 2001). It has been shown that opsonized C  jejuni are 
phagocytosed by neutrophils and then attacked by the oxidative defence system 
within the phagosome. Moreover, some Campylobacter strains induced the 
extracellular release of toxic oxygen species which might contribute to the local 
inflammation due to tissue damage during infection (Walan et a l, 1992). However, 
these authors have found that different clinical isolates showed a great variability in 
this association and one strain which evoked an intracellular generation of oxygen 
intermediates also showed the highest sensitivity to killing. Therefore, it is likely that 
oxidoreductase enzymes, if they contribute to the clinical outcome of infection, may 
have two different effects. Firstly, in resistance to the extracellular reactive oxygen 
intermediates (ROl) at the site of colonization and secondly in relation to 
extracellular release of toxic oxygen species from neutrophils and monocytes. In the 
cun’ent study, the presence of oxidoreductase enzymes was observed more than other 
proteins in the 81-176 strain. However, it is not still clear if this potential can have an 
affect on the ability of C. jejuni for better colonization of the host or escape from the 
phagocyte oxidative burst defence. This may require the creation of mutants in the 
oxidoreductase enzymes and then to assess the colonisation capacities of the mutants 
in comparison to the parent strain.
In addition, intracellular existence provides bacteria with a niche to shelter from 
immune surveillance. However, internalized bacteria must be able to survive a 
variety of reactive oxygen species, particularly in the phagolysosome of professional 
phagocytes. These products are inactivated by superoxide dismutase and catalase (as 
bacterial factors) and allow invasive bacteria to persist in host cells and tissues. 
Experiments to test the effect of oxygen radicals on the survival of Salmonella 
typhimurium have been conducted (De Groote et a l, 1997). They found that a sodC
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mutant of S. typhimurium was more susceptible than the wild-type isolate to killing 
by superoxide and nitric oxide. The role of SOD in C. jejuni survival in macrophages 
has been addressed by assays performed with a C. jejuni sodB mutant of 81-176 and 
the J774A. 1 murine macrophage-like cell line. In the survival of the C. jejuni sodB 
mutant in J774A.1 cells, no difference was noted when compared to the C. jejuni 81- 
176 wild-type isolate. However, at 24 h after inoculation, a C. jejuni katA mutant (a 
gene that encodes the enzyme catalase) was not recovered from J774A.1 cells (Day 
et a l, 2000). Moreover, when the respiratory burst or production of nitric oxide was 
inhibited, the C. jejuni katA mutant was recovered. This finding indicates that C. 
jejuni is able to survive intracellulaiiy within mononuclear phagocytes by possession 
of certain virulence attributes.
The above observations suggest that additional work is required to determine 
whether the C. jejuni oxidoreductase system is able to help in avoiding killing by 
ROl and the precise role of neutrophils and monocyte/macrophages as an important 
component of the inflammatory reaction in the development of campylobacteriosis.
Another report (Holmes et a l, 2005) showed that there were differences in protein 
expression between strains of C. jejuni grown under different conditions. A 
proteomic analysis of a wild-type strain and a fur  (ferric uptake regulator) mutant of 
C. jejuni strain 11168 was done by compaiing 2-DE gels of cell protein extracts from 
bacteria grown in iron-rich and iron-limited conditions (Holmes et al, 2005). The 
results showed that 30 genes were transcribed at lower levels in the fu r  mutant than 
in the wild-type strain in iron-rich conditions. In the wild-type strain, the putative 
iron-transport genes (pl9, Cjl658, Cj0177, Cj0178 and cfrA) and all of the proposed 
iron-transport systems for haemin, feme iron and enterochelin were expressed at
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higher levels under iron limitation and, in the fur  mutant, they were expressed in 
iron-rich conditions, which suggested that they were regulated by Fur. An ABC 
transporter encoded by genes Cj 1660-1663 was depressed in the fu r  mutant, 
indicating its role in iron transport. Several genes containing a perR/Fur box 
consensus sequence, such as those encoding bacterioferritin {bfrldps, Cj 1534c), 
glutamyl-tRNA reductase {hemA, CJ0542), thioredoxin reductase {trxB, Cj0146c), 
cytochrome c peroxidase (ccp, CJ0358), superoxide dismutase {sodB, CJ0169) and 
the peroxide stress regulator perR (CJ0322) appeared to be derepressed in fur  
mutants (Holmes et al., 2005).
Taken together, the results suggest that the oxidoreductase proteins may be important 
among C. jejuni strains for adaptation and survival in different growth conditions, 
particularly growth under stress conditions. The virulence of a bacterium depends on 
its potential ability for infecting the host and the cytopathic effects that it causes, and 
also on its strategies for avoiding host defences (Abbas & Lichtman, 2003). C. jejuni 
can use these strategies to benefit its adaptation to new environments. In the current 
study, alteration of protein profiles, e.g. in binding proteins and oxidoreductases, 
may be relevant in both of the above strategies. Any change in expression of 
bacterial binding proteins may influence the adhesion of C. jejuni to the host cells, 
resulting in more or less colonization. 2-DE results (Figs. 3.45 to 3.48; Tables 3.8- 
3.10) showed that there were differences among strains 81-176, 81-176 cdtB, 11168 
and COL 12 in fibronectin binding protein (Cj 1478c, CadF) which was identified as 
spots no. 32 (Table 3.8) and 20 (Table 3.9) in strains 81-176 and 81-176 cdtB, 
respectively, but did not appear in strains 11168 and COL12. Proteomic results of 
fractions derived from DEAE sepharose column chromatography of cell-free extracts 
of strains 81-176 and COL 12 on SDS-PAGE (Table 3.7; section 3.5.1.2) showed that
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a probable ABC-type amino-acid transporter periplasmic solute-binding protein 
(PEBIA, MW 28.2 kDa) existed in the column chromatography flow-through 
fraction of strain 81-176 but was absent in the same fraction from strain COL 12. 
CadF and PEBl are the best chai'acterized C. jejuni adhesins (Konkel et a l, 1997; 
Pei et a l, 1998) which may play important roles in mediating C. jejuni binding to 
host cells. It would be of interest to compare the adhesion of strains 81-176 and 
11168 or C0L12 to mammalian cells in vitro. Four outer membrane proteins (omps) 
with apparent molecular weights of 28, 32, 36 and 42 kDa have been identified 
which in a ligand-binding assay appeard to play a role in mediating C. jejuni binding 
to host cells (De Melo & Pechere, 1990). Pei et a l (1998) suggested that PEBl, a 28 
kDa protein, mediates the binding of C. jejuni to epithelial cells. PEBl has homology 
with membrane proteins from other Gram-negative bacteria that function in amino- 
acid transporter systems. Konkel et al. (1997) cloned and partially characterized a 37 
kDa omp termed CadF from C. jejuni that mediates the adhesion of C. jejuni to 
fibronectin (Fn), a component of the extracellular matrix. It is not known if the four 
omps identified by De Melo & Pechere (1990) include PEBl and CadF. Moreover, 
our results showed that PeblA and CadF, which are implicated in the pathogenicity 
of C. jejuni, can be found in strain 81-176 (high cytotoxic strain, isolated from 
human), while they were absent in strain COLI2 (less cytotoxic strain, isolated from 
chicken).
In conclusion, although one of the aims of the proteomic study was to identify 
variation in cytotoxins amongst C. jejuni isolates, the methods used failed to detect 
such differences. This may have been due to the method of spot selection for 
identification since the staining would only reveal the most abundant components of 
the sample. It is not known exactly how many proteins are to be expected in the
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proteome of the C. jejuni cytoplasmic fraction. It has been reported that C. jejuni 
NCTC 11168 has a chromosome of 1,641,481 base pairs, which is predicted to 
encode 1,654 proteins (Parkhill et ah, 2000). However, only a proportion of the 
genes will be expressed in the cytoplasmic fraction, not all will encode proteins and 
only the reasonably abundant proteins were identified in this study. Of the large 
number of protein spots which were selected for MALDI identification, only a few of 
them were identified. Among these spots there was some interesting variation in 
proteins involved in adhesion and in the way that bacteria can escape from the host 
immune system, which is likely to have an affect on pathogenesis and clinical 
outcome. Thus, proteomic analysis by 2-DE in the present study suggests that this 
approach can be a useful tool for exploring the vaiiation in protein expression 
profiles among different strains of C. jejuni with different clinical outcomes. Overall, 
the results of this study showed that the use of 2-DE resolution of proteins and 
identification of differences by proteomic analysis can provide valuable preliminary 
data for identification of novel proteins or give insight into changes in the protein 
expression profile in relation to the alteration of bacterial virulence. However, further 
studies are needed to be performed after this stage to evaluate protein variation by 
more specific and sensitive methods. In other words, the proteomic analysis with 
MALDI using 2-DE gels can be used as an initial screening technique and followed 
by more sensitive and reliable methods such as Western blots and analysis of bands 
with MS, microarrays and mRNA analysis like that of Holmes et a l (2005). 
Together these techniques can support a better understanding of bacterial 
pathogenesis and their consistency should magnify the strength of the results.
DIGE (Difference gel electrophoresis) analysis was done for sup I fractions of strains 
81-176 and %lA16cdtB mutant (Figs 3.49 and 3.50). The CdtB subunit, the
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human peripheral blood mononuclear cells (T-cell) was compared. The results 
showed that each of the isogenic mutants exibited a reduction in the ability to induce 
T-cell apoptosis, and in each cdt mutant the ability to induce cell cycle block was 
abolished. A mutant of this strain with simultaneous deletion of ItxA and cdtABC 
genes retained ability to induce apoptosis when cell-associated, but not from a 
supernatant preparation. A neutralisation study showed that addition of E. coli anti- 
GroEL monoclonal antibody significantly diminished the apoptosis of the 
AltxAfAcdtABC cell associated preparation (Nalbant et a l, 2003). Although in our 
study GroEL was apparently down-regulated in the cdtB mutant while in the study of 
Nalbant et a l (2003) it was apparently up-regulated in a cdtAtxA deficient mutant, 
the apparent association of GroEL synthesis with Cdt production is intriguing and 
would benefit from further study.
::
difference between these two strains, was not detected by this technique which may 
be due to the possibility that the Cdt subunits are low abundance proteins, but 
proteins Cpn60 (60 kDa chaperonin) and elogation factor Tu were down regulated 4 
and 2-fold in 81-176 cdtB compared with parent strain, respectively.
Nalbant et a l (2003) reported that upregulation of GroEL-like (60 kDa chaperonin,
Cpn60) stress protein was apparent in cdt and ItxA deletion mutants of Actinobacillus 
actinomycetemcomitans. The authors constructed a series of Actinobacillus 
actinomycetemcomitans deletion mutants AcdtA, AcdtB, AcdtC, AcdtABC, AltxA 
(ItxA is the gene responsible for expression of leukotoxin, Ltx), AltxA/AcdtABC. The 
ability of the wild type and mutants to induce apoptosis and cell cycle arrest in |
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Appendix 1: Blood agar base composition (Difco)
Formula per litre:
Bacto Proteose Peptone 15 g
Liver Digest 2.5 g
Bacto Yeast Extract 5 g
Sodium Chloride 5g
Bacto Agai' 12 g
Make up to 1 litre and sterilised by autoclaving at 121 °C for 15 min
Appendix 2: Brucella Broth composition (Difco)
Formula per litre:
Bacto Tryptone 10 g
Bacto Peptamin 10 g
Bacto Dextrose 1 g
Bacto Yeast Extract 2 g
Sodium Chloride 5g
Sodium Bisulphite 0.1 g
Make up to 1 litre and sterilised by autoclaving at 121 °C for 15 min
Appendix 3: LB agar
Peptone (BDH) 10 g
Yeast extract (BDH) 5 g
Sodium Chloride (BDH) 10 g
Agar 12 g
dHzO 1000 ml
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Appendix 4: Composition of media and reagents of API CAMPY
NaCl 0.85% medium, 3 ml
AUX Medium, 7 ml
NIT 1 reagent, 5 ml
Sodium chloride 
Demineralized water
Ammonium sulphate 
Agar
Mineral base 
Amino acids 
Vitamins and nutritional 
substances
Phosphate buffer 0.04 M, 
pH 7.1
Sulphanilic acid 
Acetic acid 
H2O
8.5 g
1000 ml
2 g
1.5 g
82.8 mg 
250 mg
35.9 mg 
1000ml
0.4 g 
30 g
70 ml
NIT 2 reagent, 5 ml N,N-dimethyl-1 -naphthylamine 0.6 g
Acetic acid 30 g
H2O 70 ml
NIN reagent, 5 ml Ninhydrin
2-methoxyethanol
Vg
100 ml
FB reagent, 5 ml Fast Blue BB(> 0.1 %) 
Sodium lauryl sulphate 
Organic solvents
0.35 g
7.5 g 
100 ml
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Appendix 5: Composition of the reagent for the oxidase test
N,N,N,N-tetramethyl-l,4-phenylenediamine 10.0 g
Ascorbic Acid 2.0 g
Deionized water 1000 ml
Appendix 6: Phosphate Buffered Saline (PBS)
NaCl 10.0 g
KCl 0.75 g
KH2PO4 0.125 g
Na2HP04 1.44 g
Made up to 1 litre in distilled water
Appendix 7: Envelope Buffer (sodium phosphate)
NaH2P0 4  20 mM
Na2HP0 4  20 mM
28 ml of first is mixed with 72 ml of second and then 100 ml of dH20 is added to 
produce a 10 mM envelope buffer.
Appendix 8: Modified Lowry method reagents 
Reagent A:
NazCO] 2.0 g
NaOH 0.4 g
Sodium tartrate 0.16 g
Sodium dodecyl sulphate (SDS) 1.0 g
dHzO 100 ml
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Reagent B:
CUSO4 4 g
dHzO 10 0  ml
Reagent C:
Reagent A 100 part
Reagent B 1 part
Folin & Ciocalteu’s Phenol:
Folin- Ciocalteu Phenol reagent 1 part
dH2 0  1 part
Appendix 9: SDS-PAGE reagents 
Appendix 9.1: Separating gel
7.5 % 10 % 12.5% 15%
Aciylamide/Bis solution 2.5 ml 3.33 ml 4.16 ml 5 ml
dHzO 3.8 ml 2.97 ml 2.13 ml 1.3 ml
Tris-HCl (1 M, pH 8 ) 3.75 ml 3.75 ml 3.75 ml 3.75 ml
10 % (w/v) SDS 1 0 0  i^l 1 0 0  111 1 0 0  111 1 0 0  111
TEMED 10  111 10  |il 10  111 10 111
10 % (w/v) Ammonium persulphate (APS)
1 0 0  111 1 0 0  III 1 0 0  111 100  pi
Appendix 9.2: Stacking eel (6 %)
Acrylamide/Bis solution 157 111
dHzO 714 111
Tris-HCl (0.5 M, pH 6 .8  ) 300 111
10 % (w/v) SDS 11.9 111
TEMED 1.18 111
10 % (w/v) Ammonium persulphate (APS) 6  111
i,C
2 0 0
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Appendix 9.3; Protein sample buffer
Glycerol 5 ml
20% (w/v) SDS 2.5 ml
2-mercaptoethanol 0.5 ml
Tris (0.5M, pH 6.8) 2.5 ml
Bromophenol blue 0.25 % (w/v)
Appendix 9.4; Electrode buffer (lOx)
Tris base 30 g
Glycine 144 g
SDS 10 g
Made up to 1 litre in distilled water, pH to 8.3
4-Appendix 9.5: Coomassie blue stain solution
Methanol 400 ml
Acetic acid 100 ml
Distilled water 500 ml
Coomassie blue 0.1% (1 g)
Appendix 9.6: destain solution for SDS-PAGE
Methanol 400 ml
Acetic acid 100 ml
Distilled water 500 ml
Appendix 10: Trypan blue solution
Trypan blue 0.2 g
NaCl 4.25 g
Each component was dissolved individually in 100 ml dH20, then 4 parts of trypan 
blue solution was mixed with 1 part saline.
2 0 1
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Appendix 11: Rehydration solution
Urea 8 M
CHAPS (w/v) 0.5%
DTT (Dithiothreitol) (w/v) 0.2%
IPG Buffer or pharmaly te 0.5%
Bromophenol blue 0.002%
Appendix 12: SDS equilibration buffer (stock solution, store at -20 
°C)
Tris-HCl, pH 8.8 10.0 ml
Urea 72.07 g
Glycerol 69 ml
SDS 4.0 g
Bromophenol blue 400 pi of 1% (w/v) solution
Double distilled H2O to 200 ml
Appendix 13: 6x DNA loading buffer
Tris 60 mM
EDTA 6 mM
Sucrose 40 % (w/v)
Bromophenol blue 0.25 % (w/v)
Appendix 14: TBE buffer (5x)
Tris-Base 54 g
Boric Acid 27.5 g
EDTA (0.5 M) 20 ml
dHzO 980 ml
2 0 2
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Appendix 15: Buffers for QIAGEN® Large-Construct Kit
Buffer PI (Resuspension Buffer)
Buffer P2 (Lysis Buffer)
Buffer P3 (Neutralization Buffer)
Buffer QBT (Equilibration Buffer)
Buffer QC (Wash Buffer)
Buffer QF (Elution Buffer)
Exonuclease Solvent
TE
50 mM Tris.Cl, pH 8.0;
10 mM EDTA;
100 pg/ml RNase A
200 mM NaOH, 1% SDS
3.0 M potassium acetate, pH 5.5
750 mM NaCl;
50 mM MOPS, pH 7.0;
15% isopropanol;
0.15% Triton®, X-100
1.0 M NaCl;
50 mM MOPS, PH 7.0;
15% isopropanol
1.25 M NaCl;
50 mM Tris.Cl, pH 8.5;
15% isopropanol
20 mM KCl;
20 mM KPO4, pH 7.5
10 mM Tris.Cl, pH 8.0;
1 mM EDTA
1
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Appendix 16: Maldi mass spectrometry of spot 19 (superoxide 
dismutase, Fe) from 2-DE gel of supl of C jejuni 81-176
A- Raw maldi spectrum Voyager DE pro positive reflectron mode with delayed 
extraction. 600 transients were accumulated from m/z 800 -  3500 and internal 
calibration on trypsin autoloysis peaks was performed.
f!
1680.8759 
15SB7532
I! 28 7484 2212,07871070 5196 
1105.3436
141536 Ï 1 58 8417 2240.0919 2431 1 8 2 1 ^ 5 3 0 2  2747 1926 2925 2093 3113 4098 3324 24742000 7325«MwA
Mass (m.z|
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Appendix 16: (continued)
B- Maldi spectrum was deisotoped and truncated to exclude complex regions 
between m/z 800 and 1000 and Peak detection threshold was set at 5%. Peak masses 
were entered into the Mascot search engine (Matrix Science Ltd) against the C. jejuni 
database subset o f  NCBL
I5S6 7S2S 
15 B 7480
JWJLLL J l l l l l  IiST T3U
M a s  (m/z)
zm
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Appendix 17: Mascot pmf search results of spot 19 (superoxide 
dismutase, Fe) from 2-DE gel of supl of C jejuni 81-176
{ s c œ n c e }  Mascot Search Results
Umt : MaliAlGE^potU
■CBIbt IH9M11 (29I93I9 megwmcem; M9UMM residues)
Ca«]^alMcter )e)smi (2411 seqsemces)
21 J n  29I9 at 19:19:92 OtT
103 for g l | 51237176, si*ero%lde dissmtase, Fe [Cesgylobacter jejaa i BM1221]
Search t i t l e  
Database TaxoBOBv 
Tiaestas*
Top Score
Probability Based Mowse Score
Iona fcora if -lO^Logt^ where P if the probebihty that the obf erred match if a random event 
Protein ecoree greater than 46 are eigpi&caot ^ >Oi)5).
Hi
X%
0
25 50 75 100Probability Baaed Mowse Score
Concise Protein Summaiy Report
Format As I Concise Protein Summary jg | Help
Significance threshold p< |0 05 M ar number of hita |20
RerSeych All j Seai^  Unm&hed  ^ ^
a i l 57237176 Mass: 25025 Score: 103 Ibq^ect: 1.2e-07 Qeeries matched: 7
superoxide dismutase, Fe [Campylobacter jejuni BH1221]
gi 1531402 Mass: 25016 Score: 78 Erqyect: 4 .3e-05 Qmerles matched: 5
superoxide dismutase [Campylobacter jejuni]
gi157238699 Maes: 19575 Score: 25 Erq e^ct: 8 .4 Qmerles matched: 2
rlbosomal protein L6 [Campylobacter jejuni BH1221]
a l l 6967628 Mass: 32766 Score: 24 Ergect: 9.6 Qmerles matched: 2
homoserine kinase [Campylobacter jejuni subsp. jejuni SCTC 11168]
a l l 6968234 Mass: 19426 Score: 23 Brq e^ct: 12 Qmerles matched: 2
hypothetical protein Cj0788 [Campylobacter jejuni subsp. jejuni NCTC 11168]
a l l 6968206 Mass: 39350 Score: 19 Eiq^ect: 29 Qmerles matched: 2
hypothetical protein Cj0760 [Caiq)ylobacter jejuni subsp. jejuni NCTC 11168]
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